¥xÆW¥¼¤W¥«ªÑ²¼ °]¸gºô 

¥¼¤W¥«  

¥¼¤W¥«ªÑ²¼¦æ±¡,¿³ÂdªÑ²¼¶R½æ,¥¼¤W¥«ÂdªÑ²¼¬d¸ß,§Ö³t´x´¤¥¼¤W¥«ªÑ²¼¶R½æ¯ß°Ê

Åwªï¨Ó¨ì¥²´Iºô ¤â¾÷ª© ¥[¤J·|­û µn¤J ­º­¶
¥¼¤W¥«ÂdªÑ²¼¦æ±¡¬d¸ß,¥¼¤W¥«ªÑ²¼¶R½æ¹L¤á,¿³ÂdªÑ²¼¦æ±¡¬d¸ß¡ã§K¥I¶O±M½u¡G0800-035-178
°Q½×°Ï>¤ß®®¥ÍÂå
Åý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O     µoªí·s¸ÜÃD ¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2017/8/21 ¤U¤È 05:20:28
§N¼ö´`Àô , ¬O¥|©uªº¥²µM

º¦¶^¥æ´À , ¬OªÑ¥«ªº°¸µM

¶}³o­Óª©¤D¦³·P©ó

Cliff¤j®¦¼w¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡zªº±M·~½×­z

Åý¤p§Ìµo¨¥®É , ²`©È·\¹ï¤j®aªºµ§°O

¤]©È§j½K¤@´ò¬K¤ô , ¯}Ãa¤j®aªY½à±M·~ªº¬ü·P

©Ò¥H , ³o­Óª©

¤£¥u 543 ¥i¥H½Í 1234567890abcdef ¤]Åwªï

§Æ±æ¼ö¾x¬O­ì«h

¥»ª©¬O¦h¨¥°ó ¦h¤è¬Ý¨Æ ¦h±¡¹ï«Ý

¬ß±æ

¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡z¬O§Ú­Ìªº¦@¦Pµ§°O

¡yÅý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O¡z«h¬OÄÝ©ó¤j®aªº¦@¦P¤é°O

´Á«Ý±zªº°Ñ»P

ÁÂÁ¤j®a!

·|­û¡G¤p­·10148067  µoªí®É¶¡:2021/12/1 ¤U¤È 05:12:58²Ä 1832 ½g¦^À³
³Ì¦n¬OÀ£½L°Õ¡I®Mªº°÷¤[ªº¤H³£ª¾¹D¡A¤ß®®ªº·s»D§¹¥þµLªk¤ÏÀ³¦bªÑ»ù¤W¡A®É¶¡¨ì¤F§A·|ª¾¹D¤£·|¦³¤°»ò´Á¤¤¤ÀªRµ²ªG¡A¤]¥i¯à¨S¦³¤°»ò¤T´Á¡A¥u·|ÀR®¨®¨ªº¦n¹³¨S³o¤@¦^¨Æ¤@¼Ë¡I¤ß²Ö⋯
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/12/1 ¤U¤È 03:15:00²Ä 1831 ½g¦^À³
¨S³o»ò°¶¤j¨ì·|¦³¦³¤ß¤H·QÀ£½L,³£¤w¸gÀ£¦h¤Ö¦~¤F,¥¦­Ì¥u¬O·Qsay byebye :(
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/12/1 ¤U¤È 03:08:20²Ä 1830 ½g¦^À³
¦³¥X¤@¨Ç¶q¤F¡A·Pı¥i¯à­n°Ê¤F¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤¸´¼9110137200  µoªí®É¶¡:2021/12/1 ¤U¤È 12:36:36²Ä 1829 ½g¦^À³
³o°}¤l¤H¬°À£½L©úÅã¡A¤×¨ä¤µ¤é¡A¦³¤ß¤H³ýĪ¸Ì½æ¤°»òÃÄ¡AÄ~Äò¬Ý¤U¥h¡I
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/12/1 ¤W¤È 11:10:12²Ä 1828 ½g¦^À³
Àq¨FªF·s«a¯S®ÄÃij̲׼ƾڧC©ó¹w¦ô , ½÷·ç¨M©w´£°ªPaxlovid²£¯à

¨Ó·½¡G¡@2021-11-30

½sĶ丨§õ´ö©i

med.sina.com/article_detail_100_2_109314.html

½÷·ç­º®u°õ¦æ©xAlbert Bourla¦b¥»¶g¤@±µ¨ü¬ü°êCNBC¹qµø¥x±Ä³X®Éªí¥Ü¡A½÷·ç²{¦b¹w­p¨ì2022¦~©³±N¥Í²£8000¸UÀøµ{ªºCOVIDÃĪ«Paxlovid¡C

µM¦Ó¡A³o¤@¤Á¹w´Áªº«e´£¬O½÷·çPaxlovidªºÀø®Ä¼Æ¾Ú¬O¯u¹ê¥i¾aªº¡C... °ê»ÚÅv«ÂÂå¾ÇÂø»xBMJ¥Zµnªº¬ã¨sÅã¥Ü¡A«ö·ÓÄY®æ¼Ð·Ç­pºâ¡A½÷·ç©MModerna·s«a¬Ì­]ªº¹ê»Ú¦³®Ä²v¥i¯à¥u¦³19%~29%¡A»·§C©ó¬ü°êÃĺʧ½³]©wªº50%³Ì§C¼Ð·Ç¡C...³o©Î³\¤]¸ÑÄÀ¤FÀHµÛ¬Ì±¡¬I¥´²v´£°ª¡A°ê¥~¬Ì±¡«o¤@ª½¨S¦³±o¨ì¦³®Ä±±¨îªº­ì¦]¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/26 ¤W¤È 08:29:05²Ä 1827 ½g¦^À³
www.genetinfo.com/international-news/item/54120.html

¨S­¹¤l»Ä¹ï TNBS »¤¾Éªº¤j¹«¼ìºÅ©Êµ²¸zª¢ªº«OÅ@§@¥Î¡Gª¢¯g°Ñ¼Æªº§@¥Î

www.jimc.ir/article_66219.html

­I´º¡G

¼ìºÅ©Êµ²¸zª¢ (UC) ¬O¤@ºØª¢¯g©Ê¸z¯f (IBD)¡A¥i¾É­P®ø¤Æ¹Dªø´Áª¢¯g©M¼ìºÅ¡C¥Ø«eªº¬ã¨s¦®¦bµû¦ô¨S­¹¤l»Ä¹ï 2,4,6-¤Tµv°ò­fÁD»Ä (TNBS) »¤¾Éªº¤j¹« UC ªº«OÅ@§@¥Î¡C

¥Ñ¨ä¥L¤åÄm¨Ó¬Ý

TA ©M GA ¦ü¥G³£¥i¥HªvÀø¼~Æ{©MµJ¼{

³o¥i¥HÂùºÞ»ô¤U¨ÓªvÀø IBD ©M¨ä¤Þµoªº¼~Æ{©MµJ¼{¶Ü ?

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¤èªk¡G

42¥u¦¨¦~Wistar¤j¹«¤À¬°7²Õ¡]n=7¡^¡A6²Õ±Ä¥ÎTNBS·»²G»¤¾ÉUC¡C¥L­Ì¨C¤Ñ±µ¨ü¤£¦P¾¯¶qªº¨S­¹¤l»Ä¡]25¡B50¡B75 ©M 100²@§J/¤½¤ç/¤Ñ¡A¤fªA¡^¡C¦b²Ä 11 ¤Ñ¡A¨ú¥Xµ²¸z²Õ´¨ÃÀˬd§»Æ[©M²Õ´¯f²z¾Ç¯fÅÜ¡C¦¹¥~¡A¦bµ²¸z¤Ã¼ß¤¤´ú¶q¯e¯f¬¡°Ê«ü¼Æ¡]DAI¡^©MÅè¹L®ñ¤Æª«酶¡]MPO¡^¬¡©Ê¡C

µ²ªG¡G

»P¹ï·Ó²Õ¬Û¤ñ¡A¥Î³oºØ¤ÑµMÃĪ«¹w³B²z¥iÅãµÛ­°§C UC ¤j¹«µ²¸zªº§»Æ[µû¤À¡C¨S­¹¤l»Ä¤]ÅãµÛ­°§C¤F DAI¡C²Õ´¯f²z¾Çµo²{ÃÒ¹ê¤F¨S­¹¤l»Ä¹ïUC°Êª«¼Ò«¬ªº¦³¯q§@¥Î¡C¨S­¹¤l»Ä»¤¾Éª¢¯g¤¶½è¦p MPO ¤ô¥­ªºÅãµÛ­°§C¡C

µ²½×¡G

¦b°Êª«¼Ò«¬¤¤¥i¥H±o¥X¨S­¹¤l»Ä¥i¥H§@¬°ªvÀøUCªº¦³®ÄÃĪ«ªºµ²½×¡A¦ýÁٻݭn³q¹L¤HÅé¼Ò«¬ªºÅçÃÒ¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/24 ¤U¤È 02:36:49²Ä 1826 ½g¦^À³
²q·Q¤j¡AÁÂÁ±zªº¤ÀªR¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/24 ¤U¤È 12:37:17²Ä 1825 ½g¦^À³
¦n©_¤j

»¡¨ìªÑ»ù¤Ó±Ó·P¤F ! ¤p§Ì¶È¯à¦A±j½Õ³o¥u¬O¤@­Ó¹Ú·Q , ©Î³\¤]¬O¹ï¤ß®®ªº¤@ºØ´Á³\

¤£¹L , §Ú­Ì¤]¥i¥H¨Ó¦ô¦ô¬Ý

­Y§Ú­Ì¥Î EPS = 50 ¨Ó±À¦ô³Q±ÂÅv¤è¥i¯à¥²¶·ªºÀ禬

¤ß®®¥Ø«eªÑ¥»¬ù 12 »õ

§Ú­Ì¥H 12»õ ¡B15»õ ©M 20»õªºªÑ¥» , ÁÙ¦³Åv§Qª÷²v¬° 15%¡B 20% ¡B30%¨Ó¤À§O±Àºâ

·íªÑ¥»20 »õ : EPS = 50 ´N¬O­nÁÈ 100 »õ

Åv§Qª÷²v¬° 15% === > 100 / 0.15 / 28 = 23.81 »õ¬ü¤¸

Åv§Qª÷²v¬° 20% === > 100 / 0.20 / 28 = 17.86 »õ¬ü¤¸

Åv§Qª÷²v¬° 30% === > 100 / 0.30 / 28 = 11.91 »õ¬ü¤¸

·íªÑ¥»15 »õ : EPS = 50 ´N¬O­nÁÈ 75 »õ

Åv§Qª÷²v¬° 15% === > 75 / 0.15 / 28 = 17.86 »õ¬ü¤¸

Åv§Qª÷²v¬° 20% === > 75 / 0.20 / 28 = 13.39 »õ¬ü¤¸

Åv§Qª÷²v¬° 30% === > 75 / 0.30 / 28 = 8.93 »õ¬ü¤¸

·íªÑ¥»12 »õ : EPS = 50 ´N¬O­nÁÈ 60 »õ

Åv§Qª÷²v¬° 15% === > 60 / 0.15 / 28 = 14.29 »õ¬ü¤¸

Åv§Qª÷²v¬° 20% === > 60 / 0.20 / 28 = 10.72 »õ¬ü¤¸

Åv§Qª÷²v¬° 30% === > 60 / 0.30 / 28 = 7.15 »õ¬ü¤¸

­Y SND-13 ¦¨¥\ , ¦³¥i¯à¹F¦¨¶Ü ?

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/24 ¤W¤È 08:52:51²Ä 1824 ½g¦^À³
500§Ú³£À~¨ì°{§¿¤F¡A1000§Ú¤£´NÃz¦åºÞ¡A·PÁ²q·Q¤jªº¹Ú·Q¹w´ú¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/24 ¤W¤È 08:11:17²Ä 1823 ½g¦^À³
­è­è¤WÆ[´ú¯¸¬d¸ß

ÁöµM¨S¦³¬d¨ì¤ß®®ªº­«°T , ¦ý¬Ý¨ì¥Í§Þ¤Í¤½¥q©Òµoªº­«°T

¸Ó¤½¥qªvÀøCOVID-19­«¦M¯f±w«æ©Ê©I§lµ~­¢¯g­Ô¸s¡]ARDS¡^ªº MMP-12 §í¨î¾¯ , ¨ú±o¥¿­±·N¨£¡A¸ÕÅç±NÄ~Äò¶i¦æ

ª½Ä±

³o¨Ç¾Ç¦³±Mºëªº¦ÑÁó­Ì , ¦b¯e¯f¯f²z¾÷¨î©M¦Û®a¤½¥qÃĪ«ÃIJzªº¾Ç²z§PÂ_

°£¤F±M·~¥~ , ¨ÌµMÁÙ¬O±M·~

§Ú­Ì´Á«Ý¦³¬Û¦P­I´ºªº½²±Ð±Â¤]¯à±a»â¤ß®®ªºÃĪ«¨«¥X¤@¤ù¤Ñ

¤ß®®¥[ªo !

¥xÆW¥Í§Þ¥[ªo !

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/23 ¤U¤È 07:17:51²Ä 1822 ½g¦^À³
¤å¦r¨ÌµM¦uÅ@µÛ¥¦ªº­ì·N

¤H­Ì«o¬O¤ß·QµÛ¥¦ªºÁô³ë

´N¦p¦P¤½¥q·s»D½Zªº¥Î»y

final portion µw­n¬Ý¦¨ finals ?

significant °¾­n¸ò significant level (£\) ·Q¦b¤@°_ ?

©Ò¥H

³ÌÃø±±¨îªº , À³¸Ó¬O¦Û¤vªº¤ß¤F

¤@¤U¦b¬ü°ê , ¤@¤U¦b¼Ú¬w

¤@¤U¹Ú·QµÛ¤ß®®ªºªÑ»ù , ¤W¦^¦b500 , ³o¦^¦b1,000

¤£¹L , ²{¦b³Ì¹ê¦bªºÁÙ¬O

±q²{¦b°_ , ¨C¤Ñ¦­¤W°_§Éµ¥µÛ­«¤j°T®§

´Á«ÝSNB011©MSND-13Á{§Éµ²ªGªº­«¤j°T®§¤@¦p©Ò·Q

Åý§Æ±æ¹ê²{¡B¹Ú·Q¦¨¯u

¥h¦~Takeda»PNeurocrine Biosciences ¹F¦¨ 20»õ¬ü¤¸ªººë¯«¯e¯fÃĪ«¦X§@

²{¤µNeurocrine Biosciences ©M Sosei Heptares ¤S«Å¥¬¥H 26 »õ¬ü¤¸¦X§@¶}µo¥Î©óºë¯«¤Àµõ¯g©M¨ä¥L¯«¸gºë¯«¯e¯fªº·s«¬¬r¿¸ÆP¨üÅé¿E°Ê¾¯

¨º°²¦p SND-13¤T´Á¦¨¥\ , ¤S·|­È¦h¤Ö ?

«¢ ! ½Ð¤j®a¤£­n¯º¤pªº·ö

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/23 ¤U¤È 06:37:45²Ä 1821 ½g¦^À³
Neurocrine Biosciences ©M Sosei Heptares «Å¥¬¦X§@¶}µo¥Î©óºë¯«¤Àµõ¯g©M¨ä¥L¯«¸gºë¯«¯e¯fªº·s«¬¬r¿¸ÆP¨üÅé¿E°Ê¾¯

www.prnewswire.com/news-releases/neurocrine-biosciences-and-sosei-heptares-announce-collaboration-to-develop-novel-muscarinic-receptor-agonists-for-schizophrenia-and-other-neuropsychiatric-disorders-301429718.html

Neurocrine Biosciences ¹w­p±N¦b 2022 ¦~±Ò°Ê¤@¶µ°w¹ïºë¯«¤Àµõ¯gªº¿ï¾Ü©Ê M4 ¿E°Ê¾¯ HTL-0016878 ªº²Ä¤G¶¥¬q¬ã¨s¡A¨Ã¦b 2023 ¦~±Ò°Ê¤@¶µ°w¹ïÂù M1/M4 ©M¿ï¾Ü©Ê M1 ¿E°Ê¾¯ªº²Ä¤@¶¥¬q¬ã¨s

Sosei Heptares Àò±o 1 »õ¬ü¤¸ªº«e´Á¬ãµo¸êª÷¡A¥H¤Î°ª¹F 26 »õ¬ü¤¸ªº¼ç¦b¶}µo¡BºÊºÞ©M°Ó·~¨½µ{¸O¥I´Ú¡A¥H¤Î¤À¼h¾P°â¯S³\Åv¨Ï¥Î¶O

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/22 ¤W¤È 08:20:23²Ä 1820 ½g¦^À³
²Ä¤@«h¬O§Ú­Ì¤§«e½Í¹Lªº«¢¦òÂå¾Ç°|±Ð±Â½èºÃ molnupiravir °Æ§@¥Îªº°ÝÃD

www.genetinfo.com/international-news/item/54169.html

www.genetinfo.com/international-news/item/54144.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/18 ¤U¤È 01:28:01²Ä 1819 ½g¦^À³
ù¤ó²×¤îCOVID-19¤fªA§Ü¯f¬rÃĪ«AT-527¶}µo

¨Ó·½¡G¡@2021-11-18

med.sina.com/article_detail_100_2_108748.html

¼Æ¤Q»õ¤H·P¬V¨Ã²×¨­Äâ±a¬ã¨sµo²{¥¦·|§T«ù¥¿±`³J¥Õ¶i¦æ¶Ç¼½¡I

¨Ó·½¡G ¾Ç³N¸g½n¡@2021-11-18

med.sina.com/article_detail_103_1_108746.html

·s«aÁÙ¨Sµ²§ô¥þ·sªº¡§½Þ¶Ç¤H¡¨«aª¬¯f¬r¤S¨Ó¤F

¨Ó·½¡G ¾Ç³N¸g½n¡@2021-11-18

med.sina.com/article_detail_103_1_108745.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/7 ¤U¤È 09:48:11²Ä 1818 ½g¦^À³
¥´BNT«áª`·N2¤j¯gª¬ ÂåÃn³oÁ|°Ê¬Oª±©R¦æ¬°

21:16 2021/11/07 ¤¤®É·s»Dºô ±L¿ð¨Ø¥É ¡B¤¤®É¡B ù¥Ã»Ê

www.chinatimes.com/realtimenews/20211107003201-260405?ctrack=pc_main_headl_p01&chdtv

«JÄÁ³ù»¡´£¿ô¡A¥´BNT«Ü®e©ö¦³¤ßŦ¤£¾A¡A«Ü¦³¥i¯à¬O¤ß¦Ùª¢¡A­Yı±o¥´§¹¬Ì­]«á¦³¤ß¸õ¥[³t¡B¯Ý¤f´eµ¥2¤j¯gª¬¡A¤@©w­n¦h¥ð®§¡A¦Ü¤Ö¥ð®§¨â©P¬O¤ñ¸û¦w¥þªº¡A¨Ã¥B­n¦h³Ü¤ô¡BºÎ¯v¥R¨¬¡A¤d¸U¤£­n¤@®É½Ä°Ê´N¶]¥h¹B°Ê¡A¤@¥¹¦³¼@¯P¤£¾A·P¡A¤@©w­n¨ì«æ¶E°µ¤ß¦Ù»Ã¯Àµ¥¬ÛÃöÀˬd¡C

±j½Õ¥´§¹¬Ì­]«á¤@©w­nª`·N¨â¤j¯gª¬¡A¥Ø«e¤ß¦Ùª¢¥u¦³¤ä«ù©ÊÀøªk¡A¦]¦¹¹w¨¾³Ó©óªvÀø¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2021/11/7 ¤W¤È 11:55:21²Ä 1817 ½g¦^À³
¦U¦ì¤ß®®ªºªB¤Í¦n,

¬Ý¨ì¦n©_¤jªºµo¨¥¡A­Ó¤H¤]¬O¤º¤ß·P´n¸U¤d¡A

§Ú¤]¬O¥v¤j¹q¤l³øªº©¾¹êŪªÌ¡A¤]¤@¸ô±q¯E¹©°µ¬°²Ä¤@ÀÉ«ù¦³¥Í§Þ·sÃĪѡA¤@¸ô§ë¸ê·sÃĪѡA

¹L¥h³Ì°ª§ë¦b¯E¹©ªº¸êª÷¹F8¦ì¼Æ¡A«á¨ÓºG­«ªº·l¥¢´N¤£¦h»¡¤F¡A

ÁöµM§ë¸ê¯E¹©Á«·l¡A§ë¸ê¤ß®®¤]®M¨c¡A¦ý§Ú¤£©Ç¥ô¦ó¤H¡A

¨Ã¨S¤H®³ºj©èµÛ§Ú§ë­n§Ú§ë¸ê·sÃĤ½¥q¡A§ë¸ê§¹¥þ¬O­Ó¤H¨Mµ¦¡A

¥v¤j­Ó¤H¬ã¨sÄ@·NµLÀv¤À¨É¡A§Ú¤º¤ß¬O«Ü·P¿Eªº¡A

ª½¨ì²{¦b¡A§Ú¤]¬O¤T¤£¤­®É¥´¥h¤½¥q©M¥v¤jÁA¸Ñ¤½¥q¶i«×¡C

¨¥Âk¥¿¶Ç¡A³o´X¦~§ë¸ê·sÃĪѪº¤ß±o¬O­Y­n§ë¸ê·sÃĪѡA¥²¶·©êµÛ¦Û¤v¬O¤Ñ¨Ï§ë¸ê¤Hªº¤ßºA¡A

§ë¤Jªº¸êª÷¥²¶·¬O§Y¨ÏÂk¹s¤]¤£·|Åý¦Û¤v¨ü¨ì¼vÅTªºÃB«×¡A

·sÃĤ£¬O¥¢±Ñ´N¬O¦¨¥\¡A¥¢±Ñ¾÷²v·¥¤j¡A¤d¸U¤£¯à©êµÛ¾a·sÃħë¸ê­P´Iªº·Qªk¡A

±q¯E¹©¤§«á¡A§Ú§â¸êª÷®¿¦^¦Û¤v¼ô±xªº²£·~¡A¾a§ë¸ê¼ô±x²£·~ªºÀò§Q¦A§ë¤J·sÃĪѡA

§Y¨Ï·sÃħë¸ê¤£¦p¹w´Á¡A§Ú¤]¯à©ê«ù¥­±`¤ß¡A¦]¬°¨ä¥L§ë¸êÁÙ¬O¥i¥HÅý¸ê²£Ã­©w¼Wªø¡A

¦ý¦^¨ì¤ß®®¥»¨­¡AÁÙ¬O§Æ±æ¤ß®®¯uªº­n¥[§â«l¡A¥Ø«eÁ{§É¶i«×¤Ï¦Ó¤ñÀù¯gÃĪ«ÁÙºC¡A¹ê¦b¤£¥i«äijªººC!!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªN­ô10148223  µoªí®É¶¡:2021/11/6 ¤W¤È 11:03:24²Ä 1816 ½g¦^À³
¥»¤p§Ì¤]¬O­Ó¤ß®®§ë¸ê¤H¡A·íµM§Ú¤]¬O¤@¦ì®M¨cªÌ

¤]¨ÓÁ¿Á¿§Ú¹ï¤½¥qªº¤@¨Ç·N¨£¡G

1.´N§Úª¾¹Dªº¥Ø«eSND-13Á{§É¦¬®×ªº¦ì§}À³¸Ó¦³¤£¤U¤Q­Ó¥i¯à¬Æ¦Ü¦³§Ö¤G¤Q­Ó¡A¤§©Ò¥HªÑªF­Ì·|¤£­@·Ð·íµM¬O¦]¬°¦¬®×¯uªº¤ÓºC¡A¬O¶}ªº±ø¥ó¤£°÷¡HÁÙ¬O®Ú¥»´N¨S¦³¶}±ø¥ó¡H

·íµM¤½¥q¦³§V¤O¶Ò¸ê³o¤j®a·íµM³£¦³¬Ý¨ì¡A¶Ò¸ê¤]«Ü¦p´Á§¹¦¨¡A¤]¬Ý¨ì¤½¥q¦³¦b§ïÅÜ¡I¦ý¿ú¦³¤@¤Ñ¤@©w¤]·|¿N§¹¡A¦p¦ó¦b¿ú¥Î§¹¤§«e§¹¦¨¤ÀªR¤Î°ê»Ú½Í§P¬O¥Ø«e¸Ó¤½¥q­n«Ü§V¤Oªº¤@­Ó½ÒÃD¡A¤£¯à¦h»¡¤°»ò¡A¥u¯à´Á¬ß¤½¥q¦h¦h¥[ªo¡I

2.Ãö©óSNB011 ¡G

³o­Ó¯uªºÆZ¤£À³¸Óªº¡A­ì¥»»â¥ýªº¦a¦ì²{¦bÅܦ¨¤j¸¨«á¡A¬O¦Ò¼{±M§Qªº§G§½¡H¤S©ÎªÌ¹ï¦Û®aÃĪ««D±`¦³«H¤ß¡H¬Ý¨ì¤@¶¡¶¡¤£ºÞ°ê¤º¥~ªº¥Í§Þ¤½¥q¶i«×¤@ª½°l»°¬Æ¦Ü¶W¶V¡A«Ü¾á¤ß³o·|¤£·|Åܦ¨¤@³õªÅ¡H±N¨ÓÁÙ­n¬ãµoSNB012....¬Æ¦Ü...¡H45¤H¥i¥H´Á¤¤¤ÀªR¡Aªá¤F¤j¥b¦~ÁÙ¨S§ä§¹¦¨¡A¤½¥qÀ³¸Ó·í¦¨°¨©ÔªQ¦b¶]¡A¤è¦V¬O¹ï¤F¡A¦ý¨ä¥L¿ï¤â³£¶]¦b«e­±¡A¤ß®®«h¬OºCºC±y«vªº¶]¡A¬Ý¨ì¦p¦¹ªº¦¬®×³t«×¡A¤£­n¨D²Ä¤@¡]¤]¤£¥i¯à²Ä¤@¡^¡A¥u¨D¯à¶]¨ì²×ÂI¤F¡I

»{¬°¤½¥qÀ³¸Ó¦hµoÂI·s»D½Z¨Ó¼W¥[Ãn¥úªº¾÷²v¡AÅý¥@¬É¦h¦hª¾¹D¡A¤~¤£·|Åý¤@ª½¥H¨Ó·Å§]ªº¤ß®®³£¨S¤Hª¾¹D¡I

¥t¥~¡A¦b¤UÁÙ¬O«Ü»{¦P¥v¤jªº¬ÛÃö¬ã¨s¸gÅç¤Î¤ÀªR¯à¤O¡A§Æ±æ¦³¤@¤Ñ¤ß®®µo¥úµo¼ö¤j®a¯à°O±o¥L¡I

¦Ü©óªÑ»ù¡A­ü¡Aºâ¤F§a¡I¦Aµ¥µ¥¬Ý§a¡I

¥H¤W¦p¦³¤£¹ï¤§³B¡A·Ð½Ð«ü¥¿ ¤]ÁÂÁ¤j®a¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/11/5 ¤U¤È 04:45:43²Ä 1815 ½g¦^À³
«x? ¥v¤j¤É©x¤F¶Ü? «ç»ò¦³ºØ¦í®üÃäºÞ«Ü¤jªº¬Jµø·P? ³Ì¦n¬O¤@­Óµo¨¥¤H¦³¯à­@ºÞ¨ìÁ{§Éªº¶i«×, ¦¬®×ªº³t«×.....!? ³o´É¼Ó»\±oÅý¦b¤U¦³ºØ¤½¿ËÅܨƥDªº¶Ø¹Ä, §Ô¤£¦í¯B¥X¤ô­±¸H©À´X¥y

ª©¤Wªº¦Ñ«e½ú¤@©w¹ï¦b¤UªºÆ[ÂI¤£­¯¥Í, ¬Ý¨ì³Ìªñªº´ºªp¥[¤WªÑªFªº¤ß±¡¯uªº¤£±o¤£§â³o¦ê»q¸}¥¬¦A½¥X¨Ó!

¬Oªº!! ªÑ»ùªº§C°g¨S¦³§Oªº­ì¦], ¤£¥Î¦A²o©ì¤jÀô¹Ò, ¶Ò¸ê, ¬Ì±¡...... , ®ö¼é°h¥h½Ö¨S¬ï¿Ç¤l¤@²M¤G·¡!

®Ú¥»­ì¦]´N¬O¸Û¦pKingko¤jªº©Ò¨¥¦p¾ðÃi½½¤û¯ëªº¦¬®×³t«×!

¦³¨ÇªÑªF²±Æg¤ß®®ªº¬ì¾Ç¬ã¨s, ¾K¤ß©ó±Ð±Âªº°ªÂ¤»·Æf, ³o¨Ç§Ú³£»{¦P, ¦ý¬O²{¹ê´N¬O²{¹ê! ½Ð°Ý±q¥v¤j¥[¤J¤ß®®¤§«á¶Ò¤F¦h¤Ö¿ú?¤j®a­n¤£­nºâ¤@ºâ?

¬Û¸û¤½¥qªº¶i«×, §Oªº¤£»¡, §Ú´N½Ð°ÝSND-13¦¬¤F¦h¤Ö¤H? ¬Ì±¡¿N¦¨³o¼Ë, §Ú´N°Ý!! SNB-01¤£¬O¥u­n45­Ó¤H´N¥i¥H´Á¤¤¤ÀªR? ±q¤»¤ë¨ì²{¦b, 45­Ó¤H¦³³o»ò§xÃø? ¨ì²{¦b§Ö¥b¦~¹L¥h¤F,´Á¤¤¤ÀªR«¨?

±q2016­·¥ú¤W¿³Âd¨ì²{¦b, ¯Ó±¼¤F¦h¤Öoverhead? ¤£Á¿§Oªº, SND-13¦pªG¥¼¨Ó¦³¦¨¯à°÷½Í¨ìªº±ÂÅv±M§Q·l¯Ó¤F¦h¤Ö?

¦pªG¨S¦³¥v¤jª÷¿Ä·~ªº±Ó·P«×©M¤H¯ß, ½Ð°Ý¦U¦ì¾K¤ß¬ì¬ãªºªÑªF, ¤½¥q²{¦b·|¬O¬Æ»ò´ºªp¤F? ¬O½æ¤FÁÙ¬Oª½±µ¥]µö¦¬¤@¦¬¦^¥hLab?

¦U¦ì§ë¸ê¤Hªº¾÷·|¦¨¥»§Ú­Ì¤]´N¤£­p¸û¤F~

½Ð°Ý¬O½Öªº³d¥ô?°ÝÃD¦b­þ¸Ì?

Á¿¨ì³o­Ó§Ú´N¨Ó®ð! ¨C¦~ªºªÑªF·|«e§Ú³£¦bªO¤Wµo¨¥, ¦ý©{¦pª¯§p¤õ¨®, ³£¨S¦³¤HÆgÁn¤@°_·FÃצ¬®×³t«×, ¥u¬OÅ¥¨Ç¬ì¾Ç¬ã¨s¤@´h¤@´hªº....µM«á´N´²·|!

¦Ñ¤l§Ú¤S¤£¬OÂå¾Ç°|¾Ç¥Í, ´Nºâ¤ß®®ªº¬ã¨s®³¤F¿Õ¨©º¸¼ú¤]¤£¬O§Úªº¦¨´N, ¥u¬O§Æ±æ§ë¸ê­Ó¥¿¬£¸gÀ窺¤½¥q, ¦³­Ó¸ê¥»§Q±oÅý®a¤H¦n¹L,¦P®É¤]¹ï¤HÃþªºµo®iºÉ¨Ç´ÖÁ¡¤§¤O

¯à§ïµ½¤HÃþ¥Í¬¡·íµM«Ü¦n, ¦ý¬O¦Û¤v³£½ß¤F¤@§¾ªÑ,¥s§Ú¦³°ª¤j¤Wªº¹Ú·Q?! §Ú¬O¨S¨º­Ó°ª©|ªº±¡¾Þ!

¬Oªº! §Ú¸ÜÁ¿­«¤F, ¤]¨S¦³§åµûª©¤W¥ô¦ó¥ý¶iªº·N«ä!¥u¬O§Æ±æ¦P¦í¤@¶¡®M©Ðªº¹Ù¦ñ, ¥i¥H¹Îµ²¬Ý²M°ÝÃDªº¥»½è, ¤@°_§â®M©ÐÅÜ»¨¦v¡I

¶¶±a¤@´£, §Oªº¤j¤á­n«ç»ò½æªÑ²¼§Ú·Q¨º³£¤£¬O§Ú­Ì¸ÓÀË°Qªº­«ÂI,¤Ï°Ý¦pªG§Ú­Ì¶i«×°÷§Ö, Àç¹B°÷¦n, ­þ¸ÌÁÙ©È¥«³õ¨S¦³¶R¶iªº¤O¹D¡H­þ¸ÌÁÙ©È­ì©lªÑªF½æªÑ²¼¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/11/5 ¤W¤È 09:53:08²Ä 1814 ½g¦^À³
¦n©_¤j¥J «ëÅK¤£¦¨¿û §Ú+1 §Ú¯R+1 §Ú®Q+1 §Ú®a¦n´X¤f¤l³£+1

­n¬O§A¤TÀ\Ãפ½¥qÁ{§É¹³½½¤û¾ðá §Ú®¼§A

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/5 ¤W¤È 08:55:02²Ä 1813 ½g¦^À³
¦U¦ì¤j­ô¤j©j¤j¤á¹ï¤£°_¡A§Ú¨S¦³­n§ðÀ»¥ô¦ó¤Hªº·N«ä¡A§Ú¥u¬O¼g¼g§Úªº¤ß±o·P·Q«ëÅK¤£¦¨¿û¡A²¦³º§Ú¥u¬O¤@­Ó¤p¤pªº´²¤á¡A¤@­Ó¤ë¨S´X¸Uªº¤p¤W¯Z±Ú¡A·íªì¦]¬°¬Ý¨ì¯E¹©öt¨ì750¤¸¡AµM«á¤Sı±o¥v¤j¤ÀªRªº«Ü¦³¹D²z¡A²{¦b§ÚÁÙ¬O«Ü¬Û«H¥v¤jªº¬ã¨s¡A©Ò¥HºCºC¶R¤]¶R¤F50±i¡A±z­Ì³o¨Ç¤j¤á¥i¯à¶R¤W¦Ê±i¡A¤ñ¤£¤W±z­Ì¡A¨ì²{¦b¤]4,5¦~¤F¡A´X¦Ê¸U¤]½ß¤F¤£¤Ö¡AÁöµM¤ñ¤£¤W±z­Ì¡A¦ý¬O§Ú¤]¥u¬O·Q¤½¥q¯àÁÈ¿ú¦­¤éüݤɦʤ¸­Ñ¼Ö³¡¡AÅý§Ú¤Ö½ß¨Ç¿ú¡A¯à¦­¤é°h¥ð¦Ó¤w¡A¦pªG§Úªºµo¨¥¦³Åý±z­Ì³o¨Ç¤j¤á·P¨ì¤£µÎªA¡A§Ú¦V±z­Ì¹Dºp¡A²{¦b¶}©l§Ú¤]¤£¦A©ê«èµo¨¥¤F¡A¤Ï¥¿®M¨c¨º»ò¤[¤F¡A¥u¯àÀRÀRµ¥«ÝªÑ»ù¦³©Òªí²{¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/11/5 ¤W¤È 08:21:48²Ä 1812 ½g¦^À³
·|­û¡G²q·Q10148412 µoªí®É¶¡:2021/4/20 ¤W¤È 09:41:24²Ä 1655 ½g¦^À³

ªü¤Ñ¤j

700P¬O¥üOO¨Êªº¥N¸¹ , ¬O¤ß®®ªñ´ÁªÑ»ù±²°_¤d°ï³· ( ­É¨ä[§N]·N )ªº¥D¦]

[ ¶È³Ñ ¤­¤é¨Ê¥ü ªº¾l«Â ? ] ¬O¦b²q´ú³o¦ì¤j­ô¤j©j§Y±N½æ§¹¤F¶Ü ?

²¦³º¥L ( ¦o )¤w¥X²æ¶W¹L 2,300 ±i¤F

µM¤]½Ð³o¦ì¤j­ô¤j©j¦b³o¤ß®®²{¼W´Á¶¡°ª©ï¶Q¤â , Åý¤ß®®¼W¸ê¶¶§Q

µü¤£¹F·N¤§³B , ·q½Ð®ü²[

ÁÂÁ¤j®a !

­Þ¦³ÀY¶Å¦³¥D...¬O700P³o¦ì¤j­ô¤j©j

¬Ý²M·¡¨Ó ²¦³º¥L ( ¦o )¤w¥X²æ¶W¹L 2,300 ±i¤F ²¦³º¥L ( ¦o )¤w¥X²æ¶W¹L 2,300 ±i¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/4 ¤U¤È 09:42:49²Ä 1811 ½g¦^À³
±z¬O¨S¬Ý²M§Ú¼g¤°»ò¶Ü¡H¬G·NÀ£§CÅý´²¤á©ñ±ó»{ÁÊ¡A¤jªÑªF¤]¤½§i¥þ³¡©ñ±ó»{ÁÊ¡A¦nÅýÄw½Xµ¹¯S©w¤H¤h¦Y³f¡A§Ú­þ¸Ì©Ç¥v¤j¤j¤F¡C§Ú»¡³o©Û¼F®`¡CÄw½X¤£¸¨¤J´²¤á¤â¤W¡A¥H«á¾Þ§@·|¤ñ¸û¶¶§Q¡C§Ú¬O­þ¥y¸Ü©Ç½Ö¤F¡C­n©Ç©Ç§Ú¦Û¤v¤â½â¶Ã¶RªÑ²¼¦Ó¤w¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/11/4 ¤U¤È 02:55:08²Ä 1810 ½g¦^À³
©Ç©ÇªºÄV©N¦³part 2

ªÑ»ù¤£¦n²o©ì¥v¤j¤j¬G·NÀ£§C????????¯«ÅÞ¿è ­n¬O§A¤TÀ\Ãפ½¥qÁ{§É¹³½½¤û¾ðá §Ú®¼§A

¥v¤j¤j¤S¤£§¤¦b±i©¾¿Ñ¨º¦ì¤l¤W

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/4 ¤W¤È 11:20:02²Ä 1809 ½g¦^À³
¥D¤O¥Î¤O±þ±þ±þ¨ì©³¡A¹G¥X®M¨c¶q¡A²M¬~Äw½X¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/3 ¤W¤È 10:49:49²Ä 1808 ½g¦^À³
·s»D¤W³øÁÙ¬O¨S¥Î¡A§Ú¬Ýª½±µ¦b§âªÑ²¼±þ¨ì20.88¤¸ýf¥v§CÂI¦n¤F¡A±j­¢¹G¥X´²¤áÄw½X¡Aª½±µ±þ¨ì©³§a¡I¤£­nºCºC§é¿i¤F¡K¡K¨S¦³º¦¶^´T¤@¦¸³e±þ¨ì©³§a¡I
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/3 ¤W¤È 10:12:32²Ä 1807 ½g¦^À³
¥v¤jªº¾Þ±±¤]°÷¬½ªº¡A¤W¦¸ªºªÑªF»{ªÑ40¤¸»{ÁÊ»ù¡A·í®É¬G·N§âªÑ»ùÀ£¦b40¤¸¥ª¥k¡AÅý¤pªÑªF­n»{Áʤ]¤£¬O»{Áʤ]¤£¬O¡A¦]¬°»ù®t´X¥G¨S¦³¡Aª½±µ¦b¥«³õ¶R¤]¬O®t¤£¦h¡AµM«áµ¥»{Áʮɶ¡¹L«á¡A¹j¤Ñ°¨¤W©Ô¶}ªÑ»ù¡A»ù®t5,6¤¸¥H¤W¡AµM«á¤S¤½§i¤jªÑªF¥þ³¡©ñ±ó»{ÁÊ¡AÅý¯S©w¤H¤h¥Î40¤¸»{ÁÊ¥þ¼Æ¦Y³f¡AÅýÄw½X¤£®ö¶O¦b´²¤á¤â¤¤¡A³o©Û¤Ó±j¤F¡A²{¦b¤]¦³¥i¯à¥D¤OÄw½X¦Yªº¤£°÷¡AªÑ»ù¤@ª½À£¦b¦¹³B¡A¦A¹G¤@¨Çªø´Á®M¨cªº´²¤á»{½ß¥X³õ¡A·d¨ì¤ß®®¹³©t¨à¤@¼Ë¨S¤H­n¡A¥¼¨ÓÁÙ¦³¤°»òªá©Û§Ú­Ìµ¥µÛ¬Ý¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/11/3 ¤W¤È 08:23:11²Ä 1806 ½g¦^À³
«C¤Ö¦~½w¥´BNT²Ä¤G¾¯¡H¦ó¬ü¶m¡G¤ß¦Ùª¢¬O²Ä¤@¾¯¤Q¦h­¿

2021-11-03 05:34 Áp¦X³ø / °OªÌ­×·ç¼ü¡þ¥x«n§Y®É³ø¾É

udn.com/news/story/122190/5862525?from=udn_ch2_menu_v2_main_index

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/11/2 ¤W¤È 11:47:00²Ä 1805 ½g¦^À³
´À¥v¤j»¡´X¥y¸Ü

1. ·í®É¥L¬O¦]¦n¤Í±o¤Fºë¯«¯e¯f, µM«á¬ã¨s¨ì¤ß®®³o®a¤½¥q, ¦Ó¦b¹q¤l³ø¤W°lÂܨäÀªR, ¦P®É´Á¥t¦³¯E¹©¤Î¨ä¥L¥Í§ÞªÑ§ó¼öªù

2. ¬O¨â±iBTD(¨Ã«D¨â±iÃÄÃÒ)¦b¥«³õªº¦ô­ÈÀ³¸Ó±o¥H¤ä¼µ¤½¥qªÑ»ù¦b200, ¦ý¬O¥xÆW¥Í§ÞªÑªº¦ô­È¦b¯E¹©¨Æ¥ó«á, ¦³ÄY­«§C¦ôªº²{¶H, ¦]¬°¥«³õÅܱo¤£¤Íµ½, Äw¸ê§xÃø

3. ¥v¤j¤£¬O¶RªÑ¦h¨ì¤J¥D¤½¥q·í°ÆÁ`, ¥L¬O·í®É°µ¥\½Ò°µ¨ì¨ü½²±Ð±Â½àÃÑ, ¤~³Q«õ¨¤¥h¤½¥q! ¤@­Ó¾Ç¾ú¥vªº, ¦bÃҨ饫³õ¥´ºu¤Q¨Ó¦~, ¬°¤FÆp¬ã¤ß®®ªºÁ{§É¬ã¨s±q°ê¤¤¥Íª«½Ò¥»¶}©l¬ãŪ, ¨ìªÑªF·|¤W½²°õ¦æªø¤½¶}»¡¥v¤j§Y¬O¥L¦b¥xÆWªº¤À¨­, Á|¨¬»´­«¨o

4. ¤ß®®§@­·§t»W¤ºÀÄ, ªÑ»ù¨S¦³¹êÃÒ¤ä«ù, ¦ÛµM©|¥¼¯à¤j»ï¤j©ñ, »P¨ä¾E«ã¥v¤j, ¤£¦p¶X¾÷¦A¦h¶R´X±i

5. ¬Q¤Ñªº¤½¶}°T®§, ¤@¨Ö¦^µª¤FÄvª§ªÌ¶i«×¹ï¤½¥qªº¼vÅT, ¦pCliff¤j¥ý«e©Ò´£¥Üªº, ¤½¥q¨S¦³ÄF¤H!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/2 ¤W¤È 10:27:31²Ä 1804 ½g¦^À³
ªÑ²¼¦Û¤vªº¿ú¡A¦Û¤v¥ÌÄ@¶Rªº¡A¨S¤H®³ºj¹GµÛ¶R¡A¦Û¤v¶R­n­t³d¡A´Nºâ¶^¨ì¤U¥«¤]¬O½ß¦Û¤vªº¿ú¡A¤j¤j¤£­n¥Í®ð¡A§Ú¨S­n¤H­t³d¡K¡K¥u¬Oµoµo¨¥¡A²¦³º¤ß®®¤w¸g§ë¸ê¦n´X¦~¤F¡A§Æ±æ¥L¦¨ªø¦Ó¤w¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/11/2 ¤W¤È 09:50:46²Ä 1803 ½g¦^À³
©Ç©Ç­Ó巄©N

¥v¤j¤jÀ°¤½¥q§ä³o»ò¦h¿ú,ÁÙ­n¥L´ÀªÑ»ù­t³d,³o­ÓÅÞ¿è«Ü©_§®

¸Ó¬°ªÑ»ù­t³dªºÀ³¸Ó¬O§O¤H§a

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/2 ¤W¤È 09:23:32²Ä 1802 ½g¦^À³
°O±o·í®É¯E¹©750¤¸®É¡A¦³·s»DÁÙ¦b»¡¥H¤ß®®ªº¹ê¤O¡A¦³¥i¯à·|¦¨¬°·í®É¥Í§ÞÃþªºªÑ¤ý¡A¨S·Q¨ìªÑ¤ýÁÙ¨S·í¨ì¡AÁÙ¦¨¤FªÑž¡A¯uªº¦³°÷¿Ø¨ë¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/2 ¤W¤È 09:00:38²Ä 1801 ½g¦^À³
³o®a³Ì©_©Çªº¬O¡A·íªì¹q¤l³ø¦b¬ã¨s¦æ±¡®É¡A¯E¹©¸ò¤ß®®¡A³£¦³³Q¤ÀªR¨ì¡Aµ²ªG¯E¹©öt¨ì750¤¸¡A¤ß®®ÁÙ©¹¤Uöt¨ì²{¦b40´X¶ô¡A§ó©_©Çªº¬O¤ÀªRªÌ³ºµM·í¨ì¤F¡A³o®a¤½¥qªº°ÆÁ`¡A¨ì©³¤â¤¤­n¦³´X±iªÑ²¼¡A¶R¨ì·í¤F³o®aªº°ÆÁ`¡A·d¤F¦n´X¦~ªÑ»ù¶V·d¶V§C¡AÃÄÃÒ¨â±iÁÙ¤ÀªR³o¨â±iÃÄÃҭȪѻù200¤¸¡A·í®ÉÀ³¸Ó³o¼Ë¦n¦h¤H®M¦b¦Ê¤¸¥H¤W¡A·|¤ÀªRªÑ²¼ªº±M·~¤H­û·d¨ì¦Û¤v·í¤W°ÆÁ`¡AªÑ»ù½T³Ñ´X¤Q¤¸¡A³oÁÙ¯u¦³ÂI·N«ä¡C¤£¹L§ÚÁÙ¬O¯uªº«Ü¬Û«H¹q¤l³øªº¤ÀªRÃÄÃÒªº»ù­È¡A¥u¬O­nµ¥¦ó¦~¦ó¤ë´N¤£ª¾¹D¤F¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2021/11/1 ¤U¤È 06:44:58²Ä 1800 ½g¦^À³
³Ì­«­nªº¤½¥q¤è­±¤]­n°µ§V¤O¡AÅý¥~¬É§ó¤F¸Ñ¤½¥qªº²£«~¥H¤Î¥«³õ¼ç¤O

­n§ó¥[ªº«ùÄòªº¦h°µ«Å¶Ç¡A¼W¥[Ãn¥ú«×

ªÑªF©ê«è¥«³õ¬Ý¤£¨£¤½¥qªº¦n¡A¸gÀç¼h¤]­n¬O­nÀË°Q

Á{§É¶i«×½wºC¡A¯à¨£«×¤£°÷¡A³o³£¬O¤½¥qªº°ÝÃD¡A¬O¤½¥q­n§ïµ½ªº

´X­Ó·s»D«á¤S®ø­µ¤F¡A¥~¬É«ç»ò·|À´±o¤½¥q²£«~ªº¦n¡A«ç»ò·|À´¤½¥qªº»ù­È

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2021/11/1 ¤U¤È 05:57:29²Ä 1799 ½g¦^À³
§O«æ¡A§Ú²q´ú©ú¦~©³©ÎªÌ«á¦~¦~ªì¤§·|½ü¨ì¤ß®®ºt¥X¤F¡A·íµM³o­n¬Ý¤½¥qªºÁ{§É¶i«×

§Úªº·Qªk¬O³o¼Ëªº¡A·|¶i¥X¥Í§Þªº¥D¤O¦h¬O¦P¤@¸s¤H¡A´²¤á¤]¤@¼Ë¡A©Ò¥H¶i¥Xªº¸êª÷´N¨º¨Ç¶q

¤µ¦~´XÀɥͧުѲ¼³£ÁÙ¦bª£¡A´²¤á³£ÁÙ¦b®M¡A¸êª÷¤À´²¡AªÑªF´N¤£¥²¬°¤ß®®µÛ«æ¡A

¥D¤O²{¦b©Ô©ïªÑ»ù¡A³Q§l¤Þ¶i¨Óªº´²¤á¤£°÷¦h¡A¥D¤O¤@½æ¡AªÑ»ù¥i¯à´N¤S·|³Q½æ¤U¥h¡A¥X³f¨S¤H±µ

·í¯E¹©¡B¦X¤@³oºØ·í¦~«×¸ÜÃD©Ê¼Ðªº¤~¬O¦n¨Æ¡A¨ä¥L¤jµ§¸êª÷¤~·|¸òµÛ¶i¨Ó

©Ò¥H§Ú´Á«Ý©ú¦~©³©ÎªÌ«á¦~½ü¨ì¤ß®®·í¥D¨¤(³o­n¬Ý¤½¥qªºÁ{§É¶i«×)

¦Ó¥B¤ß®®ÁÙ¦b¿³Âd¡A¬y³q¶q¤£¦h

­@¤ßµ¥«Ý¤W¥«Âd¬O¤ñ¸û¦nªº¡AÁקK¤â¤¤«ùªÑ¥X¤£±¼

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/11/1 ¤W¤È 10:50:42²Ä 1798 ½g¦^À³
¥v§V¤ñ°ÆÁ`¸g²z¡A¥~°ê¨p¶Ò»ù77¤¸¡A±z¦Ü¤ÖªÑ»ù¤]©Ô¨ì77¤¸§a¡I40´X¶ô¿ú¡A¯à¬Ý¶Ü¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/30 ¤U¤È 07:23:56²Ä 1797 ½g¦^À³
Molecular imaging suggests long-COVID symptoms may be caused by fatigue, not regional brain dysfunction

OCTOBER 29, 2021

by Society of Nuclear Medicine & Molecular Imaging

medicalxpress.com/news/2021-10-molecular-imaging-long-covid-symptoms-fatigue.html

®Ú¾Úµoªí¦b¡m®ÖÂå¾ÇÂø»x¡n¤Wªº¤@¶µ´£«e¦L¨êªº¬ã¨s¡ACOVID-19 ¶EÂ_«áªºªø´Á»{ª¾°ÝÃD¥i¯à¬O¯h³Òªºµ²ªG¡A¦Ó¤£¬O¤j¸£ªº¯f²zÅܤơC¹ï¯«¸g¤ß²z¾Ç´ú¸Õ©M 18F-FDG PET ¦¨¹³ªº¤ÀªRªí©ú¡Aªø´Á COVID ±wªÌªº»{ª¾©M¸£¯f²z´X¥G¨S¦³©Î¨S¦³Æ[¹î¨ì«ÈÆ[·l¶Ë.

¬ã¨s¤H­ûÁ`µ²»¡¡G¡§³oªí©ú¯h³Ò¡A¦Ó¤£¬O¤j¸£°Ï°ì¥\¯à»Ùê¡A¥i¯à¬O¾É­P³\¦hªø´Á COVID ¯gª¬ªº­ì¦]¡C¡¨

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤¸´¼9110137200  µoªí®É¶¡:2021/10/29 ¤W¤È 10:39:23²Ä 1796 ½g¦^À³
¥x¿n¹q¦³¤H®M¤F10¦~¤~½¨­¡A¿Ë·Rªº¤ß®®§A­nÅý§Ú®M´X¦~¡I¡I¡I
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/27 ¤U¤È 08:58:45²Ä 1795 ½g¦^À³
news.gbimonthly.com/tw/article/show.php?num=43867&page=1&kind=22

Axcella ¦b­^°ê±Ò°Êªø´Á Covid ªvÀø¸ÕÅç

µo§G®É¶¡¡G2021 ¦~ 10 ¤ë 26 ¤é °¨§J¡P¯S¨½

www.biospace.com/article/axcella-therapeutics-launches-a-clinical-trial-in-long-covid/

¤@¯ë¨Ó»¡¡A¤j¦h¼Æ COVID-19 ±wªÌ·|¦b¼Æ¶g¤º±d´_¡C¦ý¬O¦³¨Ç¤H·|¹J¨ì¦UºØ¦U¼Ëªº·sªº¡B´_µoªº©Î«ùÄòªº°·±d°ÝÃD¡A³o³QºÙ¬°ªø·s«a¯f¬r¡C®Ú¾Ú¬ü°ê¯e¯f±±¨î©M¹w¨¾¤¤¤ß (CDC) ªº»¡ªk¡A ¯gª¬ ¥i¯à¥]¬A©I§l§xÃø©Î®ðµu¡B¯h³Ò¡B³Ò²Ö«á¤£¾A¡B©Ò¿×ªº¡§¸£Ãú¡¨©Î«äºû©Îµù·N¤O¤£¶°¤¤¡B«y¹Â¡B¯Ýµh©Î­Gµh¡BÀYµh¡B¤ß±ª¡BÃö¸`©Î¦Ù¦×¯kµhµ¥¡C

¥þ²y¤w³ø§i¤F¶W¹L 2.4 »õ¨Ò COVID-19 ¯f¨Ò¡A¨ä¤¤¬ù 25%¡]§Y 6000 ¸U¨Ò¡^³ø§i¤Fªø´Á¼vÅT¡C

¥D­n²×ÂI±N¬Oµû¦ô±q°ò½u¨ì²Ä 28 ¤Ñ°©Àf¦Ù¤º½u²ÉÅé¥\¯àªº§ïµ½¡C

½u²ÉÅé¥\¯à»Ùê³QÃhºÃ¬O¾É­P»P Long Covid ¬ÛÃöªº¯h³Òªº­ì¦]¡C

SNB011 ¬O§_¦³­pµe¨Ó¶i¦æªvÀø long COVID ªºÁ{§É ¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/27 ¤W¤È 08:14:51²Ä 1794 ½g¦^À³
¬Q¤Ñ¤ß®®¨ú±oªvÀø«aª¬¯f¬r·P¬V¤èªkªº¬ü°ê±M§Q

¤µ¤Ñ§Ú­Ì¨Ó¬Ý¬Ý¤]¬O¥x¿n¹qªº¬ü°ê«Ø¼t¦a---¨È§Q®á¨º¦{ªº¬Ì±¡

³Ìªñªº½T¶E 7 ¤Ñ¥­§¡­È¦b2,500¤Hªþªñ

¨Ì¤H¤f¤ñ¨Ò

¤j»ñ°Ä«°³£·|°Ï¬ù¦û¨È§Q®á¨º¦{¤H¤fªº 2/3 ​, ¬ù¦ô¨C¤Ñ¤j»ñ°Ä«°³£·|°Ïªº½T¶E¼Æ·|¦b 1,600 ~ 1,700 ¤§¶¡

©Ò¥H

¤ß®®½Ð§Ö¥[ªo

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/26 ¤W¤È 07:57:19²Ä 1793 ½g¦^À³
©µÄò SPAC ªº¸ÜÃD

***

¥Í§Þ·~±ÈSPACºÆ1¡þ¥xÆW§ë¸ê¤H¤£·R¿N¿ú¤½¥q¡@¿W¨¤Ã~­u¬ü¨D¥Í

www.ctwant.com/article/146774

«e¯eºÞ§½ªø±iÂE¤¯¤]´¿ªí¥Ü¡A¥xÆW¤H¹ï©ó¿N¿úªº¦æ·~¨Ã¤£¼ö°J¡A¦ý¥Í§Þ¤£¿N¿ú´N¨S¦³³Ð·s¡A¡u¦Ó¬ü°ê¯Ç´µ¹F§J¬O³Ì¤ä«ù¿N¿úªº¦a¤è¡A«Ü¦h¿W¨¤Ã~³£¦b¨º¸Ì¤W¥«¡v¡C

***

¥Í§Þ·~±ÈSPACºÆ2¡þ§ä¤j©@·í¸g²z¤H¡@·~¤º¤j¨Ð¡GÀ³¸Ó¬O¤T¤è¤H°¨ª`¸ê

www.ctwant.com/article/146775

***

¥Í§Þ·~±ÈSPACºÆ3¡þ¥Ø¼Ð¨ÖÁÊ60»õ¤¸¥H¤W¤½¥q¡@¥x±d¡B³ß±d¾÷²v§C

www.ctwant.com/article/146776

¤ß®®¥ÍÂå10¤ë1¤éªñ´Á¤~¦b¬ü°ê³]¥ß¤l¤½¥q¡A¥[¤Wºë¯«ÃĪ«¥H¤Î·s«aªÍª¢ÃĪ«¬ãµo»á¦³¦¨ÁZ¡A¤@ª½³Qµø¬°±¾µP¼ç¤OªÑ¡C

***

¡i·s»DÂIµû¡j75·³·dStartupª±SPAC

hk.finance.yahoo.com/news/%E6%96%B0%E8%81%9E%E9%BB%9E%E8%A9%95-75%E6%AD%B2%E6%90%9Estartup%E7%8E%A9spac-191900335.html

¨S®Æ¨ì¡A75·³ªº¬ü°ê«eÁ`²Î¯S®Ô´¶¤]»°¼é¬y¡A­è«Å¥¬¦¨¥ßTRUTH SocialªÀ¥æ¥­¥x¡A¨Ã¤w¸ò¤@°¦SPACªÑ¹F¦¨­É´ß¨óij¡C

¯S®Ô´¶¤W©P¤T«Å¥¬³Ð¿ì·s´CÅ餽¥qTrump Media & Technology Group¡]TMTG¡^¡AºX¤UÀY¬¶¬OªÀ¥æ´CÅ饭¥xTRUTH Social¡A¨äÀ³¥Îµ{¦¡¤w©óÄ«ªGApp Store¤W¬[¡A¦ý©|¥¼¶}©ñ¤U¸ü¡A¹w®Æ11¤ë¶i¦æ´ú¸Õ¡A2022¦~­º©u¥¿¦¡±À¥X¡C

»P¦¹¦P®É¡ATMTG¤w¸ò¤@°¦SPACªÑ²¼Digital World Acquisition Corp¡]DWAC¡^¹F¦¨¨óij¡A±N¥H¤Ï¦V­É´ß§Î¦¡¦bNasdaq±¾µP¡C¸Ó®ø®§¤@¥X¡A¨ë¿EDWACªÑ»ù¦bµuµu3¤é¶¡öt¤É¶W¹L8­¿¡A¥«­È¥Ñ­ì¥»3.2»õ¬ü¤¸¡A¨ì¤W©P¤­¦¬¥«¿±µÈ¦Ü30»õ¬ü¤¸¡C

***

³o¬O³½À°¤ô , ÁÙ¬O¤ôÀ°³½ ? ¬Û¤¬¥[«ù , ³Ð³y³Ì¤j»ù­È

½²±Ð±Â¦b¤µ¦~ªÑªF·|»¡ ,¤W¥«¶V§Ö¶V¦n , ¬O§_¸ò SPAC ¦³Ãö , ¤£±o¦Óª¾

°²¦p¬O©M SPAC ¦³Ãö

§Ú­Ì§Æ±æ¤½¥q¯à¦Ò¶q¤pªÑªFªºÅv¯q , ½Í­Ó¦n±ø¥ó©M»ù®æ

Åý¶R¦b¨â¦Ê¦h¤¸ªºªÑªF¤]¯àÀò§Q

·íµM , §Ú­Ì²{¦b¤]±H§Æ±æ©ó SND-12 , 13 , SNB011

¤×¨ä SND-13 ¦~©³ªº¤G¦¸´Á¤¤¤ÀªR , ¯àÀò±o¦n¦¨ÁZ , ¹F¨ì³½¤ô¤¬À°ªº¨Î¹Ò

­Y¬O¨«³o­Ó¤è¦V

«Ü¦n©_ , ¬ü°ê§ë¸ê¤H·|µ¹¨â­Ó BTD ªº¤½¥q¦h¤ÖÁ`¥«­È ?

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/25 ¤U¤È 12:53:17²Ä 1792 ½g¦^À³
¥Í§Þ·~±ÈSPACºÆ3¡þ¥Ø¼Ð¨ÖÁÊ60»õ¤¸¥H¤W¤½¥q¡@¥x±d¡B³ß±d¾÷²v§C

°OªÌ¡G¬h¦W¯Ñ 2021-10-25¡@06:00

www.ctwant.com/article/146776

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/13 ¤U¤È 04:06:43²Ä 1791 ½g¦^À³
¬°¤°»ò¡§ªø´ÁCOVID¡¨ªº¼vÅT¥i¯à¤ñ¤j¬y¦æ§ó«ù¤[

2021 ¦~ 10 ¤ë 12 ¤é¤W¤È 9:20 2021 ¦~ 10 ¤ë 12 ¤é¤W¤È 9:24 §ó·s

By ³Ç´Ë¡P»\º¸

´^³ÕªÀ

www.seattletimes.com/nation-world/why-impact-of-long-covid-could-outlast-the-pandemic/

¾¨ºÞ¤j¦h¼Æªø´Áªº COVID ¯gª¬¦ü¥G¤£·|¦M¤Î¥Í©R¡A¦ý 2021 ¦~ 4 ¤ëµoªí¦b¡m¦ÛµM¡nÂø»x¤Wªº¤@¶µ¬ã¨sµo²{¡A±wªÌ¦b¤»­Ó¤ë¤º¦º¤`ªº­·ÀI¼W¥[¤F 59%¡C³o¬Û·í©ó¨C 1,000 ¦W COVID ±wªÌ¤¤¼W¥[¬ù 8 ¤H¦º¤`¡X¡X³o¼W¥[¤F¤j¬y¦æªºÁô©Ê¦º¤`¤H¼Æ¡C

®Ú¾Ú 10 ¤ë 8 ¤éµoªí¦b¡m¬h¸­¤M¡n¤Wªº¤@¶µ¬ã¨s¡AªÀ·|­­¨î¡B«ÊÂê¡B¾Ç®Õ©M¥ø·~Ãö³¬¡B¥Í­p³à¥¢¡B¸gÀÙ¬¡°Ê´î¤Ö¥H¤Î¬F©²Àu¥ý¨Æ¶µªºÂàÅܳ£¦³¥i¯à¹ï¤ß²z°·±d²£¥Í­«¤j¼vÅT¡C¥¦µo²{¡A¤j¬y¦æ¾É­P¥þ²y·s¼W 5320 ¸U¨Ò­««×§íÆ{¯g©M 7620 ¸U¨ÒµJ¼{¯g¡C

¤@¨Ç¬ã¨s¤H­ûªí¥Ü¡A¤j¬y¦æ¥i¯à·|¤Þµo¤@¨t¦Cªø´Á°ÝÃD¡A¨Ò¦pºC©Ê¯h³Òºî¦X¯g¡Bè§b¯g¡B©¬ª÷´Ë¯f¡B¿}§¿¯f©MµÇ¥\¯à·l®`¡C§íÆ{¯g¡BµJ¼{¯g©M¯kµhªvÀøªº¼W¥[¤Þµo¤F¤H­Ì¹ï¦Û±þ©Mªü¤ùÃþÃĪ«¹L¶q¨Ï¥Î¿E¼Wªº¾á¼~¡C¬ü°ê¯e¯f±±¨î»P¹w¨¾¤¤¤ß³ø§iºÙ¡A2020 ¦~¹L¶q¦º¤`¤H¼Æ¿E¼W¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/10 ¤W¤È 08:31:31²Ä 1790 ½g¦^À³
¨C¤Ñ³Ü©@°Ø¶W¹L³oªM¼Æ ¬ã¨s¡G¥¢´¼­·ÀI¤j¼W53¢H

08:13 2021/10/10 ¤¤®É·s»Dºô ©ú¤é¬ì¾Ç

www.chinatimes.com/realtimenews/20211010000674-260418?ctrack=pc_main_rtime_p01&chdtv

°ò¥»¤W¨Ó»¡¡A¨C¤Ñ³Ü¶W¹L¤»ªM©@°Ø¥i¯à·|±N§A¼ÉÅS©ó¤j¸£¯e¯fªº­·ÀI¤¤¡A¨Ò¦p¥¢´¼¯g¥H¤Î¤¤­·¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/10/9 ¤U¤È 06:54:44²Ä 1789 ½g¦^À³
ºÙÀq¨FªFÃĹ襤«×±wªÌÀø®Ä®t ¦L«×¼t±Nµ²§ô¸ÕÅç

2021-10-09 17:45¤¤¥¡ªÀ ¯Z¥[ùº¸8¤éºî¦X¥~¹q³ø¾É

money.udn.com/money/story/5599/5805591

¦L«×ÃÄ«~ºÞ¨îÁ`§½¡]Drug Controller General ofIndia¡^¤@¦ì®ø®§¤H¤hªí¥Ü¡A¾¨ºÞ²ö¯Ç¥Ö©Ô­³¹ï©ó»´¯g¦³®Ä¡A¦ý¹ï©ó¤¤«×¯gª¬±wªÌ«o¥¼®i²{¡uÅãµÛÀø®Ä¡v¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJACK10152317  µoªí®É¶¡:2021/10/4 ¤W¤È 11:38:20²Ä 1788 ½g¦^À³
»{¦P kinmen3015 ¤j ¤£¹L¤j®a­·ÀIÁÙ¬O­nºÞ±±¦n ¤ß®®¥[ªo!!
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/10/4 ¤W¤È 11:28:16²Ä 1787 ½g¦^À³
¤½¥q¸gÀç¼h´N¬O¨S¦³¤À¤ß°µªÑ²¼, ¤~Åýªø§ëªÌ¤ß¦w!!!¤£¬O¶Ü?

Merckªº·s«a¤fªAÃÄ­YºÉ¦­³q¹LEUA¤W¥«

¹ïSNB011¤]¬O¦n¨Æ

¥«³õ·|ªÖ©w¤fªA¤Î»ó¼Q¾¯ªº¶}µo¤è¦V

³v¨Bª¾¾å¤ß®®¬O¨«¦b¬Û¦P¥¿½Tªº¹D¸ô¤W

¥u¬O¤j®a¶û¥LºC

­Ó¤H¥H¬°SNB011¬OÂI¤ß, ¤]§Æ±æÅÜ«eµæ

¨ä¥Lºë¯«¯e¯f¥ÎÃĤ~¬O¥Dµæ

§Ú­n¦Y¤jÀ\°Õ!!!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/9/30 ¤W¤È 11:22:14²Ä 1786 ½g¦^À³
«Øij¤µ¦~ªºªÑªF·|¬ö©À«~¡A°e¤ß®®¦Û¤v¥Í²£¼~Æ{¯gªºÃÄ¡A¨C­ÓªÑªF³£µo¤@­Ó¤ë¥÷¨ÓªvÀø¤@¤U¦n¤F¡C¦n¹³¤ß®®ªÑªF·|¨S°e¹L¬ö©À«~¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/9/26 ¤U¤È 06:12:34²Ä 1785 ½g¦^À³
·s«a¤fªAÃÄ ¤j¼t·m¶}µo

2021-09-25 00:34 ¸gÀÙ¤é³ø / ½sĶ³¯®a»ô¡þºî¦X¥~¹q

udn.com/news/story/121707/5769960

¥Ø«e¥«­±¤W°ß¤@ªº·s«aªÍª¢§Ü¯f¬rÃĪ«¬O·ç¼w¦è­³¡]Remdesivir¡^¡A³o´Ú¥Ñ¦N¥ß¨ÈÂåÃĤ½¥q¶}µo¡B¥D­n¨Ï¥Î¦b­«¯g¯f¤HªºÃĪ««D±`©ù¶Q¡A¨C¾¯­n»ù2,100¬ü¤¸¡A¦pªG¦UÃļt¯à¶}µo¥X¸û«K©y¡A´N¹³§J¬y·P¤@¼Ë¤è«K¨Ï¥Îªº¤fªAÃĪ«¡A¥i±æ¬°ªý¾×¬Ì±¡°^Äm§ó¦h¤O¶q¡C

·ç¼w¦è­³¤µ¦~²Ä2©uªº¾P°âÃB´N°ª¹F8.29»õ¬ü¤¸¡A¦Û·s«a¬Ì±¡Ãzµo¥H¨Ó¤w¸g¶W¹L50»õ¬ü¤¸¡CªvÀø»´¯gªº¤fªA§Ü¯f¬rÃÄ°Ó¾÷¡A¥i¯à¤ñ·ç¼w¦è­³ÁÙ­nÅå¤H¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/9/21 ¤W¤È 08:35:50²Ä 1784 ½g¦^À³
Å礣¥X¯f¬r¤£¥Nªí²¬Â¡ ³¡¤À»´¯g·s«a±wªÌ«á¿ò¯g§ó¼@¯P

2021-09-21 00:09 Áp¦X³ø / °OªÌ³\¸Ö·_¡B§õ¾ð¤H¡B¿½¦Ð¯Ð¡þ¥x¥_³ø¾É

udn.com/news/story/120940/5760010?from=udn_ch2cate6638sub120940_pulldownmenu_v2

¬°¦ó»´¯g¡BµL¯gª¬±wªÌ·|¥X²{ÄY­«ªº«á¿ò¯g¡HªL©û¼Ý¬ã§P¡AACE-2¬O·s«a¯f¬r«Iŧ¤HÅé¦U¾¹©x²Ó­Mªº¤J¤f¡A·U¨Ó¦h¬ã¨sÃÒ¾ÚÅã¥Ü¡AACE-2ªí²{¶q·U°ªªº¾¹©x¡A¥X²{«á¿ò¯g¤ñ²v´N·U°ª¡C

***

Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19

www.hindawi.com/journals/ecam/2020/7493281/

5¡Cµ²½×

§Ú­Ìªº¬ã¨sªí©ú¡AåÚ¥Ö¯À¡B¥ú¥Ì¯ó©w©M¨S­¹¤l»Ä³o¤TºØªvÀø COVID-19 ªº¼ç¦b¤Æ¦Xª«¥i¯à³q¹L½Õ¸` ACE2 ªº TF ©Î miRNA ¨Ó­°§C ACE2 ªºªí¹F¡A±q¦Óµo´§§Ü¯f¬r§@¥Î¡C

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/9/4 ¤U¤È 05:04:36²Ä 1783 ½g¦^À³
µÇŦ¦Ñ¤F30·³ ·s«aªÍª¢²¬Â¡ªÌµÇŦ¨ü·l¾÷²v¼Æ¦rÃn¥ú

16:06 2021/09/04 ¤¤®É·s»Dºô ¦¿¬Rã¸

www.chinatimes.com/realtimenews/20210904002655-260408?ctrack=pc_main_recmd_p13&chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/9/2 ¤U¤È 03:10:52²Ä 1782 ½g¦^À³
***

JAMA¤l¥Z¡GX¬V¦âÅé¼vÅTªü¯÷®üÀq¯g ¨k¤k¤j¤£¦P

¨Ó·½¡G Âå¾Ç·sµøÂI¡@2021-09-02

med.sina.com/article_detail_103_1_105157.html

***

¥´3¾¯¬Ì­]¤´½T¶E¡I°ê¤º­º¨£«Xù´µ¬Ì­]¡u¬ð¯}©Ê·P¬V¡v

udn.com/news/story/122190/5717471

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/9/1 ¤W¤È 07:58:13²Ä 1781 ½g¦^À³
COVID-19 ªº¨â¤T¨Æ

www.genetinfo.com/international-news/item/52160.html

www.genetinfo.com/international-news/item/51930.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/30 ¤U¤È 07:35:07²Ä 1780 ½g¦^À³
Breakthrough Symptomatic COVID-19 Infections Leading to Long Covid: Report from Long Covid Facebook Group Poll

www.medrxiv.org/content/10.1101/2021.07.23.21261030v1

¦b¹ï¥Á·N½Õ¬d°µ¥X¦^À³ªº 1,949 ¦W°Ñ»PªÌ¤¤¡A44 ¤H³ø§i¤F¦³¯gª¬ªº¬ð¯}©Ê¯f¨Ò¡A¨ä¤¤ 24 ¤H³ø§i»¡¸Ó¯f¨Ò¾É­P¤Fªø«aª¬¯f¬rªº¯gª¬¡C¾Ú³ø¾É¡A³o 24 ¨Ò¯f¨Ò¤¤¦³ 1 ¨Ò°£ªø«aª¬¯f¬r¥~ÁپɭP¦í°|ªvÀø¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/26 ¤W¤È 07:40:59²Ä 1779 ½g¦^À³
***

Åܺدf¬r¦³¸Ñ ¬ü¬ã¨s¡G¶W¯Å§ÜÅéSARS2-38 ¥i¤¤©M©Ò¦³Åܲ§®è

23:32 2021/08/25 ¤¤¥¡ªÀ ¤¤¥¡ªÀ

www.chinatimes.com/realtimenews/20210825006363-260408?chdtv

***

­^°ê¬ã¨s¡G¥´§¹2¾¯½÷·ç©ÎAZ ¥b¦~¤º«OÅ@¤O´N¤U­° ÁÙ±o¦A¥´

03:35 2021/08/26 ¤¤¥¡ªÀ ¤¤¥¡ªÀ

www.chinatimes.com/realtimenews/20210825006302-260408?ctrack=pc_main_recmd_p11&chdtv

***

ªÍª¢«á¿ò¯g¥i¯à¦³¸Ñ ¤@ºØ§ÜÀùÃĪ«¥i°fÂàªÍ³¡ÅÖºû¤Æ

22:33 2021/08/25 ¤¤®É·s»Dºô ¦¿­¸¦t

www.chinatimes.com/realtimenews/20210825006262-260408?ctrack=pc_main_headl_p10&chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GABC10134671  µoªí®É¶¡:2021/8/23 ¤U¤È 01:15:12²Ä 1778 ½g¦^À³
¯uªº
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/8/23 ¤W¤È 10:52:01²Ä 1777 ½g¦^À³
§Ú¤ß®®¸ÛªA¤F¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/22 ¤U¤È 12:19:21²Ä 1776 ½g¦^À³
¯Î±Ò´f¡G·s«aªÍª¢®£¬y·P¤Æ ¥u¯à¾a¬Ì­]¡B¤fªAÃÄ

2021-08-22 11:16 ¤¤¥¡ªÀ / ¥x¥_22¤é¹q

udn.com/news/story/120940/5690935?from=udn_ch2cate6638sub120940_pulldownmenu_v2

¥Íµ¦·|·|ªø¯Î±Ò´fªí¥Ü¡ACOVID-19¯f¬r¤@¦AÅܺءA®£±N¡u¬y·P¤Æ¡v¡A±µ¤U¨Ó¡uÃĪ«¡vÀ³¹ïCOVID-19¬Ì±¡«Ü­«­n¡A¤×¨ä¬O¤fªAÃÄ¡A¥¼¨Ó¥u¦³¾a¡u¬Ì­]¡v¤Î¡u¤fªAÃÄ¡v¤~¯àÅý¥@¬É³v¨B«ì´_¯´§Ç¡C

¦­¦b2020¦~2¤ë¬Ì±¡Ãzµo¤§ªì¡A¯Î±Ò´f§Y¦b¥Íµ¦·|ºô¯¸¼¶¤å¥Üĵ¡ACOVID-19¯f¬r®£±N¡u¬y·P¤Æ¡v¡A­n¦³»P·s«a¯f¬rªø´Á¦@¦sªº¤ß²z·Ç³Æ¡A³Ì¦³®Ä¤èªk¬O¾a¬Ì­]¡C

¯Î±Ò´f¥Ø«e¤H¦b¬ü°ê¶i¦æ¬ÛÃö¤u§@¡A¥L±µ¨ü¤¤¥¡ªÀ°OªÌ¹q¸Ü±Ä³X®É«ü¥X¡A¥H²{¦bª¬ªp¬Ý¨Ó¡ACOVID-19¯f¬r·|«ùÄò¦s¦b¤HÃþªÀ·|¡A¥B·|¤@ª½¬ðÅÜ¡A³Ì¥i©Èªº¬O¦³«Ü¤jªº¤ñ¨Ò¬OµL¯gª¬ªº·P¬VªÌ¡C

¥Lªí¥Ü¡A¦³¥v¥H¨Ó¥u¦³¤Ñªá¤@­Ó¯f¬r³Q®ø·À¡A¨ä¥L³£ÁÙ¦b¡A²{¦bCOVID-19¯f¬r¤w¶i¨ì¦U¦¡¦U¼Ëªº¤HÅé¸Ì¡A«ÜÃø¥h°£¡A¥u¯à»P¥¦¦@¦s¡F¦]¦¹±µ¤U¨Ó¡uÃĪ«¡vÀ³¹ïCOVID-19¬Ì±¡«Ü­«­n¡A¤×¨ä¬O¤fªAÃÄ¡A¥¼¨Ó¥u¦³¾a¡u¬Ì­]¡v¤Î¡u¤fªAÃÄ¡v¤~¯àÅý¥@¬É³v¨B«ì´_¯´§Ç¡C

¤£¹L¡A¯Î±Ò´f©Z¨¥¡A¬Ì­]¤£¤Ó¥i¯à§¹¥þ¹w¨¾·P¬V¡A¦ý¥i¹w¨¾­«¯g¡AÃĪ««h¥iªvÀø»´¯g¡A´N¹³¡u§J¬y·P¡v¤@¼Ë¡A¦³¯gª¬ªº¸Ü¥i¥H³z¹LªAÃÄ­°§C­«¯gµo¥Í²v¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/17 ¤U¤È 12:32:21²Ä 1775 ½g¦^À³
70%¤p¹«®ø°£¯Ø¸¢Àù¡IµØ¤H¬ì¾Ç®a´£¥X§ð§J¡§Àù¯g¤§¤ý¡¨·s¤èªk

¨Ó·½¡G ¾Ç³N¸g½n¡@2021-08-17

med.sina.com/article_detail_103_1_104218.html

»â»Î³o¶µ¬ã¨sªº¬O«¢¦òÂå¾Ç°|µØ¤H¬ì¾Ç®a¿c©[¥­±Ð±Â©M©P¤p¬Ã±Ð±Â¡C¨â¦ì¬ì¾Ç®a¦b¹L¥h¦h¦~ªº¦X§@¤¤¡A³ò¶¤@ºØ¿W¯Sªº²ã®ò»Ä²§ºc酶Pin1¶i¦æ¤F¸Ô²Ó¬ã¨s¡C

¹êÅçµ²ªGÅã¥Ü¡A¦b¦hºØ¯Ø¸¢Àù¼Ò«¬¤p¹«¤¤¡A¨Ï¥ÎÁ{§É¤W¤w¶}µoªºPin1§í»s¾¯¡A»P§K¬ÌÀøªkPD-1§í»s¾¯¡B¤ÆÀøÃĪ«¦N¦è¥LÀØ¡]gemcitabine¡^¨ó¦P§@¥Î¡A¥i¥H§¹¥þ®ø°£©Î«ùÄò½w¸Ñ¤p¹«Å餺ªº¸~½F¡I

¦b¤Þ¤J¨âºØ­PÀù°ò¦]Kras©Mp53¬ðÅܪº¯Ø¸¢Àù¤p¹«¤¤¡A¦pªG¶È¥Î¦N¦è¥LÀØ©MPD-1§í»s¾¯ªvÀø¡A®ÄªG¬Æ·L¡A¤j³¡¤À¤p¹«¦b3­Ó¤ë¤º¦º¤`¡FµM¦Ó¡A¥[¤JPin1§í»s¾¯ªºªvÀøÅãµÛ´£°ª¤F¥Í¦s²v¡A70%ªº¤p¹«¦bªvÀø«á¦Ü¤Ö¦s¬¡6­Ó¤ë¡A¨Ã¥BÅ餺ªº¸~½F®ø¥¢¤F¡C

½×¤å : doi.org/10.1016/j.cell.2021.07.020

¥t¥~¾Ú¤é¥»¾ÇªÌªº¬ã¨s

Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target

www.researchgate.net/publication/350143611_Prolyl_isomerase_Pin1_plays_an_essential_role_in_SARS-CoV-2_proliferation_indicating_its_possibility_as_a_novel_therapeutic_target/fulltext/605376ff299bf173675226ba/Prolyl-isomerase-Pin1-plays-an-essential-role-in-SARS-CoV-2-proliferation-indicating-its-possibility-as-a-novel-therapeutic-target.pdf

In conclusion, our study clearly showed an essential role of Pin1 in SARS-CoV-2 proliferation.Accordingly, the use of Pin1 inhibitors might be an effective therapy against COVID-19.

¦A¨Ó

Food polyphenols targeting peptidyl prolyl cis/trans isomerase Pin1

doi.org/10.1016/j.bbrc.2018.03.212

The IC50 value of tannic acid for Pin1 was determined to be 1.6 £gM .

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/15 ¤U¤È 08:18:41²Ä 1774 ½g¦^À³
ÁÂÁ Cliff¤j®¦¼w¹ï©óTANCOVIDÁ{§Éµ²ªG³Ì±M·~ªº¸Ñ»¡

³o­ÓÁ{§É³]­pÅý¤H¤£ª¾¸Ó«ç»ò»¡ , ¦ý²¦³º¸ÕÅçÃĪ«¤£¬O³æ¹ç»Ä

¥B¨ä¸ÕÅçÃĪ«¥i¯à¥u¬O´£¨úª«¨Ã¥¼¸g¯Â¤Æ , ³o©Î³\¬O°µ°·±d­¹«~·~ªº«äºû

¬°¤F¦A¶i¤@¨B¤F¸Ñ¸Ó¸ÕÅçÃĪ«

¤pªº§ä¨Ó¤F¤@½g¦³Ãö¸Ó¸ÕÅçÃĪ«ªº¤å³¹

³q¹LÅé¥~­G¸z®ø¤Æ-µo»Ã¬ã¨s¥Õ¤ì©MªO®ß³æ¹ç ( quebracho and chestnut tannins

) ªº§Ü®ñ¤Æ¯à¤O©M¥NÁÂ

www.sciencedirect.com/science/article/abs/pii/S1756464618304110

October 2018

Quebracho (QUE) ©M®ß¤l (CHE) ¬O³æ¹çªº¤ÑµM¨Ó·½¡A¦ý QUE¡BCHE »P¤HÃþ°·±d¤§¶¡¨S¦³Ápô¡C¸Ó¬ã¨s½Õ¬d¤FÅé¥~³æ¹ç´£¨úª«ªº§Ü®ñ¤Æ¤ÏÀ³©M¥NÁ®ø¤Æ-µo»Ã¡CFRAP ( ¦å¼ßÅKÁÙ­ì¯à¤O ) ¤ÀªRªí©ú CHE ªºÁÙ­ì¯à¤O°ª©ó QUE¡]6.90 ¹ï 5.07 mmol Trolox/g¡^¡A¦Ó QUE ªº²M°£¬¡©Ê§ó±j¡]8.16 mmol Trolox/g ¹ï 6.70 mmol Trolox/g¡^¡Cµ²ªGªí©ú¡A·L¥Íª«µo»Ã«á³æ¹çªº§Ü®ñ¤Æ¯à¤O­°§C¡A¦ý³q¹LÄÀ©ñ CHE (11.14 mmol/g) ©M QUE (4.79 mmol/g) ªºµuÃì¯×ªÕ»Ä¡AÆ[¹î¨ì°ª¯q¥Í¤¸¬¡©Ê¡C¹ï®ø¤Æ©Mµo»Ã³æ¹çªº UPLC-MS ¬ã¨s¹ï 18 ºØ¤Æ¦Xª«¶i¦æ¤FŲ©w©M¥b©w¶q¡A¥]¬A¥i¤ô¸Ñ©MÁY¦X³æ¹ç¤Î¨ä¥NÁª«¡Cµ²ªG¥Nªí¤F¶i¤@¨B¬ã¨s³o¨Ç¤ì§÷´£¨úª«¦b¤HÃþ¶¼­¹¤¤ªº¼ç¦b¥Î³~ªº¦³®Ä°ò¦¡C( G¤j½Ķ , ½Ð°Ñ­ì¤å )

³o18 ºØ¤Æ¦Xª«¤¤¥]§t GA

Table 2 : Tannins and metabolites identified in supernatants derived from digestion and fermentation of QUE and CHE

¦ý§t¶qªºªí¥Ü¤è¦¡ , ¤pªº¨Ã¤£¤F¸Ñ

¦ý¨ÌGA ©MEA ( Ellagic acid ) ¼Æ­Èªº¬Û¹ï¤ñ¸û ( GA : EA = 125 : 25.7¸U )

À³¥i§PÂ_ GA§t¶q¨Ã¤£°ª

¤S

¥H§Ü®ñ¤Æ¯à¤O¨Ó»¡

¸Ó¸ÕÅçÃÄ«~À³¤¶©ó6.90 ©M 5.07 mmol Trolox/g ¤§¶¡

¦Ó GA©O ?

www.hindawi.com/journals/bmri/2016/4287461/

Table 5.

In general, these phenolic compounds had very high antioxidant capacities.

FRAP values ¡K gallic acid had the highest value (35.45 ¡Ó 1.46 mmolFe2+/g)

TEAC values ¡K gallic acid had the highest TEAC value (23.56 ¡Ó 1.17 mmol Trolox/g)

©Ò¥H

GA ´X¬°¸Ó¸ÕÅçÃĪ«ªº 6 ­¿

¶È´£¨Ñ¤j®a°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GCliff10135274  µoªí®É¶¡:2021/8/15 ¤U¤È 03:13:51²Ä 1773 ½g¦^À³
·PÁ²q·Q¤j¤j§âTanCOVIDªº¸ÕÅçµ²ªG§ä¤F¥X¨Ó¡C

³o­ÓTanCOVIDªº¤HÅéÁ{§É¸ÕÅç¥Ñ¤@®a¦ÑµP·Ò»s³æ¹çªº¤½¥qSilvateam¡]²M«wÂ×4¦~©ó¸q¤j§Q¦¨¥ß¡^©ÒÃÙ§UªºÂùª¼¡BÀH¾÷³]­pªºÁ{§É¬ã¨s¡C

¦]¬°¦­´Á³æ¹ç¶È¥Î©ó¤Æ¤u¥Ö­²Âý»sµ¥¤u·~¥Î³~¡A«á¨Ó¸ó¨¬°·±d­¹«~»â°ì¡A±q¤ÑµM¥Õ°í¤ì¤ÎªO®ß´£·ÒTanins¡A¥[¤Wºû¥Í¯ÀB12»s¦¨·L¥Íª«¸s¿¯­¹¸É¥R¾¯¡AÄÝ©ó¤@ºØ«O°·­¹«~¡A²£«~¦W¬OArbox microbiota¡C(articulo.mercadolibre.com.ar/MLA-924477760-arbox-microbiota-suplemento-dietario-_JM)¡C

¸ÕÅç­pµe¡G

¨CÁû½¦Ån§t¦³240mg³æ¹ç¡A¦í°|¤¤·s«a¯f¬r±wªÌ¨C¤é¦­¡B±ß¦U¦Y¤@Áû·í»²§UªvÀø¡]­ì¥»ªº§Ü·s«aªvÀø·Ó±`¶i¦æ¡^¡A14¤Ñ«á¬Ý¬Ý¯à¤£¯àÁYµu¦í°|¤é¡H

¥D­nÁ{§É«ü¼Ð¡G¦í°|¤Ñ¼Æ¡]±q²Ä¤@ÁûArbox¶}©l¤é´Á¨ì¥X°|¤é´Á¡^¡C

¦¸­nÁ{§É«ü¼Ð¡G

1.²Ä28¤Ñ®Éªº¦º¤`²v¡C

2.²Ä28¤Ñ®É«I¤J©Ê©I§l³]³Æªº»Ý¨D©Ê¡C

3.²Ä21¤Ñ®ÉCRPÂà³±ªº¦Ê¤À¤ñ¡C

4.µoª¢°Ñ¼Æªº§ïÅÜ(ESR¡BCRP¡BÅK¡B¥Õ³J¥Õ)ºû¥L©RD¡A²Ä1¤Ñ»P²Ä14¤Ñ®Éªº®t¶Z¡C

5.µoª¢«e²Ó­M¿E¯À(pro-inflammatory cytokines)¤Îµoª¢²Ó­M¿E¯À(inflammatory cytokines)¡A²Ä1¤Ñ»P²Ä14¤Ñ®Éªº®t¶Z¡C

6.°Æ§@¥Î¡C

7.¡K¡K¡K

¦¬®×±ø¥ó¡G18·³¥H¤W¡B©Ê§O¤£©ë¡B¶ñ¨ã¦P·N®Ñ¡B¸gPCR½T¶E¤§·s«a±wªÌ¡C

±Æ°£±ø¥ó¡GÃh¥¥¤Î­÷¨ÅªÌ¡B¤w¦í¶iICU©Î»Ý¨Ï¥Î©I§l¾¹ªÌ¤£¦¬¡C

¦¬®×¦aÂI¡Gªü®Ú§Ê±Æ¦W³Ì°ªªº¤j¾Ç¡]¥¬©y¿Õ´µ¦ã§Q´µ¤j¾Ç¡^ªþ³]Âå°|¡A¦¬®×140¦W¡C

¦¬®×®É¶¡¡G¬ù¦Û2020¦~7¤ë°_¡C

©Ò¥H±N¦¬¤J»Ý¦í°|¦ý©|¤£»Ý­n¦í¶iICUªÌ©Î¤£»Ý¨Ï¥Î©I§l¾¹ªÌ¡Aºâ¬O¤¤«×±wªÌ¡H¥¼¦bÁ{§É­pµe¤¤ª½±µ«ü©ú¡A¦¬®×±ø¥ó¼eÃP¡C

Arbox microbiota§t¦³240mg³æ¹ç¡A¥¼¸g¯Â¤Æ¡F´Nºâ¤w¯Â¤Æ¡A³o­Ó¾¯¶q¤]»·§C©óSNB01ªº¾¯¶q¡C

©Ò¥H¦¨¥\²v¤£¬Ý¦n¡C

³ø§i¥X¨Ó«á§¹¥þ¨S´£¨ì¥D­nÁ{§É«ü¼Ð¡G¡uÁYµu¦í°|¤éªº¡vµû¦ô³ø§i¡C¥u´£¨ì¦¸­n«ü¼Ðªº²Ä5¶µµ²ªG¡A³q±`ªí¥Ü¥D­n«ü¼Ð¤Î¦¸­n«ü¼Ðªº«e¥|¶µµ²ªGºÉ¾¥¡C

³o¬O¥Ñ°·±d­¹«~¤½¥q©Ò¥D¾ÉªºÁ{§É¸ÕÅ窺±`¨£µ²ªG¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/15 ¤U¤È 12:25:43²Ä 1772 ½g¦^À³
¹ù¥Sªü¤g³Õ¤À¨Éªº

CDCµo¥¬COVID-19ºC©Ê¯g­Ô¸sPASCªº¦^ÅU

liawbf.pixnet.net/blog/post/49750475

¥t¥~¬Q±ßªº [ °·±d 1+1 ] ªº¼v¤ù

www.youtube.com/watch?v=xCi1qXV4ZH8

³o­Ó¼v¤ù»¡©ú ¥|ºØ¬Ì­]ªºABC , ÁÙ¦³¨ë¬ð³J¥Õ³y¦¨ªº·L¦å®ê¹ï²Õ´²Ó­MÃa¦ºªº¼vÅT

¨Ã±j½Õ·s«aÃĪ«¦h­«¾÷¨îªº­«­n©Ê

¥B©IÆ~¹ï©ó­è½T¶EªÌªº·ÓÅU , À³¦³ÃĪ«´£¨ÑªvÀø , ¤Å¥ô¨ä¦ÛµMµo®i , µ¥´c¤Æ¬°­«¯g¦A¨Ó³B²zªvÀø

´Á«ÝSNB011¦³¯à¤O¨¾¤î»´¯g½T¶EªÌµo®i¬°­«¯g

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/15 ¤W¤È 10:00:12²Ä 1771 ½g¦^À³
¤j®a©Î³\¥i¥H°Ñ¦Ò¤@¤U

³o¬O¤@­Ó¤fªA³æ¹çªºÁ{§É¸ÕÅç , ¤£¹L¤£¬O³æ¹ç»Ä

Tannin Specific Natural Extract for COVID-19 Infection (TanCOVID)

clinicaltrials.gov/ct2/show/NCT04403646?term=TANCOVID&draw=2&rank=1

ClinicalTrials.gov Identifier: NCT04403646

¨Ì¾Ú¸Ó¸ê®Æ

¥¦©ÒªA¥Îªº¸É¥R¾¯¬O¤@ºØ¥Ñ¥Õ¤ì©MªO®ß³æ¹ç´£¨úª« ( a molecular complex of quebracho and chestnut tannins extract ) ©Mºû¥Í¯À B12 ²Õ¦¨ªº¤À¤l½Æ¦Xª«¡C

¤S¨Ì

´I§t³æ¹ç´£¨úª«ªº­¹ª«¥i«P¶i¤HÃþ¸z¹D·L¥Íª«¸sªº°·±dÅܤÆ

www.frontiersin.org/articles/10.3389/fmicb.2021.625782/full

§Ú­Ìªº¤ÀªR´¦¥Ü¤F¤TºØ³æ¹ç´£¨úª«¹ï SCFA ²£¥Íªº½Õ¸`ªº¤@¨Ç®t²§¡]¹Ï 7B¡Fªí 1¡^¡CQUE¡]¤@ºØÁY¦X³æ¹ç¡^¡BCHE¡]¤@ºØÂýªá³æ¹ç¡^... ¨ã¦³¤£¦Pªº¤Æ¾Çµ²ºc

©Ò¥H , ¸ÓÁ{§É¸ÕÅç¬O¤fªA ( ÁY¦X³æ¹ç + Âýªá³æ¹ç + ºû¥Í¯À B12 ) ªº²Õ¦X

¦Ü©ó¸ÓÁ{§Éµ²ªG

Fr578

ORAL TANNINS REDUCE PROINFLAMMATORY CYTOKINES ASSOCIATED WITH DIARRHEA AND PNEUMONIA IN HOSPITALIZED COVID-19 PATIENTS.

Fr578

¤fªA³æ¹ç´î¤Ö¦í°| COVID-19 ±wªÌ¤¤»P¸¡Âm©MªÍª¢¬ÛÃöªº«Pª¢²Ó­M¦]¤l¡C

www.gastrojournal.org/article/S0016-5085(21)01599-7/pdf

2021¦~5¤ë10¤é¦b½uµoªí

²¤¶¡G

¦³ÃÒ¾Úªí©ú¸z¹D·L¥Íª«¸s¤Î¨ä»P§K¬Ì¨t²ÎªºÃö«Y¥i¯à»PCOVID-19ªºµo¯f¾÷¨î¦³Ãö¡CSARS-CoV-2¥i¦b¯e¯fªº¦­´Á¶¥¬q¤Þ°_­G¸z¹DÄpª¬¡C¸z¹D¥\¯à»Ù껤µo¸z¹D·L¥Íª«ªºÅܤơA¨Ã¼W¥[ª¢¯g²Ó­M¦]¤l¡C¦]¦¹¡A·L¥Íª«½Õ¸`¥i¥H¦bCOVID-19ªvÀø¤¤µo´§§@¥Î¡C³æ¹ç¤w³QÃÒ©ú¦b­G¸z¹D·L¥Íª«¹Ï¤W§@¬°¯q¥Íµßµo´§§@¥Î¡C¯S§O¬O¡A«¶¥¬©Ô³ì©M®ß¤l³æ¹ç ( quebracho and chestnut tannin) ¤w¸gªí©ú¡A³q¹L·L¥Íª«¸sµo»Ã»²§U¥NÁª«¡A¦pquercetin©MSCFAs¡A¥i¥H½Õ¸`§K¬Ì¤ÏÀ³¡A´î¤ÖÅé¥~²Ó­M¦]¤lªº²£¥Í¡C

¥Ø¼Ð¡G

µû¦ôCOVID-19±wªÌ³æ¹ç¯S²§©Ê¤ÑµM´£¨úª«ªºÀø®Ä©M¹ï²Ó­M¦]¤l¤ô¥­ªº¼vÅT¡C

§÷®Æ©M¤èªk¡G²¤

( §Ú­ÌÂùª¼ÀH¾÷¤À°t¤F124¨ÒRT-PCR½T¶ECOVID-19¯f¨Ò¡]>18·³¡^¡A±µ¨ü®æ¥¬©Ô³ì©M®ß¤l³æ¹ç¡]240²@§J¡^©MB12ºû¥Í¯À¡]0.72·L§J¡^©Î¦w¼¢¾¯ªº¤fªA°®´£¨úª«¡A¨C¤Ñ¨â¦¸¡A¬°´Á14¤Ñ¡A§@¬°¹ï¨ä¼Ð·ÇÅ@²zªº»²§UªvÀø¡C)

µ²ªG :

¦bÀH¾÷¤À°tªº124¦W±wªÌ¡]¥­§¡¦~ÄÖ55+/-15·³¡A¨k©Ê63¤H [50.81%]¡^¤¤¡A121¦W¡]97.58%¡^§¹¦¨¤F¸ÕÅç¡C³æ¹ç²Õ¥¼Æ[¹î¨ì¤£¨}¨Æ¥ó¡C¥X²{¸¡Âmªº±wªÌ¡]13%¡^¦³¦å²GMIP-1£\¤ô·Ç¤É°ªªºÁͶաA³q¹L³æ¹çªvÀøÅãµÛ­°§C¡]ªí1¡^¡C¦b°ò½u¤è­±¡AMIP-1£\¤ô·Ç¸û°ª¤]»PªÍª¢¶EÂ_¦³Ãö¡]¹Ï1¡^¡A¸Ó¶EÂ_¦b°w¹ï¤zÂZ¦]¤l¡]¦~ÄÖ¡B©Ê§O¡B¿}§¿¯f ; p=0.04¡^½Õ¾ã«áºû«ù¡C¦¹¥~¡A¦b°ò½u¤W¡AMIP-1 £\»PIL-1ra¡BIL-2¡BMIP-1b©MTNF-£\¤§¶¡¦³¥¿¬ÛÃöÃö«Y¡A©Ò¦³³o¨Ç²Ó­M¦]¤l¥D­n³q¹L³æ¹çªvÀø¦Ó´î¤Ö¡C

µ²½×¡G

¾Ú§Ú­Ì©Òª¾¡A³o¶µÁ{§É¸ÕÅç¬O­º¦¸°w¹ï¦í°|COVID-19±wªÌªº¸z¹D·L¥Íª«¸sªº¬ã¨s¡C¹ï©ó³o¨Ç¼Ð·ÇÅ@²zªº±wªÌ , ¤fªA³æ¹ç§@¬°»²§UªvÀø¡AÅãµÛ­°§C¤F»P¤£¨}¹w«á¡]§YªÍª¢©M¸¡Âm¡^¬ÛÃöªº«Pª¢²Ó­M¦]¤l¤ô¥­¡C¦¹¥~¡A§Ú­Ì¥¼¨Óªº¬ã¨s±N½T©w­þ¨Ç·L¥Íª«¸s¤¶¾É¾÷¨î¥i¥H«d®z²Ó­M¦]¤l­·¼É¡A³o¦bCOVID-19µo¯f¾÷¨î¤¤¬OÅã¦Ó©ö¨£ªº¡C

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/14 ¤W¤È 11:47:47²Ä 1770 ½g¦^À³
¥L½T¶E·s«a¸£¶Ë¡u¤£»{±o¦Ñ±C¡v Âå¡G¥þ¨­³£³Q§ðÀ»

2021-08-14 10:40 Áp¦X³ø / °OªÌ³\¬F·®¡þ¥x¥_§Y®É³ø¾É

udn.com/news/story/120940/5673258?from=udn_ch2_menu_v2_main_index

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/13 ¤U¤È 05:19:18²Ä 1769 ½g¦^À³
¨p¶Ò±Ò°Ê

¤½§i¥»¤½¥q¸³¨Æ·|¨Mij110¦~«×²Ä¤@¦¸¨p¶Ò´¶³qªÑ©w»ù

1.¸³¨Æ·|¨Mij¤é´Á:110/08/13

2.¨p¶Ò¦³»ùÃÒ¨éºØÃþ:´¶³qªÑ

3.¨p¶Ò¹ï¶H¤Î¨ä»P¤½¥q¶¡Ãö«Y:

Numoda Capital Innovations LLC

1)¥»¤½¥q¦P®É»P Numoda Capital Innovations LLC ¤§Ãö«Y¥ø·~ Prevail InfoWorks

(prevailinfoworks.com) ñ­q CRO ¦X¬ù¡A¥Ñ Prevail InfoWorks ´£¨Ñ

¥»¤½¥q SNB011 ±M®×¦b¬ü°ê¤§²Ä II ´Á¤Î²Ä III ´ÁÁ{§É¹êÅç CRO ªA°È¡C¦­¤w±Ò°Ê

Á{§É¸ÕÅç¡C

2) Prevail Partners, LLC. ¬O Numoda Capital Innovations LLC. ¹ï¥~Àç¹Bªº°Ó¸¹

(Fictitious Business Name)

4.¨p¶ÒªÑ¼Æ©Î±i¼Æ:

¹w­p¨p¶ÒÃB«×¬°433,212ªÑ(¹ê»Úµo¦æªÑ¼Æ¥HÀ³¶Ò¤H»{ÁʼƬ°·Ç)¡A

¦û±o¨p¶ÒÃB«×20,000¥aªÑ¤§2.16%¡C

5.±o¨p¶ÒÃB«×:

©ó´¶³qªÑ20,000¥aªÑ¼Æ(§t)¤º¤§ÃB«×¡A©ó110/07/01ªÑªF·|¨Mij¤§¤é°_¤@¦~¤º

±ÂÅv¸³¨Æ·|¤À4¦¸¿ì²z¡C

¹w­p¨p¶ÒÃB«×¬°433,212ªÑ(¹ê»Úµo¦æªÑ¼Æ¥HÀ³¶Ò¤H»{ÁʼƬ°·Ç)¡A

¦û±o¨p¶ÒÃB«×20,000¥aªÑ¤§2.16%¡C

6.¨p¶Ò»ù®æ­q©w¤§¨Ì¾Ú¤Î¦X²z©Ê:

¥»¦¸¨p¶Ò´¶³qªÑ¹ê»Ú»ù®æ¤§­q©w¡A¥H¤£§C©ó°Ñ¦Ò»ù®æ¤§¤E¦¨¬°­q©w¨p¶Ò»ù®æ¤§¨Ì¾Ú¡C

°Ñ¦Ò»ù®æ¬°¤U¦C¤G°ò·Ç­pºâ»ù®æ±E°ªªÌ©w¤§¡G

a¡B©w»ù¤é«e 30 ­ÓÀç·~¤é¿³ÂdªÑ²¼¹q¸£Ä³»ùÂI¿ï¨t²Î¤º¸Ó¿³ÂdªÑ²¼´¶³qªÑ¤§¨C¤@Àç·~

¤é¦¨¥æª÷ÃB¤§Á`©M°£¥H¨C¤@Àç·~¤é¦¨¥æªÑ¼Æ¤§Á`©M­pºâ¡A¨Ã¦©°£µLÀv°tªÑ°£Åv¤Î°t

®§¡Aº[¥[¦^´î¸ê¤Ï°£Åv«á¤§ªÑ»ù¡C

b¡B©w»ù¤é«e³Ìªñ´Á¸g·|­p®v¬d®ÖñÃҩή־\¤§°]°È³ø§iÅã¥Ü¤§¨CªÑ²b­È¡C

7.¥»¦¸¨p¶Ò¸êª÷¥Î³~:¥»¦¸¨p¶Ò¸êª÷ÀÀ¹B¥Î©ó¥R¹êÀç¹B¸êª÷¡A¨Ò¦p¡GÁ{§É¹êÅç¡C

8.¤£±Ä¥Î¤½¶}¶Ò¶°¤§²z¥Ñ:¤½¥q¦Ò¶q¥Ø«e¸ê¥»¥«³õª¬ªp¡A¬°´x´¤¶Ò¶°¸ê¥»¤§®É®Ä©Ê

¤Î¥i¦æ©Êµ¥¦]¯À¡A©óµu´Á­­¤º¨ú±o©Ò»Ý¤§¸êª÷¡AÀÀ³z¹L¨p¶Ò¤è¦¡¿ì²z¼W¸ê¡C

9.¿W¥ß¸³¨Æ¤Ï¹ï©Î«O¯d·N¨£:µL¡C

10.¹ê»Ú©w»ù¤é:110/08/13

11.°Ñ¦Ò»ù®æ:53.65

12.¹ê»Ú¨p¶Ò»ù®æ¡BÂà´«©Î»{ÁÊ»ù®æ:¨CªÑ·s¥x¹ô 77.25¤¸¡C(USD2.77@27.888)

13.¥»¦¸¨p¶Ò·sªÑ¤§Åv§Q¸q°È:

¥»¦¸¨p¶Ò·sªÑ¤§Åv§Q¸q°È»P¥»¤½¥q¤wµo¦æ¤§´¶³qªÑ¬Û¦P¡A±©¨ÌÃÒ¨é¥æ©öªk²Ä 43 ±ø¤§8

³W©w¡A¥»¦¸¨p¶Ò¤§¦³»ùÃÒ¨é©ó¥æ¥I«á¤T¦~¤º¡A°£²Å¦Xªk¥O³W©w¤§¯S©w±¡§Î¥~¤£±o¦Û¥Ñ

ÂàÅý¡A¥»¤½¥qÀÀ©ó¸Ó¨p¶Ò¦³»ùÃÒ¨é¥æ¥Iº¡¤T¦~«á¡A¨Ì¬ÛÃöªk¥O³W©w¦V¥DºÞ¾÷Ãö¸É¿ì

¤½¶}µo¦æ¤Î¥Ó½Ð¥»¦¸¨p¶Ò¦³»ùÃҨ鿳Âd©Î¤W¥«Âd¥æ©ö¡C

14.ªþ¦³Âà´«¡B¥æ´«©Î»{ªÑªÌ¡A¨ä´«ªÑ°ò·Ç¤é:¤£¾A¥Î¡C

15.ªþ¦³Âà´«¡B¥æ´«©Î»{ªÑªÌ¡A¹ïªÑÅv¥i¯àµ}ÄÀ±¡§Î:¤£¾A¥Î¡C

16.¨ä¥LÀ³±Ô©ú¨Æ¶µ:

(1)¸³¨Æ·|¨Mij©w»ù¤é¤§¤é°_¤Q¤­¤é¤º»Ý§¹¦¨ªÑ´Ú¦¬¨¬¡A¥»¦¸¹ê»Ú¼W¸ê°ò·Ç¤éÀÀ±ÂÅv

¸³¨Æªø¨Ì¹ê»Ú±¡§Î¥t¦æ­q©w¤§¡C

(2)¥»¦¸¨p¶Ò´¶³qªÑ¡A­Y¦]ªk¥O­×¥¿©Î¥DºÞ¾÷Ãö³W©w¤Î°ò©óÀç¹Bµû¦ô©Î«ÈÆ[Àô¹Ò¤§¼vÅT

¶·Åܧó©Î­×¥¿®É¡A´£½Ð¸³¨Æ·|±ÂÅv¸³¨Æªø¥þÅv³B²z¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/13 ¤U¤È 03:21:59²Ä 1768 ½g¦^À³

¤@½g²`«×ªº³ø¾É

¡m¯Ã¬ù«È¡n²`«×¡G·s«a¯f¬r¤£Â_¬ðÅܦó®É¬O­ÓÀY¡H

¨Ó·½¡G ¾Ç³N¸g½n¡@2021-08-13

med.sina.com/article_detail_103_1_104056.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/11 ¤U¤È 07:07:32²Ä 1767 ½g¦^À³

Prof. Andrew Pollard : Åܺدf¬rÅý¥þÅé§K¬ÌÅܱo¤£¥i¯à !?

www.genetinfo.com/international-news/item/51413.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/11 ¤W¤È 09:32:09²Ä 1766 ½g¦^À³
COVID-19 Ãø¸Ñªº«á¿ò¯g

www.genetinfo.com/international-news/item/51273.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/9 ¤W¤È 09:01:23²Ä 1765 ½g¦^À³
¹ù¥Sªü¤g³Õ¤µ¤Ñ¦­¤Wªº¤j¤å

liawbf.pixnet.net/blog/post/49741935

¤å³¹¸Ì¦h©Ò¤¶²Ð Regeneron §Ü·s«aªº§ÜÅéÃĪ« REGEN-COV

®Ú¾Ú Regeneron °]³ø , ¸ÓÃĦb¤µ¦~²Ä¤G©uªº¦¬¤J¬° 27.6»õ ¬ü¤¸

FDAÁÙ¦b7¤ë31¤é±NEUA¤H¸s½d³òÂX¤j¦Ü¼ÉÅS«e¹w¨¾¡A«áÄòÁÙ±NÂX¤j¦Ü¦í°|±wªÌ¡C¦A¥Í¤¸­t³d°O¿ý¸Ó²£«~¦b¬ü°êªº¦¬¤J¡Aù¤ó­t³d¬ü°ê¥H¥~°ê®a©M¦a°Ï¡CREGEN-COV¤W¥b¦~¦b¥þ²yªº¾P°âÃB¤w¸g¹F¨ì35.1»õ¬ü¤¸¡C

ºK¦Û :

¦A¥Í¤¸¥b¦~³ø¡G·s«a¤¤©M§ÜÅé35»õ¬ü¤¸ªü¬f¦è´¶45»õ¬ü¤¸

¨Ó·½¡G¡@2021-08-08

¤å³¹¨Ó·½¡G ÂåÃÄÅ]¤èInfo

med.sina.com/article_detail_100_2_103692.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/9 ¤W¤È 08:15:28²Ä 1764 ½g¦^À³
­°§Cªü¯÷®üÀq¯g­·ÀI³Ì¦³®ÄªºÃÄ ´N¬O¥¦¡@

www.chinatimes.com/realtimenews/20210809000003-260418?chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/6 ¤U¤È 12:37:29²Ä 1763 ½g¦^À³
¹ù¥Sªü¤g³Õ¤µ¦­¤Þ­z¦L«×¯«µ£°ÚÃø±oªº³ø¾É

liawbf.pixnet.net/blog/post/49737946

¨Ã´£¤F¤@­Ó¦³½ìªº¸ÜÃD---·|¤£·|¤ß®®ªº TA ©M ¤Í¤½¥qªº Antro...¦¨¬°¯«µ£¤f¤¤¶Ç²Î§Ü¬Ìªº¤è¦¡©M¤ä¬W ?

¦]¬°¨â­Ó·sÃij£¬OµÑ¨ú¦Û´Óª« , ¤]³£¬O¶Ç²Î¥H¨Óªº¥ÎÃÄ , «á¨Ó¤~¥H¤Æ¾Ç¦X¦¨

·íµM

¯«µ£¦³¦Û¤vªº·Qªk , »{¬°¶Ç²Î [ ªü¨|§pªû ] ¦ÛµMÂå¾Ç , ¹³¬O­¹¥Î Giloy µ¥¤ÑµM¯óÃĨ㦳®Ä¥Î

¥©¦Xªº¬O

Giloy ¸g¬ã¨sÃÒ¹ê§t¦³ Tannins ©M GA

***

www.researchgate.net/publication/306060650_Phytochemical_and_Biological_Analysis_of_Tinospora_cordifolia

Preliminary phytochemical screening of T. cordifolia showed the presence of carbohydrates, glycosides, flavonoids, phenols, tannins and amino acids in the

crude drug.

***

Anti-acetylcholinesterase activities of mono-herbal extracts and exhibited synergistic effects of the phytoconstituents: a biochemical and computational study

Conclusion: HPLC method was developed and validated for the analysis of Giloy - methanolic extract using five marker compounds. It was found that 0.134 mg/gm gallic acid, 0.159 mg/gm palmatine, 0.022 mg/gm berberine, 0.494 mg/gm vanillic acid and 0.205 mg/gm ferulic acid were present in Giloy methanolic extract.

ǢǢ !

§Æ±æ¸g¹L¯«µ£ªº¥[«ù , SNB011 ¤Î SNB02 ¯à¦³¥ú©úªº«e´º

¥H«e§Ú­Ì½Í¤F¤£¤Ö¬ì¾Ç

³o¦¸´NÅý§Ú­Ì»´ÃP¤@¤U¨Ó¾Ö©ê«H¥õ

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/6 ¤W¤È 07:35:16²Ä 1762 ½g¦^À³
NRF2 ¤]¦³«ú§Ü¾¯¥Î¥HªvÀøNRF2¨Ì¿àªºÀù¯g , ÁÙ¦³§Ú­Ì«e´X¤Ñ´£¹LªºªvÀøª¢¯g©Ê¯e¯fªº¿E°Ê¾¯¡C

«ô¦Õ20»õ¬ü¤¸¦¬ÁÊÀù¯g¤p¤À¤l¹v¦VÃĬãµo¤½¥q

¨Ó·½¡G ³ÐŲ¶×¡@2021-08-05

Vividionªº¥þ³J¥Õ½è²Õ¤p¤À¤lÃĪ«¶}µo¥­¥x¬O°ò©ó¥[§QºÖ¥§¨È¦{Scripps¬ã¨s©Òªº¶}³Ð©Ê¤u§@¡A¥i¥HÃѧO³J¥Õ¹vÂIªº¤p¤À¤l°tÅé¡AµM«á³q¹L¦hºØªvÀøµ¦²¤¡]¨Ò¦pª½±µ§í¨î¡AÅܺc½Õ¸`¡A¹v¦V­°¸Ñ¡^¥[¥H§Q¥Î¡A¶}µoªvÀøÃĪ«¡A³Ìªìªº­«ÂI¬O¸~½F¾Ç©Mª¢¯g¾Ç¡C

¸Ó¤½¥q­º§å¥þ¸ê¸ê²£¥]¬A¥HKEAP1-NRF2¶b¬°¹vÂIªº¶µ¥Ø¡AªvÀøNRF2¬ðÅÜÅé©MNRF2¨Ì¿àÀù¯gªº«ú§Ü¾¯¥H¤ÎªvÀøª¢¯g©Ê¯e¯fªº¿E°Ê¾¯¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/4 ¤W¤È 09:42:09²Ä 1761 ½g¦^À³
¹ù¥Sªü¤g³Õªº²`¤JÆ[¹î

liawbf.pixnet.net/blog/post/49735374

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/8/4 ¤W¤È 09:29:02²Ä 1760 ½g¦^À³
®¥³ß¥_·¥¬PÃÄ·~²{¼W¦¨¥\ , ¤@Á|¶Ò±o·s¥x¹ô 51.2 »õ¤¸

³o¦¸¸Ó¤½¥q¿ì²z²{¼W¬O¦b¥¦ªºªÍ¶¡¥ÖÀù¤T´Á¸ÕÅç ( OS»PPFS¤§CP­È§¡¤w¶W¹L80% )Àò±oDSMB«Øij´£¦­µ²§ô¤T´ÁÁ{§É¸ÕÅç«á¤~¨M©wªº

¦Ó¥B²{¼W»ù®æ ( 80 ¤¸ ) ¶W¹L·í®Éªº¥«»ù

©Î¥i±À´ú , ¨M©w¿ì²z²{¼W·í®É©Î¤w»P¯S©w¤H¨ú±oÀq«´ --- ­ìªÑªF¥¼»{³¡¤À¥Ñ¯S©w¤H»{ÁÊ

¥_·¥¬PÃÄ·~¤W¦¸¤j´T¼W¸êÀò±o³¯¦ÑÁó¤j¤O¬Û®¼ , ©Î­É§U¤H¯ß

³o¦¸ªº¼W¸ê¦¨¥\ , ©Î¥H¦Û¨­Á{§É¸ÕÅ窺¦¨ªG¨ÓÀò±o¯S©w¤Hªº«C·ý

¥_·¥¬PÃÄ·~ªº¼W¸ê¾úµ{©M¼Ò¦¡ , ©Î¥i´£¨Ñ¤ß®®¤@­Ó°Ñ¦Ò

¤H¯ß«Ü­«­n , ¤×¨ä¬O¦bÁ{§É¦¨ªGÁÙ¥¼§e²{®É , ¦ý³Ì²×ÁÙ¬O±o¾a¦Û¤vªº§V¤O¿ïÃD¿ï§÷©ÒÀò±oªºÁ{§É¦¨¥\»P¥«¦û , ¤~¯àµo¥úµo¼ö

¤ß®®¥[ªo !

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/31 ¤U¤È 04:58:50²Ä 1759 ½g¦^À³
¬üCDC°±°l·P¬V¯}¤f ¦p¤µÅã¥Ü¬Ì­]®£¤]Ãøªý¶Ç¬V

2021-07-31 13:55 ¤¤¥¡ªÀ / µØ²±¹y30¤éºî¦X¥~¹q³ø¾É

udn.com/news/story/121707/5640851

¤µ¤Ñ¤½¥¬ªº¬ã¨sµo²{¡A7¤ë³Â¦{µo¥Í¦h°_¸s»E·P¬V¡A469°_­Ó®×¤¤°ª¹F74%¤w¥´§¹¬Ì­]¡A¥BÅ餺¯f¬r¶q»P¥¼±µºØ¬Ì­]ªÌ¬Û·í¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/29 ¤W¤È 08:37:52²Ä 1758 ½g¦^À³
NIH ¬ã¨s : ¦~»´¤H¨Ï¥Î¤j³Â»P¦Û±þ¬ÛÃö©Ê°ª ! ¤k©Ê­·ÀI§ó°ª

www.genetinfo.com/international-news/item/49830.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/29 ¤W¤È 08:28:57²Ä 1757 ½g¦^À³
®¥³ß¤Î¸r¼}¥_·¥¬PÃÄ·~ 1/3 ´N¹F¼Ð

§Ú­Ì¬O§_¤]¨Ó·ö¤ß¦k·Q¤@­Ó¼Æ¦r 2/3

­Y¦³¹³³o¼Ëªº¾÷·| , §Ú­Ì¬O¤£¬OÁÙ­n¨Ä¨Ä¦a¨«§¹¥þµ{ ?

´eÃa¤F , ¶}­Ó¹I·Qªºµ¡¤á , ´«¤@´«®ðª^¦Û·M

¶È¨Ñ®T¼Ö¤§¥Î

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/7/22 ¤U¤È 09:36:05²Ä 1756 ½g¦^À³
¤µ¤Ñ«D¤Z·s»D¦³¤ß®®ªº±M³X³á¡I

¤£¥u¤½¶}´¦ÅS¶i«×¡A¤]«Ü¿n·¥ªº¸ò¤j²³·¾³q´M¨DÃn¥ú

¤½¥q¤µ¦~¯uªº«D±`ªº¤£¤@¼Ë

³Ð·s°ª!¥xÆW¥Í§Þ²£·~§ë¸êÃB¹Gªñ700»õ ¥x¼t·s«aªvÀø·sÃÄ©é±ÂÅv¡U«D¤Z°]¸g·s»D¡U20210722

youtu.be/i1TXzhxEgVg

¡]­è­è¶K¿ùª©¤F¡AÁÙ¬O²ßºDµo¦b³o¸Ì ^_^¡^

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/21 ¤W¤È 08:08:43²Ä 1755 ½g¦^À³
¨È¬w¥Í§Þ®i¤µ¤Ñ´¦¹õ

¨Ó¦Û¹ù¥Sªü¤g³Õªº´£¥Ü

½²±Ð±Â±N¨üÁÜ°Ñ¥[©ú¤Ñ·s«a¯f¬r¬Ì­]±µºØ«áªº¤j¬y¦æ±±¨îÁ¿ºt

ÃD¥Ø¬O : From Russian Flu to COVID-19. Will History Predict the Future? Yes.

bioasiataiwan.com/en/teacher/article_list/86

¦b³o­Ó¥DÃD¤U¨üÁܪº¥xÆW¥»¤g¤½¥q¬° ¥ÍµØ¬ì ¤ß®® ©M °ê¹©

°£¤ß®®¥~ , ¥ÍµØ¬ì ©M °ê¹© ªºÁ¿ÃD³£¦b¤¶²Ð¦Û®aªº²£«~

©Ò¥H , §Ú­Ì¤]§Æ±æ½²±Ð±Â¯àÂǦ¹¾÷·|¶Ç¹F SNB011 µ¹¥~¬É»{ÃÑ

¥»¨Ó·Q½ÍªÑ»ù

¦ý¬O¬Ý¨ìªÑ»ù³Q³o¨Ç­ì©lªÑªFºR´Ý±o´X¥G©a©a¤@®§

¤S·Q¨ì³o¨Ç­ì©lªÑªF¤w±q¥«³õÅܲ{´X¤Q»õ¥x¹ô«oÁÙµLªkº¡¨¬

¤pªº´N¥u¯à´n¼Û¤£»y¤F !

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/20 ¤W¤È 08:23:44²Ä 1754 ½g¦^À³
Identification of over 200 long COVID symptoms prompts call for UK screening programme

UNIVERSITY COLLEGE LONDON

www.eurekalert.org/pub_releases/2021-07/ucl-ioo071321.php

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/19 ¤W¤È 11:25:02²Ä 1753 ½g¦^À³
®u±²¥þ²yªºDelta·s«aÅܺضǬV©Ê³o»ò±j¨s³º¬O¤°»ò­ì¦]¡H

¨Ó·½¡GÃÄ©ú±d¼w¡@2021-07-19

med.sina.com/article_detail_103_2_102633.html

·sªñµo¥¬ªº¦h¶µ¬ã¨sÅã¥Ü¡ADeltaÅܺضǬV©Ê±jªº¤@­Ó­«­n­ì¦]¡A¦b©ó¥¦¦b¨ü¨ì·P¬Vªº±wªÌÅ餺¼W´Þ³t«×§ó§Ö¡A¾É­P±wªÌ§ó¦­ÄÀ©ñ¯f¬rÁû²É¡A¨Ã¥BÄÀ©ñªº¯f¬rÁû²É¼Æ¥Ø§ó¦h¡C

¬ã¨s¤H­ûµo²{¡A¦b³o¨Ç³Q¹jÂ÷ªº¤H¸s¤¤¡A±q­º¦¸¯f¬r¼ÉÅS¨ìPCRÀË´ú§e¶§©Êªº¥­§¡®É¶¡¬°4¤Ñ¡A¦Ó¦b2020¦~·s«a¬y¦æ®É¡A³Q·í®Éªº¯f¬r®è·P¬Vªº¤H¸s³o¤@¼Æ­È¬°6¤Ñ¡C

¦Ó¥B¡A¨Ï¥ÎPCRÀË´úªºCt¼Æ­È¨Óµû¦ô±wªÌ¼Ë¥»ªº·s«a¯f¬r¸ü¶q®Éµo²{¡A¨ü¨ìDeltaÅܺطP¬Vªº±wªÌªì¦¸PCRÀË´ú¬°¶§©Ê®Éªº¯f¬r¸ü¶q»P2020¦~ªº¯f¬r®è¬Û¤ñ´£°ª¤F1260­¿¡C¹ï©óDeltaÅܺطP¬VªÌ¡A80.65%ªº¤f«|«ø¤l¼Ë¥»¦b³ÌªìPCRÀË´ú¶§©Ê®ÉÄâ±a¶W¹L6X105«þ¨©/²@¤É¯f¬rRNA¡C¦Ó2020¦~·s«a¬y¦æ®Éªº±wªÌ³o¤@¼Æ­È¬°19.05%¡C

³o¨Ç¼Æ¾Ú³£»PDeltaÅܺئb±wªÌÅ餺¼W´Þ³t«×§ó§Ö¤@­P¡C¥Ñ©óDeltaÅܺؼW´Þ§ó§Ö¡A±wªÌ¦b¨ü¨ì·P¬V«á§ó§Ö¥X²{PCR¶§©ÊÀË´ú¡A¦Ó¥B¼Ë¥»¤¤¯f¬r¸ü¶q§ó°ª¡C³o¤]·N¨ýµÛ¥L­Ì¥i¯à§ó¦­¨ã¦³¶Ç¬V©Ê¡C

¦Ó¯f¬r§ó§Öªº½Æ¨î¯à¤O¹ï·s«a¬Ì­]ªº«ù¤[©Ê¤]´£¥X¤F¬D¾Ô¡C¥Ø«eªº¦h¶µ¬ã¨s¤w¸gÅã¥Ü¡A§Y¨Ï§¹¦¨¬Ì­]±µºØ¤§«á¡AÀHµÛ®É¶¡ªº±À²¾¡AÅ餺ªº¤¤©M§ÜÅé¤ô¥­·|¥X²{¤U­°¡A³o¬O¤HÅé§K¬Ì¨t²Îªº¥¿±`¤ÏÀ³¡C¦b³o®É­Ô¡AÅ餺ªº°O¾ÐB²Ó­M©MT²Ó­M¦b¹w¨¾²Ä¤G¦¸·P¬V®Éªº§@¥Î­«¤j¡C³o¨Ç²Ó­M¤w¸g°O¦í¤F·s«a¯f¬rªº¼Ë¤l¡A¦b¯f¬r¤G¦¸¤J«Iªº®É­Ô¯à°÷¨³³t²£¥Í§ÜÅé©M²Ó­M§K¬Ì¤ÏÀ³¡CµM¦Ó¡A³oºØ§K¬Ì¤ÏÀ³ÁöµM¤ñ²Ä¤@¦¸¹J¨ì·s«a¯f¬r®Éªº²£¥Í³t«×§ó§Ö¡A¦ý¬O¤´µM»Ý­n®É¶¡¡C¦pªG¯f¬rªº½Æ¨î³t«×¥[§Ö¡Aµ¹§K¬Ì¤ÏÀ³²£¥Í¨¬°÷«OÅ@¯à¤O¯d¤Uªº®É¶¡¤]§ó¤Ö¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤j¤á¤H®a10140174  µoªí®É¶¡:2021/7/18 ¤W¤È 09:56:30²Ä 1752 ½g¦^À³
¦pªG¤½¥q»ù­È¤@ª½µLªk¹üÅã, ±N¨Ó¦pªG¤S­n¤@ª½Äw¸ê, §ä­Ó¨p¶Ò°òª÷ ¾Ç¥x·LÅé,Âà¨ì®ü¥~¤W¥«¤]¤£¬O¤£¦æ. ¤£µM¨C¦~Äw¸êºû«ù²b­È¤­¤¸¥H¤W¤]¬O«Ü¨¯­Wªº.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/7/18 ¤W¤È 09:11:30²Ä 1751 ½g¦^À³
¨ØªA«i©¹ª½«e¤j¤@³e«O«ù²z©Ê¤S¤£ÁB±¡ªºµo¨¥

¹j¾À¬P¬P§ä¨ì¤@»õ¬üª÷¥H«á»Ä¨¥»Ä»yÁÙ¬O¨C¤Ñ·Ó¤T¹y¨Ó

ª½¨ìÁ{§É¦³¤Fµ²ªG,»Ä·È·Èªº¸Ü´N·Ï®ø¶³´²¤F

½Ð½²±Ð±Â»°ºò°µ§¹Á{§É¦n¶Ü

ÁÙ¦³§rX¹©³Ìªñ¯u¥O¤H----¿e¥Øµ²¦Þ,

­è­è¦bºô¸ô¤W§ä¨ìX¹©ªº±M³X¤º®e----cnews.com.tw/203210702a01/---²´¯]¤l®tÂI±¼¥X¨Ó¤F

¥h­«°T°Ï°Â¤F¤@°é----­ì¨Ó­«°T³o¯ë·G»ù,³£­nºÎı¤FÁÙ¦bµo­«°T,

¤ß®®ºâ¬O³Q±aÁɧa?!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/7/16 ¤U¤È 09:30:01²Ä 1750 ½g¦^À³
´X¦ì¤j¤jªº¤ß±¡, ¦b¤U¤]·P¦P¨­¨ü

±q­·¥ú¤W¿³Âd¶}¤F¤@³õ«D¨å«¬ªºªk»¡·|¤§«á, ªÑ»ù«K¤@¸ô©¹¤U, ³Ñ250ªº1/6¤£¨ì!!«ü¼Æ8000ªº®É­Ô, ¤]¦b³o¸Ì, «ü¼Æ18000ªº®É­Ô, ¤]¦b³o¸Ì, ­n»¡¨S¦³±¡ºü, ¤]¤Ó°²

¦ý¬Oµû¦ô¤@®a¤½¥q, ÁÙ¬O±o¦^Âk«ÈÆ[²z©Êªº¨¤«×, ¦³¿³½ìªº¤j¤j¤£§«¦h¤F¸Ñ¤µ¦~°]°Èªø¦bªÑªF·|¤W²µu§ã­nªº³ø§i, §¹¥þ´x´¤¤F¤½¥qªº­«ÂIµo®i¤è¦V:

- Äw¸ê

- SNB-01 & SND-13ªº¶i«×

- IPO

ªÑ»ù¤§©Ò¥H¦b40-60¤§¶¡±r«Þ, »¡¦Ñ¹ê¸Ü, ¤½¥qªº½T¤]­n­t°_«Ü¤jªº³d¥ô, ¦pªG¤£¬O«e´X¦~ªº¶i«×½w¦p¤û¨B, ¤S«ç·|¤Þµo³¡¤À¤jªÑªFªº¤£­@? ¹ð¹ð½Õ¸`«ùªÑ

·íµMªÑªF³£§Æ±æ¤½¥q¨B¨B°ª¤É, ¦ý¬O©¹«e¨«ªº¦P®É¤]¥²¶·Ã­°·¸gÀç

¦³­Ó¤£»·ªº«e¨®¤§Å²¥i¥H°Ñ¦Ò, °]°ÈªøÁÙ¤£ª¾¬°¦ó¦bñ°]³ø«e¤U¥x¤@Áù°`!?

ec.ltn.com.tw/article/breakingnews/3604937

©Ò¥H§Y«K¤½¥q¸gÀç¦b¤µ¦~¦³¤F·s®ð¶H, ¤@¤Á©¹¦nªº¤è¦VÁÚ¶i, ¦ý¬O§Ú¬Û«H¤½¥q¦b¥¿¬£¸gÀ窺¸ô¤W, ±oªá¤W¤ñ§O¤H§ó¦hªº¤O®ð¤~¯à¬ð¯}»ù®æ°Ï¶¡, ²¦³º, ½w¦p¤û¨Bªº¹L©¹, ¹ð¹ð¸õ²¼ªº¹L©¹, ªÑªF·|¤£ª¾©Ò¤ªªº¹L©¹, ¤£¬O¤@®É¥b¨è´N¥i¥H§áÂ५³õªºª^³ò, ¥X²{¶R½L¨Ó©Ó±µ¨º¨Ç¤£­@ªºÄw½X!

¸Ü»¡¸êª÷³£³°Äò¨ì¦ì¤F, ¥u¯à»¡, ½²¸³¨Æªø(Or ½²±Ð±Â)±µ¤U¨Ó¯uªº´N¬O¬Ý§Aªº¤F!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G§d¨ÎÀM10141531  µoªí®É¶¡:2021/7/16 ¤U¤È 04:58:45²Ä 1749 ½g¦^À³
109¦~ªº¦~³ø¦³¼g¤@¨Ç¸ê°T¡C·Q¤F¸Ñªº¥i¥H¬Ý¤@¤U¡C

¾Ö¦³ªºªÑ¼Æ¡Cµ¥µ¥ªº¸ê®Æ¡C

¨ä¹ê¤p§Ì¬Oı±o²¦³º¤ß®®´N¨S¦¨¥\¡C

ÁÙ¨S¦³¤°»ò¹ê½èªºµ²ªG¡CªÑ»ù­n¤W¥h¡C¦³ÂIÃø¡C

¥i¥H¬Ý¤@¤U¡C¹ù¤jªº¤å³¹¡C

¨ä¹ê§Úı±o¦h¤F¸Ñ¤@¤U¦Û¤v

¶RªºªÑ²¼¬O¤°»ò¡C¦b°µ¤°»ò¡C¶i«×¨ì­þ¤F¡C

¤ß¤¤¤ñ¸û·|¦³¤@¨Ç©³¡C

¥Í§Þ¡C¯uªº¤£¹³¨ä¥LªÑ²¼¡C¦]¬°°ªºb±ì¡C©Ò¥H¯uªº

¤@½¨âÀü²´¡C¸Ñª¼¶}µP¡C¤£ª¾¹Dµ²ªG¡A´Nºâ¶}µP¦¨¥\¡AÁÙ¤£ª¾¹DªÑ²¼·|¤£·|º¦¡C

¸Ñª¼¥¢±Ñ§óºG¡C¦pªG¤ñ¸û§Æ±æ¦Û¤vªºªÑ²¼¯à¦³«Ü´Îªºµo®i¡C¨ä¹ê§OªºªÑ²¼¦³«Ü¦h¤£¿ùªº¼Ðªº¡C

§Ú¤]¸ò¦U¦ì¤@¼Ë¡C²Ä¤@±i¶R¦b260©ê¨ì²{¦b¡C

¦hÁ«²q·Q¤j¡C»P¹ù¤j¡C¬Ý¬ÝÂå¾Ç³ø§i¡C·|¤j·§¦³­Ó©³¡C

¥u¬O»¡¡C¯à¤£¯à¦¨¥\¡CÁÙ¬O¹ù¤j»¡ªº¤@¥y¸Ü¡C¥Ø«e©Ò¦³ªºµ²ªG´N¬O¡uÃ䨫Ãä¬Ý¡v

·íµMªÑ²¼«Ü¤£¦n¡C¤j®a³£¨¯­W¤F¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gphliao10139754  µoªí®É¶¡:2021/7/16 ¤U¤È 03:25:34²Ä 1748 ½g¦^À³
¥v¤j¤§«e¤£¬O¦b»È¦æ·~¶Ü?
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/7/16 ¤W¤È 09:57:20²Ä 1747 ½g¦^À³
¦n¹³¦b¤ß®®·í°ÆÁ`¡A¸³¨Æ­Ýµo¨¥¤H¡A§Ú¤£ª¾¹D»¡ªº¹ï¤£¹ï¡IªÑ²¼¤£ª¾¹D¦³¦h¤Ö¡A¶R¨ì·í¸³¨Æ¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gphliao10139754  µoªí®É¶¡:2021/7/16 ¤W¤È 09:54:26²Ä 1746 ½g¦^À³
½Ð°Ý¥v¤j¦b¤ß®®¶Ü? §Ú¦Û±q¹q¤l³ø¨S§ó·s«á¡A´N¨S¥Lªº®ø®§¤F...
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/7/16 ¤W¤È 09:16:07²Ä 1745 ½g¦^À³
­ì¨Ó¤j®a³£¶R¦b«Ü°ªªº»ù¦ì¡A¥u¯à«ô°U¥v¤j·ÓÅU§Ú­Ì³o¸s¦º©¾ªºªÑªF¤F¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/7/15 ¤U¤È 09:53:45²Ä 1744 ½g¦^À³
¤p§Ì¤£¤~(°]?)

±q238¶R¨ì38

­W¦u°Ú~~

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p³¯10152058  µoªí®É¶¡:2021/7/15 ¤U¤È 07:19:12²Ä 1743 ½g¦^À³
¨S¿ù,±q250¤¸¶^¨ì³Ì§C20¤¸,¨ì©³¦³½Ö¯à©êªº¦í....

³oÀɪѲ¼¯uªº¥u¯à¦b40-60°Ï¶¡¨Ó¦^§a

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤ß®®¨H¯B10142041  µoªí®É¶¡:2021/7/15 ¤U¤È 03:22:11²Ä 1742 ½g¦^À³
Äêªd§ß¤£¤WÀð
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/7/15 ¤W¤È 10:42:32²Ä 1741 ½g¦^À³
¯uªº¬OµLÃÄ¥i±ÏªºÄêªÑ¡K¡K
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/14 ¤W¤È 07:54:57²Ä 1740 ½g¦^À³

ÀY±ø´¦±K¡n¬Ì­]±µºØ«á¬Ì±¡¨«¦V ³Ì·s¬ã¨s¹w´ú3ºØ¥i¯à³õ´º

04:12 2021/07/14 ¤¤®É·s»Dºô ¿c§BµØ

www.chinatimes.com/realtimenews/20210714000591-260407?ctrack=pc_main_recmd_p16&chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/9 ¤U¤È 04:14:22²Ä 1739 ½g¦^À³

FDA ­±Á{¿E¯P§åµû¡A±N¦³ª§Ä³ªºªüº¸¯ý®üÀq¤ó¯gÃĪ«ªº¨Ï¥Î½d³òÁY¤p¨ì¦­´Á¯e¯f±wªÌ

www.washingtonpost.com/health/2021/07/08/aduhelm-new-alzheimers-drug-who-is-eligible/

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/7/8 ¤U¤È 02:53:58²Ä 1738 ½g¦^À³
ºô·j¥x§üªº³ø¾É

www.cpmda.org.tw/news_show_n1.php?news_id=8740

·s·½¥Í§ÞÁ`¸g²z¨H§Ó¶©§Y±N±µ¥ô¥x§ü¥Í§ÞÁ`®y¡A¾á¥ô¥x§ü¤½¥q¤ô¤û2¸¹¥Í§Þ°òª÷¾Þ½L¤â¡A·~¬É«ü¥X¡A¥L¬O¥xÆW²Ä¤@¥N°µ¥Í§Þ³Ð§ëªº¸ê²`§ë¸ê±M®a¡A¥Í§Þ§ë¸ê¸gÅç¹O20¦~¡A§ë¸ê¹L¦h¶µ¦¨¥\ªº°ê»Ú¶µ¥Ø¡A¬O¤£¤G¤H¿ï¡C

¨H§Ó¶©¬O¥D¾É¥xÆW²Ä¤@¥N¥Í§Þ³Ð§ëªº¤j±N¡A´¿¨ü¥xÆW¥Í§Þ³Ð§ë¤§¤÷§õ¥¿©úÂȳ³¡A°Ñ»P¹L§õ¥¿©ú³Ð¿ìªº¸Û«H³Ð§ë¡A«á¤]¾á¥ô¸Ó³Ð§ëÁ`¸g²z¡C¥L©Ò°Ñ»Pªº¸Û«H³Ð§ë·í®É¦b§õ¥¿©ú·í®É¸¹¥l¤U¡A§ë¸ê¥Ñ¥xÆW¤H¡B¥Í§Þ±M®a­ð«n¬À©Ò³Ð¿ìªºTanox¡A1998¦~Tanox¦b¬ü°ê¤W¥«¡A¸Û«H¨ú±o3,000¦h¸U¬ü¤¸§ë¸ê¦^³ø¡AÁȤF¤»­¿¥X³õ¡C

¦h¦~«e¡A§õ¥¿©ú¦]¯fÆJ³u¡A¨H§Ó¶©¦b¥Í§Þ¤Ñ¤ý¡B¦w¦¨ÃÄ·~³Ð¿ì¤H³¯§Ó©úªºÁܽФU¥[¤J·s³¯³Ð§ë¡A¦P¼Ë¤]¼g¤U³\¦h§ë¸ê¨ÎÁZ¡A¦Ó³¯§Ó©ú·R¤~¡A«á¤SÁܽШH¾á¥ô¥L©Ò§ë¸êªº·sÃĤ½¥q·s·½¥Í§ÞÁ`¸g²z¡A¨â¤H¤]¼g¤U¥Í§Þ²£·~ª¾¹Jªº¤@¬q¨Î¸Ü¡C

¼ô±x¨H§Ó¶©ªº¤H¤h«ü¥X¡A¨H¤£¶È¦b¥Í§Þ§ë¸ê»â°ì¸gÅçÂ×´I¡B¦³¿W¨ìªº²´¥ú¡A§ó­«­nªº¬O¡A¥L¬°¤H¥¿ª½¡B¥¿¬£¡A¾Ö¦³¬ü°ê«Â´µ±d¨¯¤j¾Ç¤Æ¾Ç¤uµ{³Õ¤hªº¥L°µ¨ÆÄYÂÔ¡A»á¦³¬ì¾Ç®aªººA«×¡A¥¼¨Ó¾Þ½L°ê®a¥Í§Þ°òª÷¡A¥i±æ¬°¥xÆW³Ð³y§ó¦h¨ã¦³Ävª§¤Oªº¥Í§Þ³Ð·s¥ø·~¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/7/6 ¤U¤È 07:23:48²Ä 1737 ½g¦^À³
SNB-01ªº·Q¹³ªÅ¶¡¦³¦h¤j? ¸ê¥»¥«³õªº³q«h´N¬O¶W¯Å¤ñ¤@¤ñ!

½²¸³¨Æªø¤µ¦~ªÑªF·|¤W´£¤Î, COVID-19 oral treatment ¶Õ¥²¬O¦U®a¤jÃļtÄv¬Û°l³vªº¼Ðªº, ¦Ó¤ß®® SNB-01 ¤]¦Ò¼{ºÉ³t±ÂÅv, ÀHµÛSNB-01 Phase2 ªº®i¶}, ¨ì©³±ÂÅvªº·Q¹³ªÅ¶¡¦³¦h¤j? ¤£§«°Ñ¦Ò¦P¼Ë¤]¬O¤G´Á±ÂÅvªºAT-527

2020/10/20 Roche ªá¤F3.5»õ¬üª÷, ¶R¤U»PAtea Pharmaceuticals Inc ¦X§@¶}µoAT-527 ªºÅv§Q, ¥h¦~¤Q¤ëAT-527 ¤´¦bPhase 2¡AATEA¥«­È¬ù19»õ¬üª÷

¥Ø«e¤ß®®¥«­È¬ù2»õ¬üª÷

¥H¤U¬ORoche ©xºô¤ÎBloombergªº¬ÛÃö°T®§, ¨Ñ°Ñ¦Ò

www.roche.com/media/releases/med-cor-2020-10-22.htm

www.bloomberg.com/news/articles/2020-10-22/roche-buys-covid-treatment-rights-from-atea-in-350-million-deal

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/7/6 ¤U¤È 07:14:05²Ä 1736 ½g¦^À³
2021ªºªÑªF·|«á, ¯uªº¤£±o¤£»¡2021¬O¤ß®®¤¸¦~¡I¦Ó·s¥ô°]°Èªø¬O¤ß®®°_­¸«e³Ì«á¤@¶ô«÷¹Ï¡I

´§§O¹L¥h Lab¦¡¸gÀç, ¦b·s¥ô°]°Èªø¥[¤J«á, ¤µ¦~ªºªÑªF·|¤£¶È¦³¥ø·~ªº¼Ò¼Ë,¥¼¨ÓªºÀ¼µe,¤]¬Û·í¥O§ë¸ê¤H´Á«Ý¡I¥Ø«e¤w¦³¥x§ü»âÀY§¹¦¨²{¼W, ¦ÓÄw±¹ªºÂ³¯ó¶Õ¥²¥[³t¦¬®×¤Î¶}®×, ¨­¬°©`¦ÌªÑªFªº§Ú, ¦bªÑªF·|«á²`²`ı±o CFO ªº¥[¤J®Ú¥»Åý¤ß®®¦pªê²KÁl

1. SND-13ªº¦¬®×: ·|¤¤½²¸³¨Æªø´£¨ì­^°êªºSites ¦b¸g¾ú¬Ì±¡pending¤§«á, ¤S§Y±N¶}©l¦¬®×, ´_¥H¥xÆW°ò¶©ªø©°¤]¤w¥[¤J¦¬®×, Â÷²Ä¤G¦¸´Á¤¤¤ÀªR¤H¼Æ¤£»·, À³¸Ó¥i±æ¦b¦~©³¶i¦æ´Á¤¤¤ÀªR

2.SNB-01: ¬Ý¨Ó³o·|¬O¤ß®®¤µ¦~ªº­«ÀYÀ¸¤§¤@

a. ¥Ø«e¤ß®®»PÂå°|¦X§@, ¦V½ÃªA³¡¥Ó½Ð®¦·OÀøªk

b. ½²¸³¨Æªø¤À¨É COVID-19 oral treatment ¶Õ¥²¬O¦U¤jÃļt¦³°ª«×¿³½ìªº²£«~,µL½×¬O¦Û¦æ¬ãµo©Î¬O±ÂÅv (³o³¡¤À¦b¤U¥t¥~¶K¤å¤À¨É¤ß±o¡^, ÁöµM¥Ø«eSNB-01ÁÙ¦b¤G´Á(¥H¬ü°ê¦¬®×¬°¥D¡^,¦ý¬O¤]¦³³¡¤À¤j¼tÃö¤ß

c. SNB-01 ¦]¬°¦¬®×¤H¼Æ¤£¦h, ¬ù90¤H, ¤µ¦~À³¸Ó·|¦³¨â¦¸¶}µP, ¤@¦¸´Á¤¤¤ÀªR, ¤@¦¸¸Ñª¼

¥t¥~¡AÂ^¨úCFO³ø§iªº«GÂI¨Ñ¦U¦ì°Ñ¦Ò:

1. ¥x§üªº­«­n©Ê»·°ª©ó¦b¤Uªº·Q¹³, ¬Ý¨Ó¤§«eÃö©ó¥x§ü¤@¤åÁÙ¬O¨SÂI¨ìÃöÁä, ¥¦°£¤F¦b¥xÆW¥Í§Þ¦³»âÀY¡]Or »â§ë)ªº®ÄÀ³, ¦b®ü¥~ªº±ÂÅvµ¥µ¥¤]¦³¬Û·íÂ×´Iªº¸gÅç

´Á¶¡´£¨ì, ¥x§ü¸g¹L¤F¥b¦~ªºDue diligence, ¥H¥»¨­Â×´Iªº¸gÅç, ³o¦¸¥[¤J«eªº DD µ´¹ï«D±`§¹¾ã, °£¤F¬ì¬ã³¡¤À, ¥]¬A¤½¥qÀç¹B, °]°Èµ¥¦U­±¦V, ¥H¥¼¨Ó¥x­m«ùªÑ¥e¤ñ, ¶Õ¥²¹ï¤½¥qªºÀç¹B±a¨Ó¥¿­±ªº¼vÅT¤O

2. Prevail Partners ÁöµM¥u§ë¤F120¸U¬ü¤¸, ¥Ø«e¬O¦]¬°¬Ì±¡¤À¬y¤W¯Zªº¦]¯À, ©Ò¥H¸êª÷¤J±bµy¦³pending, ¦ýÀ³¸Ó·|«ö·Ó­ì©w­pµe°õ¦æ

®Ú¾Ú CFO ªº³ø§i, Prevail ¤£¶È¬O¤@®aÁ{§É³]­pªº¤½¥q, ­I«áªº¶°¹Î¦³¬Û·íÂ×´Iªº§ë¸ê¦X§@¸gÅç

µ¥¤F¼Æ¦~, ¥Ñ°J´Á¬ß¤µ¦~¬O¤ß®®®i¯Í°ª­¸ªº¤¸¦~¤F!!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2021/7/5 ¤U¤È 02:06:59²Ä 1735 ½g¦^À³
§Úı±o¤@®a¥Í§ÞªÑ­n¤Wº¦¬O­n¬Ý¤½¥q¦³¤°»ò§Q¦hÃD§÷

¦Ó¸gÀç¼h¹ï¶i«×¶V³z©ú§ë¸êªÌ¶V¯à¨ü¯q

¤µ¦~¾Þ§@¤T¤äªÑ²¼´N¬O¥H³o­Ó­ì«h¾Þ§@

³o¤T¤äÀò§Q°ò¥»³£¦³30%

¦~ªì²Ä¤@¤ä¬O¶h¹F

¥h¦~11¤ë±ÂÅv¤¤°ê«á´Nªí©ú¤µ¦~ªì·|¦³¬ü°ê±ÂÅv

§Ú¬ÝªÑ»ù¶^¤U¨Ó¤F´N¶X¾÷¶R¶i

¬ü°ê±ÂÅv¤@¥X¨ÓªG¯u³s´X®Úº¦°±ªO

²Ä¤G¤ä¬O¤¯·s

¤¯·s±q¸³¨Æ·|¨Mij³q¹L¥Ó½ÐªÑ²¼¤W¥«¡]Âd¡^©Îµn¿ý»OÆW³Ð·sªOªº®ø®§µo§G«á

ªÑ»ù´N¶}©l¤Wº¦

¤¯·s§Ú¤@ª½³£¦³¦bÆ[¹î¡A¬Ý¨ì¸³¨Æ·|¨Mij³q¹L¡AªÑ»ù´N¶}©lº¦

§Ú´N«ÜªÖ©w¡A¨ìªÑ²¼¤W¥«¡]Âd¡^³o¬q®É¶¡·|¦³Àò§QªÅ¶¡

¦A¨Ó´N¬O°ê¹©

°ê¹©¤j®a¤]ª¾¹D¥L¦³COVID-19·sÃÄÁ{§É

¥¼¨Óªº§Q¦h¤@¬O¸Ñª¼¤G¬O±ÂÅv

°ê¹©ªÑ»ù¤@ª½¦b50¤¸¤W¤U¡A³oºØªÑ»ù¤£¶R¥i±¤

°Q½×ª©ªº¤j®aÀ³¸Ó¹ï¥Í§Þªº§Q¦h¦³¬Û·íµ{«×ªº¤F¸Ñ

¦A¨Ó´N¥u¯Ê

¸gÀç¼hªº¸Û«H¡A¹ï¶i«×¬O§_¤½¶}³z©ú

¤ß®®¦³¨â­Ó§Q¦h

²Ä¤@¬O¤W¥«Âd

²Ä¤G¬O¸Ñª¼©Î¸Ñª¼«eªº±ÂÅv

¥Ø«e50ªºªÑ»ù¥u­n­@¤ßµ¥«Ý´N¦n¤F

¤ß®®¶i«×¶V§Ö

¤Wº¦®É¶¡´N¤£»·¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/5 ¤U¤È 01:09:58²Ä 1734 ½g¦^À³
ªü¤Ñ¤j

¤@ª½¥H¨Ó©Ò°Ñ¦ÒªºÄw½X²Î­pºô¯¸¤w¸gÃö³¬¤F

³o¦¸´IªÇªºÄw½X¬O®Ú¾ÚªÑÅv¤À´²ªí¦A¥[²q´ú¦Ó¨Ó

norway.twsthr.info/StockHolders.aspx?stock=6575

2021/06/18 ±¼¥X¤d±i±Æ¦æ , ·í®É¤j©ó400±iªÑªF«ùªÑ ¦@¦³ 70,684 ±i

2021/07/02 ®É , ¤j©ó400±iªÑªF«ùªÑ ¦@¦³ 70,419 ±i

¨âªÌ¬Û®t 265 ±i , ³o­Ó®É¬q¥u¦³´IªÇ¤j¶q½Õ¸`

©Ò¥H¦ô¬ù 700 ±i

¥H¤W»¡©ú

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªü¤Ñ10149120  µoªí®É¶¡:2021/7/5 ¤U¤È 12:41:30²Ä 1733 ½g¦^À³
¯uªº¦³°÷§é¿i¡K

¸Ü»¡²q·Q¤j¡A¦p¦ó±oª¾­þ­Ó¨é°Ó¦³´X±iªº¡K.¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/5 ¤U¤È 12:27:50²Ä 1732 ½g¦^À³
§Ú­Ì«Ü¤Ö½Í¥«³õ­± , ¤µ¤Ñ´N¨Ó»¡´X¥y

°ê¹©ªº±±½LªÌ¦n¼F®` , §@¶q­Ý§@»ù , Åý¤j®a¦n¶i¦n¥X , ©Î¤~¯à§l¤Þ¥«³õ¦@Á¸²±Á|

¤pªº¥u§Æ±æ¤ß®®ªº¶q¦A¤j¤@ÂI , Åý·QÂ÷¶}ªº¥i¥H§ÖÂI¦pÄ@

´IªÇ¬ùÁÙ¦³700±i , ³oºâ¦h¶Ü ?! ¤j®a³Q­ì©lªÑªF§é¿i¤­¦~¦h¤F , ÁÙ·|®t³o¨â¤T­Ó¤ë¶Ü ?!

°ê¹©´X¤Ñ´N¤@­¿¤F ; «¢ ! ¤]³\¦³¤@¤Ñ , ¤ß®®ªº°ò¥»­±­Y¦³¤j©ñ²§±m , ©¡®É¤j®a¥i¯à·|«Ü¤£²ßºD ?

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/7/5 ¤W¤È 10:06:40²Ä 1731 ½g¦^À³
±j¥Í¤µ«Å¥¬¦p´Á¤j¸Ñ«Ê¡I§â·s«a·í·P«_ ¦Û¤v§PÂ_­·ÀI

2021-07-05 09:44 Áp¦X³ø / ½sĶ±i§g³ó¡þ§Y®É³ø¾É

­^°ê­º¬Û±j¥Í¡]Boris Johnson¡^5¤é±N«Å¥¬¦p´Á²×¤î­^°ê¦h¼Æ¨¾¬Ì­­¨î¬Fµ¦¡A¦Û19¤é°_¨ú®øªÀ¥æ¦w¥þ¶ZÂ÷¡B©~®a¤u§@©MÀ¹¤f¸nµ¥¬ÛÃö­­¨î¡A¦P®É±j¥ÍÁÙ±j½Õ¡u¤H­Ì¥¼¨Ó¥²¶·¾Ç·|¹³¹ï«Ý¬y·P¤@¼Ë¦a»P·s«a¯f¬r¦@¦s¡v¡C

§Æ±æ¦³§U©ó SND ¨t¦CÁ{§Éªº©Û¶Ò

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/7/1 ¤U¤È 09:46:50²Ä 1730 ½g¦^À³
Kinmen3015 & ªü¤Ñ¥S¡A

Prevail¨p¶Ò«üªº´N¬O2/22¤½§iªº¨º¤@¦¸¡A¦ý¬O¦]¬°¥~¸êfini±b¤á¶}¤áªá«Ü¦h®É¶¡¡A©µ¨ì¤C¤ë©³§¹¦¨

¤µ¤Ñ°]°Èªø³Ì«á¦³µy·L»¡©ú¤½¥qªº°]°È»P¶Ò¸ê³W¹º¡A¦]¬°IPO¦³²b­È¤Wªº­n¨D¡A³o¦¸ªº²{¼W»PPrevailªº¨p¶Ò¬O­«­nªº°_ÂI

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/7/1 ¤U¤È 09:33:09²Ä 1729 ½g¦^À³
Kingko¥S¡A

´N§Ú©Òª¾¡A¤ß®®¥Ó½Ðªº®¦·OÀøªk¬O¤£¤À»´­«¯g¡C

¤£¹L®Ú¾Ú¤µ¤Ñ°ê¹©ªº¤½§i¡A¥L­Ì¥u¥Ó½Ð»´¯g¸ò¤¤¯g¤]¹LÃö¡A¥Nªí½ÃºÖ³¡¥Ø«e»{©wÀ³¸Ó¬Û¹ï¼eÃP¡C

pchome.megatime.com.tw/news/cat7/20210701/9700004132202107011.html

¡]ÃD¥~¸Ü¡A¬Ý°ê¹©¬Q¤ÑªºªÑ»ù¸ò¤µ¤Ñªº¤½§i¡A±j¯P½èºÃ¦³¤ºXªº¥i¯à¡^

Rabbit & ¦ÌÄ_¥S¡A

©êºp¡A§Ú¨SÁ¿²M·¡¡A­^°êªºÁ{§É¦¬®×¬O¬°¤FSND12 & 13¡A¤£¬OSNB01

SNB01¤G´Áªº¦¬®×¥D­n¦b¬ü°ê¤ñ¸ûÄY­«ªº¤j«°¥«¡A¥H¬Ì­]±µºØ²v§Cªº¼w¦{¸ò¦òù¨½¹F¦{¬°¥D¡A«áÄò¤T´Á­pµe·|¨ì©Ô¤B¬ü¬w¡A¦ý¥Ø¼Ð¬O¤G´Áµ²§ô±ÂÅv¥X¥h

¦Ü©óSND³¡¤À¡A¤jÀ¸´N¬Oµ¥¦~©³«eSND13´Á¤¤¤ÀªR

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªü¤Ñ10149120  µoªí®É¶¡:2021/7/1 ¤U¤È 09:29:34²Ä 1728 ½g¦^À³
2.77¬O²Ä¤@¦¸ªº¡AÁÙ¬O«á¨Ó¦A¤@¦¸¡A¦@¨â¦¸¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/7/1 ¤U¤È 09:20:20²Ä 1727 ½g¦^À³
º©¹CªÌ¤j

ÁÂÁ±zªº¤À¨É¡I

´±°ÝPrevail­n²Ä¤G¦¸参¥[¨p¶Ò

±z¼gªº2.77 USD

¬O«ü¤°»ò¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦ÌÄ_10132489  µoªí®É¶¡:2021/7/1 ¤U¤È 07:06:59²Ä 1726 ½g¦^À³
·PÁº©¹CªÌ¤jªº¤À¨É

6. ­^°ê¦³¤C­Ó¤j«¬¬Æ¦Ü¬O¤W¦Ê¦~ªºÁ{§É¤¤¤ß¡A¹ï¦¬®×«Ü¦³À°§U

«üªº¬OSNB01 ÁÙ¬OSND¨t¦Cªº?

«ç»ò§Úı±oÀ³¸Ó¬O«üSND¨t¦C?

www.syneurx.com/2021/06/25/0625/

¥t¥~°w¹ïSND³¡¤ÀÁÙ¦³´£¨ì¤°»ò¶Ü?

ÁÂÁÂ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Grabbit10136567  µoªí®É¶¡:2021/7/1 ¤U¤È 01:51:06²Ä 1725 ½g¦^À³
6. ­^°ê¦³¤C­Ó¤j«¬¬Æ¦Ü¬O¤W¦Ê¦~ªºÁ{§É¤¤¤ß¡A¹ï¦¬®×«Ü¦³À°§U

­^°ê²{¦b¦³·sªº¤@ªi¬Ì±¡¡A¦ý¦n©_ªº¬O¦]¬°¬Ì­]±µ¿æ´¶¤Î²v¤w¸g«Ü°ª¡A¥¼¨Ó¦¬®×ªº¹ï¶H­Y¬O¦³±µºØ¹L¬Ì­]ªº±wªÌ¡A¤£ª¾¹D¬O§_·|¹ïÁ{§É¹êÅç¤W¦³¥¼ª¾ªº¼vÅT¡C¦]¬°±µºØ¬Ì­]«áªº©è§Ü¤O¤ñ¸û°ª¡A­Y¦b¦w¼¢²Õ®É¡A·|²£¥Í¬Æ»òª¬ªp©O?

¬d¹L±Æ°£±ø¥ó¡A¨ÃµL¬O§_¦³±µ¿æ¬Ì­]¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/7/1 ¤U¤È 01:49:29²Ä 1724 ½g¦^À³
@»´¯g¤]¥i¥H®¦·OÀøªk?¤£¬O«ÜÀ´

º©¹C¤j¤j¯à¤£¯à¦h»¡´X¥y

@¦pªG¥i¥H®¦·OÀøªk,¤½¥q¯à¤£¯à°eÃĵ¹¦³»Ý­nªºªÑªF§K±o´£¤ß¦QÁx^_*,§Ú´N´±¥hªÑªF·|¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/7/1 ¤U¤È 01:20:11²Ä 1723 ½g¦^À³
¬Ì±¡´Á¶¡¡A¹ê»Ú¨ìªÑªF·|²{³õªºªÑªF¤j·§¤Q¦h¦ì

«Ü°ª¿³Å¥¨ì±Ð±Â¡A°]°Èªø»P¦Ñ¥vªº¤À¨É

²³æ¾ã²z¸ê°T¦p¤U¡G

1. ¤½¥q­pµeIPO¡A³t«×¶V§Ö¶V¦n¡A¶·º¡¨¬²b­Èµ¥¦]¯À¡Aªñ´Á·|¦A¶i¦æPrevail¨p¶Ò (2.77 USD)

2. Covid-19¬y·P¤Æ¡A°£¬Ì­]¥~¡AªvÀøÃĪ«¶V¨Ó¶V­«­n¡A®Ö»Ä´À¥Nª«ªº¾÷¨î¤£·|¬O¥D¬y

3. SB01¹w­p¦~©³§¹¦¨¦¬®×¡A¤G´Áµ²§ô«á¶i¦æ±ÂÅv¡A¤w¦³¤j¼tÃö¤ß

4. ¤½¥q²{¦bªºµ¦²¤¡A·|§â¯à¤½¶}ªº¸ê°TºÉ¶q¤½¶}

5. ®¦·OÀøªkÂå°|ºÝ¤w¦P·N¡A¦ý»Ý«Ý½ÃªA³¡®Ö­ã

6. ­^°ê¦³¤C­Ó¤j«¬¬Æ¦Ü¬O¤W¦Ê¦~ªºÁ{§É¤¤¤ß¡A¹ï¦¬®×«Ü¦³À°§U

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/7/1 ¤W¤È 07:15:09²Ä 1722 ½g¦^À³
¤µ¤ÑªÑªF·|¡A³o¤@¦¸¤£§J«e©¹¡A

¦³悦¤Í·|¿Ë¦Û¥X®u¶Ü¡H

³o¤@¦~¨Ó¡A¤½¥q¸ê°Tµo¥¬¬Û·í¶}¸Û¥¬¤½¡A

¤j®a¦³¤°»ò°ÝÃD·|§Æ±æ¸gÀçªÌ§ó²`¤J¦^µª¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/6/29 ¤W¤È 11:09:00²Ä 1721 ½g¦^À³
·PÁ«i©¹ª½«e¤jªº°T®§

¸É¥R¨Ã±Æ¦C¾ãÅé®É§Çµ¹ªO¤Í­Ì°Ñ¦Ò

¡u¥x±d¡v

2018/12/24 ¥x­m§ë¸ê¥x±d, Á`­p2.5»õ, ¨CªÑ¬ù32¤¸

2019/6/13 ¥x­m¥[¤J¥x±d¸³¨Æ·|

¸É¡G2019/6/28 ¥x±d¥Í§Þ¤WÂd

2021/4 ÂE®ü»¨ÂY50»õ¤JªÑ¥x±d, ¨CªÑ¬ù90¤¸

¡u¤ß®®¡v

2021/6 ¥x§ü§ë¸ê¤ß®®, ¨CªÑ¬ù40¤¸

2022/6 ¤ß®®¸³ºÊ§ï¿ï, IPO¡H

2023¡ã ¡H

´Á«Ý«áÄòªºµo®i

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/6/29 ¤W¤È 10:26:00²Ä 1720 ½g¦^À³
³Ìªñ¬ã¨s·s¥[¤Jªº¥x­m°òª÷, §Ô¤£¦í»P²³®®¤Í¤À¨É¤@«h¶c¨Æ

2018/12/24 ¥x­m§ë¸ê¥x±d, Á`­p2.5»õ, ¨CªÑ¬ù32¤¸

2019/6/13 ¥x­m¥[¤J¥x±d¸³¨Æ·|

2021/4 ÂE®ü»¨ÂY50»õ¤JªÑ¥x±d, ¨CªÑ¬ù90¤¸

²Ó²Ó¬ã¨s¥x­m°òª÷, ¥¦ºâ¬O§ë¸ê¬Éªº°ê®a¶¤,­«ÂI¦b°t¦X¬F©²§ß´Óªº5+2³Ð·s²£·~, ¨ÓÀY¤£¯à¤pòó

¥x­mªº¥[¤J­Ë¬O¬°¦b¤U«ùªÑªºº©ªø·³¤ë¤¤ª`¤J¤@°¦±j¤ß¾¯, ¤H¥Í¤¤­Y¦³¯à°÷¸ò¤WÁo©ú¿úªº¾÷·|, ¦ó¨ä©¯¹B!

¥H¤W®Éµ{»ù®æ¦p¦³»~´Ó, ·Ð½Ðª©¤W½å¹F¤£§[«üÃÒ, ¦¹¥~¤]ªþ¤W·j´Mªº¬ÛÃö³sµ²¨Ñ°Ñ¦Ò!

hea.com.tw/newsDetail.asp?id=9107

www.moneydj.com/kmdj/news/newsviewer.aspx?a=cd7cb5c3-e049-4081-ac3f-b9ee115887bb

¥x±d¥Í§Þ¡G¥x§ü°òª÷¥Ø«e¹ï¤½¥q§ë¸êª÷ÃB¬ù¬°2.5»õ¤¸¡A¦û¤½¥q¥Ø«eµo¦æªÑ¼Æ¹O5%-MoneyDJ²z°]ºô

¤½¶}¸ê°TÆ[´ú¯¸­«¤j°T®§¤½§i(6589)¥x±d¥Í§Þ-»¡©ú´CÅé³ø¾É1.¶Ç¼½´CÅé¦WºÙ:¸gÀÙ¤é³øA142.³ø¾É¤é´Á:107/12/243.³ø¾É¤º®e:³ø¾É¼ÐÃD¡u¥x§ü§ë¸ê¥x±d ´§­x°ê»Ú¡v¡B¡u©x¥Á¦X§@ ¥´³y¥Í§Þ¥x¿n¹q¡v³ø¾É¥Zµn¦³Ãö¥»¤½¥q107¦~«×²{ª÷¼W¸êªÑªF§ë¸ê±¡§Î¡B¦Û¦æ¬ãµo¤§¥Íª«¬Û¦üÃÄEG12014¶i«×¤Î©e°U¶}µo...

www.moneydj.com

www.moneydj.com/kmdj/news/newsviewer.aspx?a=538fb3a9-3b9d-4ddf-85e3-d650d331fa95

¥x±d¥Í§Þ§ï¿ï¸³¨Æ¡B¿W¥ß¸³¨Æ¦W³æ-MoneyDJ²z°]ºô

¤½¶}¸ê°TÆ[´ú¯¸­«¤j°T®§¤½§i(6589)¥x±d¥Í§Þ-¥»¤½¥q108¦~ªÑªF±`·|¥þ­±§ï¿ï¸³¨Æ1.µo¥ÍÅܰʤé´Á:108/06/122.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¸³¨Æ¡G¼Ú¥[¥q¶ð§ë¸êªÑ¥÷¦³­­¤½¥q ¥Nªí¤H¡G§õ­«©M(¥x±d¥Í§Þ(ªÑ)¤½¥q¸³¨Æªø)¥xÄ£¤Æ¾ÇªÑ¥÷¦³­­¤½¥q ¥Nªí¤H¡Gµ{¥¿¬ê(¥x±d¥Í§Þ(ªÑ)¤½¥q¸³¨Æ)°]¹Îªk¤H¥Íª«§Þ³N¶}µo¤¤¤ß...

www.moneydj.com

money.udn.com/money/story/5612/5390709

ÂE®ü³¢¥x»Ê»¨¯{50»õ¤¸¤JªÑ¥x±d¥Í§Þ¡I±q¬ì§Þ¨ì¥Í§Þ ¤@³õ³¢¸³ºëºâªº·s¾Ô§Ð | ²£·~¼öÂI | ²£·~ | ¸gÀÙ¤é³ø

®Ú¾Ú³Ì·s¤@´Á¡m°]°T¡nÂù¶g¥Z³ø¾É¡AÂE®ü¡]2317¡^¶°¹Î³Ð¿ì¤H³¢¥x»Ê¡A4¤ëªì¨M©w»¨¯{50»õ¤¸¤JªÑ¥x±d¥Í§Þ¡A¬J¦¨¥þ¤F¥L¦b¡u¬Fµ¦¡B°Ó·~¡BªÑ¥«¡B±¡¸q ...

money.udn.com

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/28 ¤U¤È 06:35:28²Ä 1719 ½g¦^À³
GA ªºªþ±a§@¥Î

¡§¥O¤H²¿®§¡¨ªºÀù¯g¬°¤°»ò¯Ê®ñ·LÀô¹Ò¤Ï¦ÓÅý¸~½FÅܱo½a¤¿·¥´c

¨Ó·½¡G ¥Íª«±´¯Á¡@§@ªÌ¡G ½@·ì¡@2021-06-28

med.sina.com/article_detail_103_1_101542.html

Àù¯g¤§©Ò¥HÃø¥H®Úªv¡A¥D­n­ì¦]´N¬O¸~½F²Ó­M·|¤£Â_¾AÀ³©Ò³Bªº¤£¨}Àô¹Ò¡A¯Ê®ñ»¤¾É¦]¤lHIF-1£\¡]Hypoxia Inducible Factor-1 £\¡^§@¬°¤@ºØ¯Ê®ñ±ø¥ó¤U¼sªx¦s¦b©ó­÷¨Å°Êª«©M¤HÅ骺¤@ºØÂà¿ý¦]¤l¡A¨äªí¹F»P¸~½F¼W­È¡B«Iŧ©MÂಾ¡B¸~½F·s¥Í¦åºÞ¥Í¦¨µ¥¯S¼x±K¤Á¬ÛÃö¡C¦ÓªýÂ_HIF-1£\ ªºÂà¿ý¬¡©Ê«ê¦n¥i¦³®Ä§í¨î¶Â¦â¯À½Fªº¥Íªø¡C

Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1£\/VEGF signaling pathway in ovarian cancer cells

www.spandidos-publications.com/10.3892/or.2015.4354

GA inhibits VEGF production through downregulation of HIF-1£\ expression

½Ð°Ñ Figure 3

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/27 ¤U¤È 05:15:22²Ä 1718 ½g¦^À³
ÁÂÁÂÁp¦X·s»Dºô ¤Î Á¬f§»¥ý¥Í À°¦£¤ß®®¶gª¾¤j²³

¤ß®®¥ÍÂå»P°ò¶©ªø©° ñ¨â¶µºë¯«¤Àµõ¯g¤§Á{§É°õ¦æ¦X¬ù

2021-06-27 10:36 ¸gÀÙ¤é³ø / °OªÌÁ¬f§»¡þ§Y®É³ø¾É

udn.com/page/topic/495

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/6/27 ¤U¤È 03:02:50²Ä 1717 ½g¦^À³
³o¼Ë´N¹ï¤F

§ë¸ê¤H­nªº´N¬O¶i«×&°T®§

¤½¥q§@­·¤jÂàÅÜ,¦Y¿ùÃĤFÁÙ¬Oªá¥Í¤F¬Æ»ò¨Æ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/27 ¤W¤È 08:12:15²Ä 1716 ½g¦^À³
«ç¼Ëªº¤H¸û·|µo¥Í¬Ì­]»¤µoªº¦å®ê¡H ¥X²{¡u5¦MÀI¼x¥ü¡v§Ö´NÂå

07:13 2021/06/27 ¤¤®É·s»Dºô ±`¬K¤ë¥Z

www.chinatimes.com/realtimenews/20210627000027-260418?ctrack=pc_main_headl_p15&chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/26 ¤U¤È 12:26:59²Ä 1715 ½g¦^À³
¬V¬Ì®£¥Ã¤[¸£·l¶Ë¡IÂå¡GÄY­«³ô¤ñªü¯÷®üÀq¯g ¦~»´½T¶E¤]Ãø°k

2021/06/26 ¤¤®É·s»Dºô ±d°·Âø»x

www.chinatimes.com/realtimenews/20210626000024-260418?ctrack=pc_main_recmd_p09&chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤Û·Q¤p³½10151823  µoªí®É¶¡:2021/6/25 ¤U¤È 06:01:35²Ä 1714 ½g¦^À³
¤ß®®Äâ¤â°ò¶©ªø©°Âå°| ±Ò°ÊÃøªv«¬ºë¯«¤Àµõ·sÃÄÁ{§É

ctee.com.tw/livenews/aj/ctee/A88131002021062516455685

¤ß®®¥ÍÂå¡]6575¡^25¤é«Å¥¬¡A»P°ò¶©ªø©°Âå°|ñ¸pÁ{§É°õ¦æ¦X¬ù¡AÂù¦X±N¦X§@°w¹ï¸Ó¤½¥q¬ãµo¤¤ªºÃøªv«¬ºë¯«¤Àµõ¯g¡B¦X¨ÖªvÀø·sÃÄClozaBenR (SND12Á{§É¸ÕÅç)¡A¥H¤Î¦¨¤Hºë¯«¤Àµõ¯g¡B¥[¦¨ªvÀø·sÃÄNaBenR (SND13Á{§É¸ÕÅç)¡A¥¿¦¡±Ò°Ê¥xÆW¦¬®×¡C

¸Ó¨â¶µ·sÃĤwÀò¬ü°êFDA±Â¤©¬ð¯}©ÊªvÀø¡A¨Ã¤w¦b¼Ú¬ü¶i¦æ¦¬®×¡A¤µ¦~3¤ëÀò¥xÆW½ÃºÖ³¡®Ö­ã°õ¦æ²Ä¤G(b)/¤T´Á¤HÅéÁ{§É¸ÕÅç¡A¥xÆWªº¦¬®×±N·|¯Ç¤JSND12¡BSND13¤§¥þ²y¦h°ê¦h¤¤¤ßÁ{§É¸ÕÅç¡C

¤ß®®ªí¥Ü¡A°£¤F°ò¶©ªø©°Âå°|¥~¡A¸Ó¤½¥q¤]±N©óªL¤fªø©°Âå°|¡B¥x¥_¥«¥ßÁp¦XÂå°|ªQ¼w°|°Ïµ¥¨ä¥LÂå°|°õ¦æÁ{§É¸ÕÅç¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/25 ¤W¤È 10:32:34²Ä 1713 ½g¦^À³
www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19

§Y®Éµo¥¬¡G

2021 ¦~ 6 ¤ë 24 ¤é

¤µ¤Ñ¡A¬ü°ê­¹«~©MÃĪ«ºÞ²z§½µo¥¬¤FÃĪ« Actemra¡]¦«¯]³æ§Ü¡^ªººò«æ¨Ï¥Î±ÂÅv¡]EUA¡^¡A¥Î©óªvÀø¥¿¦b±µ¨ü¥þ¨­©Ê¥Ö½èÃþ©T¾J¨Ã»Ý­n¸É¥R®ñ®ðªº​​¦í°|¦¨¤H©M¨àµ£±wªÌ¡]2 ·³¤Î¥H¤W¡^¡AµL³Ð©Î¦³³Ð¾÷±ñ³q®ð¡A©ÎÅé¥~½¤ªÍ®ñ¦X (ECMO)¡CActemra ¥¼³Q±ÂÅv¥Î©ó COVID-19 ªºªù¶E±wªÌ¡C

¦b COVID-19 ¦í°|±wªÌªºÁ{§É¸ÕÅ礤¡AActemra °£¤F±wªÌ±µ¨üªº COVID-19 ªvÀø¡]¥]¬A¥Ö½èÃþ©T¾JªvÀø¡^ªº±`³WÅ@²z¥~¡AÁÙÅã¥Ü³q¹L 28 ¤ÑªºÀH³X­°§C¤F¦º¤`­·ÀI¡A¨Ã´î¤Ö¤F¦º¤`­·ÀI¡C±wªÌ¦í°|ªº®É¶¡¡C¦b 28 ¤ÑªºÀH³X´Á¶¡¡A±wªÌ¨Ï¥Î©I§l¾÷©Î¦º¤`ªº­·ÀI¤]­°§C¤F¡C

Actemra ¬O¤@ºØ³æ§J¶©§ÜÅé¡A¥i³q¹LªýÂ_¥Õ²Ó­M¤¶¯À 6 ¨üÅé¨Ó´î»´ª¢¯g¡C¦b·P¬V COVID-19 ªº±¡ªp¤U¡A§K¬Ì¨t²Î·|Åܱo¹L«×¬¡ÅD¡A³o¥i¯à¾É­P¯e¯f´c¤Æ¡CActemra ¤£ª½±µ°w¹ï SARS-COV-2¡CActemra ¬O¤@ºØ³q¹LÀR¯ß¿éª`µ¹ÃĪº³B¤èÃÄ¡A¸g FDA §å­ã¥Î©ó¦hºØª¢¯g©Ê¯e¯f¡A¥]¬AÃþ­·Àã©ÊÃö¸`ª¢¡C®Ú¾Ú¤µ¤Ñªº EUA¡AFDA ±ÂÅvºò«æ¨Ï¥Î Actemra ¨ÓªvÀø¬Y¨Ç COVID-19 ¦í°|±wªÌ¡CActemra ¥¼³Q§å­ã¥Î©óªvÀø COVID-19¡C

¦b RECOVERY ¸ÕÅ礤¡A4,116 ¦W±w¦³ÄY­« COVID-19 ªÍª¢ªº¦í°|±wªÌ³QÀH¾÷¤À°t±µ¨ü°£±`³WÅ@²z¥~ªº Actemra¡]2,022 ¦W±wªÌ¡^©Î¶È±µ¨ü±`³WÅ@²z¡]2,094 ¦W±wªÌ¡^¡C¥D­n²×ÂI³q¹L 28 ¤ÑªºÀH³Xµû¦ô¦º¤`¡A¥D­n¤ÀªRªºµ²ªG¨ã¦³²Î­p¾Ç·N¸q¡C±µ¨ü Actemra ªº±wªÌ¦b²Ä 28 ¤Ñªº¦º¤`·§²v¦ô­p¬° 30.7%¡A¶È±µ¨ü±`³WÅ@²zªº±wªÌªº¦º¤`·§²v¬° 34.9%¡C±µ¨ü Actemra ªº±wªÌ¨ì¥X°|ªº¤¤¦ì®É¶¡¬° 19 ¤Ñ¡A¦Ó³æ¿W±µ¨ü±`³WÅ@²zªº±wªÌ«h¶W¹L 28 ¤Ñ¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/24 ¤W¤È 10:21:41²Ä 1712 ½g¦^À³
GA ©M TA ªºÃD¥~¸Ü

¤ÑµM²£ª«ªº§Ü¥Í¯À¼W±j§@¥Î¡G¹ï§Ü¯f­ìµßªº¦³§Æ±æªº¥Ø¼Ð

www.eurekaselect.com/186246/article

¥¿¦p³ÌªñÃzµoªº«aª¬¯f¬r¯f (COVID-19) ©M²Óµß¹ï²{¦³§Ü¥Í¯À¤£¦A±Ó·P©ÒÃÒ©úªº¨º¼Ë¡A¯f­ì·L¥Íª«À³³Qµø¬°¤HÃþªºÀY¸¹¼Ä¤H¡C¯f­ìµßªº­@ÃÄ©Ê©M²Óµß·P¬V¾É­Pªº¦º¤`§e«ü¼Æ¼Wªø¡C²Óµß¨Ï¥Î¤£¦Pªº¾÷¨î¨Ó¤ÏÀ»²{¦³ªº§Ü¥Í¯À¡A§Y¡]i¡^酶§í¨î¡A¡]ii¡^«CÅð¯Àµ²¦X³J¥Õ­×¹¢¡A¡]iii¡^¤Õ³J¥Õ¬ðÅÜ¡A¡]iv¡^¥~±Æ¬¦©M¡]v¡^§Ü¥Í¯À¹vÂIªº¤À¤l­×¹¢¡C¶}µo·sªº§Ü¥Í¯À¨Ó¸Ñ¨M³oºØ±¡ªp±N«D±`¯Ó®É¡A¦]¦¹¦³«e´ºªº¤èªk¤§¤@¬O¼W±j²{¦³ªº§Ü¥Í¯À¡C

´Óª«¨Ó·½ªº¤Æ¦Xª«¦p¨S­¹¤l»Ä©M³æ¹ç»Ä¬O¦UºØ§Ü¥Í¯Àªº¦³®Ä¼W®Ä¾¯¡A¥]¬A·s¥ÍÅð¯À¡B´â¥ÍÅð¯À¡B­»¨§Åð¯À¡B¤Ò¦è¦a»Ä©M§QºÖ¥­ ( novobiocin, chlorobiocin, coumermycin, fusidic acid, and rifampicin )¡A¨Ï³o¨Ç§Ü¥Í¯Àªº®Ä¤O´£°ª 4 ­¿¡C

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/6/23 ¤U¤È 11:42:32²Ä 1711 ½g¦^À³
¤ÓÆg¤F¤Óhapppy¤F ¦n­Ó¦Ñ¥v¤j¤j ¦n¼Ëªº°]°Èªø¦W¤£µê¶Ç

¦w¤ßºÎ¤jÀYı¥h

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/6/23 ¤U¤È 04:02:32²Ä 1710 ½g¦^À³
¤W¦¸µo¨¥´£¨ì¡A´Á«Ý¤½¥q±µ¤U¨Ó¥i¥Hºû«ù°È¹ê¶i«×ªº·s®ð¶H

¨S·Q¨ì¤£¨ì¤@­Ó¤ë´Nªï¨Ó¡u­«½S®ø®§¡v

¥x§ü¥Í§Þ°òª÷»â§ë¡I

¥x§ü¥Í§Þ°òª÷»â§ë¡I

¥x§ü¥Í§Þ°òª÷»â§ë¡I¡]«Ü­«­n©Ò¥H­n»¡¤T¹M¡^

´X­Ó·Qªk

1. ¥x§ü»â§ë¥Nªí¤Fªk¤H±M·~¹Î¶¤¹ï¤½¥qªº»{¥i¡A¥]§t¥üÂ×»P¥ÃÂתº¸ò§ë¥i¥Hí©wªÑªFµ²ºc¡]µL¤îºÉªºX¨È¡AX¥ÝÀ£»ù½æªÑ¬O¤j®aªºµh¡^

2. °]°Èªø«Ü¦³¤O¡A¤W¥ô¨S¦h¤[´N§¹¦¨³o­Ó­«¤j¼W¸ê¡A´Á«Ý¤§«áªº³W¹º¡A¤£ºÞ¬O°ê¤ºÁÙ¬O®ü¥~

3. ¸êª÷¬Û¹ï¥R¸Î¨ì§¹¦¨ÃöÁ䪺SND13»PPentarlendirªº¶}¼ú

³o¦¸¼W¸ê«D±`·PÁ·s¥ôªº°]°Èªø¸òªø´Á§V¤Oªºµo¨¥¤H

§ó­«­nªº¬O¡AÅýªø´Á¤ä«ùªºªÑªF¬Ý¨ì¥¿¦Vªºµo®i

Ä~Äò¥[ªo¡I

·s»D³sµ²¡G

¤ß®®¥ÍÂ姹¦¨4»õ¤¸²{ª÷¼W¸ê ¥x§ü¥Í§Þ°òª÷»â§ë

udn.com/news/story/7254/5552664

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Grabbit10136567  µoªí®É¶¡:2021/6/23 ¤W¤È 11:23:00²Ä 1709 ½g¦^À³
±o¬Ì­]ªÌ±o¤Ñ¤U

±oÃĪ«ªÌ±o¦Û¥Ñ

¬Ý¨ì¬ü°ê¬F©²¼»¿ú¼úÀy·s«aÃĪ«µo®iªº¶W«e§G¸p¡A

°£¤F¸r¼}¤§¥~¡A¤]¹ï¥Ø«e¥xÆW¬F©²ªºµuµø·P¨ì¤£¸Ñ¡C

¬Ì­]¤§¾Ô¡A¤w¸g½T»{¿éµ¹¼Ú¬ü¤§»Ú¡A

¥xÆW¬F©²³ºµM§¹¥þ¨S¦³¨ä¥L§@¬°¡A±N¨¾¬Ì¾É¦Vªº¸ê·½¤À°tµ¹ÃĪ«µo®i¡C

¤£¹Lªü¡A¬Ý¨ì¥xÆW®q¥Á¹ï¬F©²§ë¸ê¦Ñ¬Oµø¬°:

¨Æ«e¬O¹Ï§Q

¨Æ«á¬O°¨«á¬¶

ªº±`ºA®z´¼¤ßºA¡A¤ß®®¬O¥H FDA ¬°¥Dªº¥þ²y©ÊÁ{§É¡A³oÂIÁÙ¬OÅý¤H¦w¤ßÂI¡A©Î³\¥ý»¡­Ó¤j¸Ü¡A

µ¥¦¨¥\¤F¡A§A¥xÆW¬F©²¦A®³¬Æ»ò¥xÆW¤§¥ú­n¨Ó¶R¡A§Ú¬Ý¤]Ãø¤F¡A¦]¬°¤T´Á¶Õ¥²·|¥æµ¹§ó¤jªºÃļt¨Ó³B²z¡C

¨ì®É­Ô´N¤£¬O¤ß®®¯à¥D¾ÉÃĪ«¤À°t¤F¡C(°£«D±ÂÅv¦³Ã±)

¤ß®® SNB011 ¦Ü¤Ö¥Ø«e¦b¾÷Âà»P¬ÛÃö¬ã¨s¤W¡A¼ç¤O¤Q¨¬¡A¦ý¤@¤ÁÁÙ¬O±o­n¦³¹ê»ÚÁ{§É¼Æ¾Ú¡A

¦ý¦Ü¤Ö¤ñ¤@°ïÂi­±¤W²ö¦W¨ä§®ªº¤£©ú¾÷Âàªü­ù©Ô¤ãªº¶ÃäøÃĪ«¡A½ä³Õ©Ê¤Ö«Ü¦h¡C

¦³ªº¬Æ¦Ü¥Ó½Ð¥b¤ÑTFDA¤@­Ó¦h¤ë³£ÁÙ¨S¹L¡A¤ß®®¦b TFDA ¥Ó½Ð¤­¤Ñ«á´N³q¹L¡A

³o¤è­±¤]©Î³\¬O FDA ¤w¸g®Ö­ã¤W¦³¥[¤À¡C

¤½¥q©Ò¦³ªº²£«~³£¨S¦³¸Ñª¼¡ASNB011¤]¤~­è¤G´Á¡AªÑ»ù§O¦³¤Ó¦h´Á±æ¡C

­Ë¬O­nÃö¤ßªº¬O¤½¥q¥Ø«eµu´Á SNB011 Á{§É¶i«×¡A¥Ø«e¬Ý¨Ó¶i«×¥i¯à¤£¦p¤@¯ë§ë¸êªÌªº¹w´Á¡C

¦ý¥D¨ÆªÌªº¨¤«×¨Ó¬Ý¤]©Î³\¤£¬O³o¼Ë¡A©Î³\¦³®É¶¡¥h°Ñ¥[ªÑªF·|ªºªÑ¤Í¥i¥H²Ó°Ý§ó¦hÁ{§É²Ó¸`¡C

¥H¤W¡A¼ç¤ô¦n¤[¤F¡AÁÂÁ Cliff ©M ²q·Q ¤@ª½¥H¨Óªº¸ê®Æ°^Äm¡A·PÁÂ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/6/23 ¤W¤È 10:56:03²Ä 1708 ½g¦^À³
«ü¼Æ³£1¸U7¤dÂI¤F¡AªÑ»ùÁÙ40´X¶ô¡A¯uªº¤£°Ê¦p¤s¡K¡K¬O¤£¬O­n¶R¤ß®®ªº§Ü¼~Æ{¯gªº¨Ó¦Y¦Y¡AªÑªF¶R¤ß®®ªºÃĨӦY¡AÀ³¸Ó¦³·|­û»ù§a¡I
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/22 ¤U¤È 06:38:49²Ä 1707 ½g¦^À³
¤»¦¨¤H±µºØ«á¡A­^°ê COVID-19 Åܦ¨¤@¯ë­«·P«_

§@ªÌ ¶À ñü | µo¥¬¤é´Á 2021 ¦~ 06 ¤ë 21 ¤é 16:03 | ¤ÀÃþ ÂåÀø¬ì§Þ

technews.tw/2021/06/21/covid-symphony-turn-into-bad-cold/

­^°ê¤wªñ 60% ¦¨¦~¤H±µºØ¨â¾¯¬Ì­]¡A¾¨ºÞ COVID-19 ¬Ì­]¦³§U©ó±±¨î¤j¬y¦æ¡A¦ý¨S¦³¤@ºØ¬Ì­]´£¨Ñ 100% «OÅ@¡A¥B¤´¦³¥i¯à³Q·P¬V¡A³Ìªñ­^°ê¨C¤é½T¶E¯f¨Ò¼Æ¤W¤É¡A20 ¤é·s¼W 9 ¤d¦h¨Ò¡C¦ýÀHµÛ¬Ì±¡µo®i¡A²{¦b­^°ê³Q·P¬VªÌªº¯gª¬»P³Ìªì¤j¤£¬Û¦P¡A´X¥GÅܦ¨¤@¯ë­«·P«_¡C

¾¨ºÞ¶åı³à¥¢¡B«y¹Â¡Bµo¿N¡BÀYµh©M¯h³Òµ¥¥D­n¯gª¬¤´«Ü­«­n¡A¦ýÀYµh¡B³ïÄVµh¡B¬y»ó®÷©Mµo¿N²{¦b¬O³ø§iªº«e¥|¦W¡A«y¹Â¦C¬°²Ä¤­¤j³ø§i¯gª¬¡A¤ñ¥H«e¤Ö¨£¡A¥B¶åı³à¥¢¤£¦A±Æ¦b«e¤Q¦W¡C©_©Çªº¬O¡A±µºØ¬Ì­]«á COVID-19 ÀË´ú§e¶§©Êªº¤H¡A§ó¦³¥i¯à³ø§i¥´¼QÀ¡¯gª¬¡A¬G»{¬°±µºØ¬Ì­]¨Ã¶}©lÀWÁc¥´¼QÀ¡ªº¤HÀ³¦Ò¼{±µ¨üÀË´ú¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/6/19 ¤W¤È 06:54:17²Ä 1706 ½g¦^À³
Dear «i©¹ª½«e¤j¤j¦³po»¡

­è­è¬Ý¨ì50¥x¬ðµoµX·Qªº¸`¥Ø, ¦³´£¨ì½÷·ç¤fªAÃĹ³§J¬y·P¤@¼Ë.....

¤£ª¾¹D¦³¨S¦³¤èªkÅý¤ß®®SNB-01¼s¬°¤Hª¾? ³yºÖ§ó¦h¤H? ©Î³\³o¤S¬O¥t¤@®yÅ@°ê¯«¤s, ¥xÆW¤§¥ú......

¦­¤W°_§É¿à¥m¾´ÅT,¹qµø¤WÂåÃÄ°OªÌ´£¨ì¤ß®®ªºÃÄ~~¬O«i¤j¤j¥X°¨ªº¶Ü?

www.youtube.com/watch?v=rWC5rKjo-D4

18¤Àªº©Ò¦b

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/18 ¤W¤È 11:50:56²Ä 1705 ½g¦^À³
¤û¬z·s¬ã¨s¡G·P¬V¹L·s«a¤£¤@©wªø´Á§K¬Ì ¤´»Ý±µºØ¬Ì­]

2021-06-18 08:46 Áp¦X³ø / ½sĶ±i§g³ó¡þ§Y®É³ø¾É

udn.com/news/story/121707/5540570?from=udn_ch2cate7225sub121707_pulldownmenu_v2

­^°ê¤û¬z¤j¾Ç¬ã¨s¤@§å¦­´Á·P¬V·s«a¬Ì±¡ªºÂåÅ@¤H­û§ÜÅéÅܤơAµo²{¤§«e·P¬V¹L¡u¤£¤@©w´N¦³ªø´Áªº§K¬Ì®ÄªG¡v¡A¤×¨ä¬O¹ï·s¥X²{ªºÅܺدf¬r®è¡A¦]¦¹§Y¨Ï·P¬V¹Lªº¤H¡uÁÙ¬O»Ý­n±µºØ¬Ì­]¡v¡C

¦¹¥~¡A¬ã¨s¹ï¶H¤¤¡A¦³¯gª¬·P¬VªÌ¤¤¡A¶W¹L1/4ªº¤H¦b6­Ó¤ë«á¡A¤w¸g¨S¦³¥iÀË´ú¥Xªº§K¬Ì¤ÏÀ³¡FµL¯gª¬·P¬VªÌ§ó¶W¹L90¢H¦b6­Ó¤ë«áÅ礣¥X§K¬Ì¤ÏÀ³¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/17 ¤W¤È 11:04:28²Ä 1704 ½g¦^À³
©d¬V¬Ì´¼°Ó°h¤Æ¥u¦³13·³ ¤Ò¤ß¸H¡u¯f¬r¯uªº¤Ó¬½¡v

09:59 2021/06/17 ¤¤®É·s»Dºô ·¨¶®´@

www.chinatimes.com/realtimenews/20210617001512-260405?ctrack=pc_main_headl_p08&chdtv

¥xÆW³oªi¬Ì±¡Ãzµo¥H¨Ó¡A³y¦¨³\¦h®a®x¯}¸H¡Cªñ¤é¤@¦Wºô¤Íªí¥Ü¡AªB¤Íªº¶ý¶ý½T¶E¡A´Á¶¡¦³Áô§Î¯Ê®ñ²{¶H¡AÁöµMºò«æ¬I±Ï«á¿ô¹L¨Ó¡A¦ý¸£²Ó­M¤w¨ü¨ì·l®`¡A°h¤Æ¨ì´¼°Ó¥u³Ñ13·³¡A·P¹Ä¯f¬r¯uªº¤Ó¬½.

§Ú­Ì³o´X¤Ñ¨Óªº¶K¤å¨Ó±À´ú

©Î³\¦­´Á¬I¥Î SNB011 ¹ï¸£ªÍ¤º¥Ö²Ó­Mªº«OÅ@©M§Üª¢¯g , ¥i¥H´î»´¬Æ©ÎÁקKÁô§Î¯Ê®ñ²{¶H , ¥H¤Î¯Ê®ñ©Ò±a¨Óªº´c¤Æ ?

Á{§É¸ÕÅç´N·|µ¹§Ú­Ìµª®×

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/17 ¤W¤È 09:54:11²Ä 1703 ½g¦^À³
¡uÁô§Î¯Ê®ñ¡v¦~»´¤H¤]Ãø°k¡I¨«¸ô6¤ÀÄÁ·|³Ý´N­nĵı

07:232021/06/17 ¤¤®É·s»Dºô ±d°·Âø»x

www.chinatimes.com/realtimenews/20210617000013-260418?ctrack=pc_main_headl_p10&chdtv

°ê¥~¬ã¨sµo²{¡A¨C2¦W·s«a¯f¬r·P¬VªÌ´N¦³1¤H¥X²{¡uÁô§Î¯Ê®ñ¡v¡CÂå®v´£¿ô¡A°ê¤º¥~¤£¥F¦³¦~»´¡B±j§§¡BµLºC©Ê¯fªº·P¬VªÌ¦]¦¹Ö`¦º¡A¤d¸U¤£¥i¦Û«î¦~»´¦Ó»´©¿¡A«Øij¿n·¥¥H¦å®ñ¾÷ºÊ´ú¡A¨Ã¯d·N¦³µL¯Ê®ñ¼x¥ü¡A¤@¥¹ÃhºÃ°È¥²ºÉ¦­´NÂåªvÀø¡C

Áô§Î¯Ê®ñ¤S³QºÙ¬°¡u¨IÀq¯Ê®ñ¡v©Î¡u§Ö¼Ö¯Ê®ñ¡v¡A¬O¤@¶µ§C¦å®ñªº¯gª¬ªí²{¡A¦]¬°ªÍ³¡µ²ºc¬OºCºC¦a³Q¯}Ãa¡A¯f¤H¨S¦³©I§l§xÃøªº·Pı¡A¦]¦¹¯ÔÀÁªvÀø¡C¦ý·íªÍ³¡¨ü·lÄY­«¡B¯f¤H¤]·Pı«Ü³Ý®É¡A´N¥i¯à¦b·¥µu®É¶¡¤º¦]¯Ê®ñ¦º¤`¡C

¿½¥@ªY¶i¤@¨B¸ÑÄÀ¡A·s«a¯f¬rªº§ðÀ»¯S©Ê¬O³z¹LACE2±µ¨ü¾¹¶i¨ìÅ餺¾¹©x¡A¦ÓªÍ³¡¦³¸û¦hªºACE2±µ¨ü¾¹¡C·í¯f¬r¶i¨ìªÍ³¡«á¡A·|ºCºC¯}ÃaªÍ³¡²Ó­M¡B­°§C¦åºÞ¤º¦å¬õ¯À¤ÎªÍªw¤¤·sÂA®ñ®ðªº¥æ´«®Ä²v¡A§Î¦¨§C¦å®ñ¡C

Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury

©w¸qªÍ¤º¥Ö²Ó­M²§½è©Ê¦b«æ©ÊªÍ·l¶Ë¤ÏÀ³¤¤ªº§@¥Î

elifesciences.org/articles/53072

ªÍ¤º¥Ö²Ó­M (EC) ¬OªÍªw®ðÅé¥æ´«¾÷¨îªº­«­n²Õ¦¨³¡¤À¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/17 ¤W¤È 09:32:03²Ä 1702 ½g¦^À³
SARS-CoV-2 ¬ðÅܤӧ֤Ӳr ...

www.genetinfo.com/international-news/item/49576.html

¹ï¬Ì­]®£©È¬O¤@­Ó¬D¾Ô ?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/16 ¤W¤È 08:15:35²Ä 1701 ½g¦^À³
®¥³ß¤ß®®ªÑªF---ºÓ¥Ý¹q§÷©M¬ì§Þ¤j¼tÂE®ü¶°¹Î¦X§@ , ¦@¦P¶}µo¹q°Ê¨®¹q¦À§÷®Æ

ÂE®ü¤JªÑºÓ¥Ý ±j§ð¹q°Ê¨®

2021-06-16 01:40 ¸gÀÙ¤é³ø / °OªÌ³¯¬Rµ¾¡A¿½§g·u¡þ¥x¥_³ø¾É

udn.com/news/story/7240/5535012

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/15 ¤U¤È 05:45:34²Ä 1700 ½g¦^À³
¥»¤½¥q¸³¨Æ·|¨MijÅܧó110¦~ªÑªF±`·|¤é´Á¤Î¦aÂI (¨Ìª÷ºÞ·| ¤½§i¤§¡u¦]À³¬Ì±¡¤½¶}µo¦æ¤½¥qªÑªF·|©µ´Á¥l¶}¬ÛÃö±¹¬I¡v¿ì²z)

1.¸³¨Æ·|¨Mij¤é´Á:110/06/15

2.ªÑªF·|¥l¶}¤é´Á:110/07/01

3.ªÑªF·|¥l¶}®É¶¡:¤W¤È9®É¾ã

4.ªÑªF·|¥l¶}¦aÂI:·s¥_¥«¦Á¤î°Ï·s¥x¤­¸ô¤@¬q93¸¹23¼Ó¤§5 (»·¶¯U-Town D´É¡^

5.ªÑªF·|¥l¶°¨Æ¥Ñ¡A½Ð¬d¾\¥»¤½¥q­ìµo¥¬¤§­«¤j°T®§¡A­«¤j°T®§¤é´Á(x¤ëx¤é):110/02/23

6.¨ä¥LÀ³±Ô©ú¨Æ¶µ:

¶à«á­Õ¤´¨ü¬Ì±¡¼vÅT¡A¬G»Ý½Õ¾ã©Î¨ä¥L¥¼ºÉ¬ÛÃö¨Æ©y¡A±ÂÅv¸³¨Æªø¥þÅv³B²z¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/14 ¤U¤È 07:05:27²Ä 1699 ½g¦^À³
·s«aÅܲ§¬r®èµ²¦X¦¨·sÅÜºØ Âå¾Ç´Á¥Z¡G¼vÅTªvÀø»P¬Ì­]¥\®Ä

17:48 2021/06/14 ¤¤®É·s»Dºô ¿c§BµØ

www.chinatimes.com/realtimenews/20210614003636-260409?ctrack=pc_main_headl_p02&chdtv

·s«aªÍª¢(COVID-19)¤j¬y¦æ¦Ü¤µ¤@¦~¦h¡A¥þ²y¥[³t¬Ì­]±µºØªº¦P®É¡A¬r®è¦b¤j¬y¦æ¤¤ªº¬ðÅܤ]¦¨¬°¬ì¾Ç®a°lÂܪºµJÂI¡Aªñ¤éÂå¾Ç´Á¥Z¡m§K¬Ì¡n(Immunity)µoªíªº½×¤åÅã¥Ü¡A·s«aªÍª¢¬r®èµo¥Í¦b¨ë¬ð³J¥Õ¤WªºÅܲ§«Ü¥i¯à·|¼vÅT·í«e§ÜÅéªvÀøÃĪ«©M¬Ì­]ªº«OÅ@®ÄªG¡A¤]¥i¯àµo¥Í¸óª«ºØ¶Ç¼½¨ì¨ä¥Lªº±J¥D°Êª«¨­¤W¡A¥i¯à¹ï¥¼¨Ó¥þ²y¬Ì±¡µo®i»P¬Ì­]§Î¦¨Ãø¥H¹w®Æªº«Â¯Ù¡C

¡m¦hºû·s»D¡n¤Þ­z³o½g¥Ñ¥_¨Ê²MµØ¤j¾Çµ¥¬ã¨s¹Î¶¤µoªíªº½×¤åºÙ¡A¦¹¶µ¬ã¨s½T»{¤F¬ðÅܯf¬r®è¨ë¬ð¿}³J¥Õ¦h­Ó¬ðÅܦìÂIªº¼vÅT¡AÅã¥ÜÅܲ§®è¹ï¥Ø«e§ÜÅéªvÀø¥H¤Î¬Ì­]«OÅ@³£¥i¯àºc¦¨ÄY®m¬D¾Ô¡C

¬ã¨s«ü¥X¡A¦b·s¥X²{ªºÅܺدf¬r¤¤¥¿¦bµo¥Í§Ü­ìÂಾ¡]¤£¦P¬r®è©Î¤£¦P¯f¬r¤§¶¡¬Û¤¬¿Ä¦X§Î¦¨·s¯f¬r¨È«¬¡^¡A³o´N­n¨D¥ß§Y¹ï³æ§J¶©§ÜÅéÀøªk©M¬Ì­]¶i¦æ­«·sµû¦ô©M§ó·s¡C±qªø»·¨Ó¬Ý¡A¥Ø¼Ð¬O¶}µo³q¥ÎªºªvÀø©M¹w¨¾¤z¹w±¹¬I¡A¥H«O«ù¹ï©Ò¦³¬ðÅܬr®èªº¦³®Ä©Ê¡C

¤ß®® SNB011 ªº§í¨î¹vÂI , §¡«D°w¹ï©ö¬ðÅܪº¯f¬r¨ë¬ð³J¥Õ , ¬G¤£¨ü¼vÅT

§Æ±æ SNB011 »°§Ö¶i¤JÁ{§É¥B§¡¯àµo´§¹w´Áªº¦h¶µ¾÷¨î³yºÖ±wªÌ

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G´M³V10132258  µoªí®É¶¡:2021/6/11 ¤W¤È 10:51:51²Ä 1698 ½g¦^À³
¡m°ê»Ú²£·~¡nù¤ó»sÃĦX§@Atea ´£¨Ñ·s«a±wªÌ¼ç¦b¤fªAªvÀø

2020¦~10¤ë22¤é ¤U¤È2:02¡P1 ¤ÀÄÁ (¾\Ū®É¶¡)

¡i®É³ø½sĶ±i´Â´Üºî¦X¥~¹q³ø¾É¡jù¤ó»sÃļt(Roche)«Å¥¬»PAtea»sÃĦX§@¡A¦@¦P¶}µo¤@¦W¬°AT-527ªº§Ü¬Ì¤fªAÃÄ¡A¥Ø«e¸ÓÃĤw¶i¤J²Ä¤G´ÁªºÁ{§É¸ÕÅç¡A¬°¤@·s«a¯f¬rªº¼ç¦bªvÀø¤è¦¡¡C ¦pªG¸Ó¤fªA¬Ì­]Àò­ã³q¹L¡AAtea±N­t³d¬ü°ê¦a°Ïªº¾P°â¡Aù¤ó«h­t³d¬ü°ê¥H¥~¥þ²y¥«³õªº»s³y©M¤À¾P¡CAtea±N±qù¤óÀò±o«e´Á¤ä¥Iªº3.5»õ¼Ú¤¸ªº²{ª÷¡C AT-527¥Ø«e¬°¦í°|ªº¤¤«×·s«a¯f±w¶i¦æ²Ä¤G´Á¸ÕÅç¡A²Ä¤T´Á¹w­p¦b2021¦~²Ä¤@©u¶}©l¡C¸Ó¤fªAÃÄÁö°w¹ï¦í°|±wªÌ¡A¥Ø«e¤]¥¿¬ã¨s©M¶i¤@¨B¶}µo°w¹ïÂå°|¥H¥~±wªÌ¡A´£¨Ñ¼ç¦bªº¨Ï¥Î¡A¶}µo¬°¥¼¦í°|ªº·s«a±wªÌ´£¨Ñ¤fªAªvÀøªº²Ä¤@¿ï¾Ü¡C ¸Ó¶µ¦X§@¦®¦b¥[³tAT-527ªºªLªø¶}µo©M»s³y¡A¬ã¨s¨ä¦w¥þ©Ê©M¦³®Ä©Ê¡A¾¨§Ö¬°¥þ²y±wªÌ´£¨Ñ«e¦bªvÀøªº¿ï¾Ü¡C

¥Î¦Yªº¤]¦æ¡I½÷·ç·s«a¯f¬r¤fªAÃĶi¦æ²Ä¤@¶¥¬q´ú¸Õ

½÷·ç (PFE-US) ¶g¤Gªí¥Ü¡A¤w¸g°w¹ï¤@ºØ¥i±æ¹ï§Ü Covid-19 ¯f¬rªºÃĤù¶i¦æ²Ä¤@¶¥¬q¸ÕÅç¡C

¸Ó¹êÅçÃĪ«§í¨î SARS-CoV-2 ¯f¬r¼W´Þ®É©Ò¥²»Ýªº酶¡A³\¦h¦¨¥\¹ï§Ü·R´þ¯f (HIV) ©M C «¬¨xª¢ªºÃĪ«§¡¥H¦P¼Ë¤è¦¡¥Í®Ä¡C

½÷·ç¬ì¾Çªø Mikael Dolsten ªí¥Ü¡A­Õ­YÁ{§É¸ÕÅçÃÒ©ú½÷·ç³o´Ú§Ü¯f¬rÃĪ«¦w¥þ¦³®Ä¡A´N¥i¥H¦b·P¬V¸ñ¶Hªì²{®É¥ß§YªA¥Î¸ÓÃĤù¡C

½÷·çªí¥Ü¡A¸ÓÃÄ¡uPF-07321332¡v¦b¹êÅç«Ç¬ã¨s¤¤Åã¥Ü¥X¦³®Ä§í¨î SARS-CoV-2 ¯f¬r©M¨ä¥L«aª¬¯f¬rªº¯à¤O¡C½÷·ç¤½¥q¥¿¦b·s«a¯f¬r¦í°|±wªÌ¨­¤W´ú¸Õ¥t¤@ºØÀR¯ß§Ü¯f¬rÃĪ«¡C

Àq§J (MRK-US) ¤]¦b´ú¸Õ¤@´Ú¹ï§Ü·s«a¯f¬rªºÃĪ«¡C§Ü¯f¬rÃĪ«±N¬OªvÀø·s«a¯f¬r·P¬Vªº¥t¤@­Ó¤u¨ã¡A¥H¤Î¤@ºØ§ÜÅé²V¦Xª«¡A«Y¥Ñ Eli Lilly (LLY-US) ©M Regeneron Pharmaceuticals (REGN-US) ¥Í²£¡C

¬ü°êÃļtÀq§Jªí¥Ü¡A¥u­nºX¤Uªº¤fªA·s«aÃĪ«Àò±o¬ü°êFDA®Ö­ã¡A¬ü°ê¬F©²±N¥H12»õ¬ü¤¸¡B¤]´N¬O¶W¹L¥x¹ô300»õ¤¸¡A¨ÓÁʶR170¸U¥÷¡C

Dailymotion Placeholder

Àq§J¶}µoªº·s«a¯f¬r¤fªAÃĪ«¡A³Ì§Ö¥i¥H¦b¤µ¦~¤U¥b¦~¥Ó½Ðºò«æ¨Ï¥Î±ÂÅv¡C³o¼Ëªº¦n®ø®§¤]ÅýÀq§J9¸¹ªºªÑ»ù¤W´­2.27%¡A¹F¨ì¨CªÑ74.04¬ü¤¸¡C³o´ÚÃĪ«»Ý­n¨C12¤p®ÉªA¥Î¤@¦¸¡AÀøµ{¤@¦@5¤Ñ¡A¥Ø«e¥¿¦b¶i¦æ¸ÕÅç¡Aµû¦ôÃĪ«­°§C¦í°|­·ÀIªº¯à¤O¡CÀq§J¤]ªí¥Ü¡A¥L­Ì¤£¥u»P¬ü°ê¬F©²©¹¨Ó¡A¤]»P¨ä¥L·Q¹wÁʳo´ÚÃĪ«ªº°ê®a¥æ¯A¡C

¾ã²z¤F¤@¤U¥Ø«eªº·s»D,¦³¿òº|¦b·Ð½Ð¨ä¥L¤j¤j¸É¥¿!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G´M³V10132258  µoªí®É¶¡:2021/6/11 ¤W¤È 10:02:05²Ä 1697 ½g¦^À³
Àq¨FªFÃļtCovid¤fªAÃĸÕÅ礤 Àò¬ü¬F©²300»õ¦X¬ù ( 12»õ¬ü¤¸ )

¤½¥q­Y¯à¶¶§Q¶}µo¥XSNB01

¤£¶È¶È¬O¤HÃþ¤§ºÖ,§ó¯àÅý¤½¥qÀç¹B§ó¥[µo®i!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/10 ¤U¤È 05:00:53²Ä 1696 ½g¦^À³
New Alzheimer¡¦s drug aducanumab - cost, side effects, timeline and other questions answered

By Jacqueline Howard, CNN

Updated 0157 GMT (0957 HKT) June 10, 2021

edition.cnn.com/2021/06/09/health/aducanumab-questions-answered-wellness/index.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤Û·Q¤p³½10151823  µoªí®É¶¡:2021/6/9 ¤U¤È 12:44:52²Ä 1695 ½g¦^À³
SNB011³o¶µÃĪ«¤w©ó¬ü°ê±Ò°ÊÁ{§É¡A¨Ì¾Ú½ÃºÖ³¡¡u¦h°ê¦h¤¤¤ßÃÄ«~Á{§É¸ÕÅç­pµe¼f¬dµ{§Ç¡v¡A¦¹¥Ó½Ð®×±N¥i´`§Ö³t³q¹D¼f¬d³~®|¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJCY10146705  µoªí®É¶¡:2021/6/9 ¤W¤È 09:55:30²Ä 1694 ½g¦^À³
SNB011ªºÁ{§É¸ÕÅç¬O6/3¤½§i¥Ó½Ð

¬Q¤Ñ6/8´N³q¹L

¤~µuµu5¤Ñ

°O±oÁ{§É¸ÕÅ窺¥Ó½Ð¨ì®Ö­ã¬O¥H¤ë¬°³æ¦ì

³o¦¸«ç»ò³o»ò§Ö??????

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤Û·Q¤p³½10151823  µoªí®É¶¡:2021/6/9 ¤W¤È 06:25:21²Ä 1693 ½g¦^À³
¥»¤½¥q¬ãµo¤¤¤§ªvÀø«aª¬¯f¬r¯e¯f(COVID-19)·sÃÄ

PentarlandirÀò¥xÆW½ÃºÖ³¡®Ö­ã°õ¦æ¾÷¨îÅçÃÒ¸ÕÅç

(SNB011 proof of principle trial)

www.genetinfo.com/investment/company-news/item/49365.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦n©_10151881  µoªí®É¶¡:2021/6/8 ¤W¤È 07:58:43²Ä 1692 ½g¦^À³
½Ð°Ý«¸§Ó¿«¬O¥H«e¨º­Ó¥v§V¤ñ¹q¤l³ø§@ªÌ¶Ü¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/6/7 ¤U¤È 06:58:26²Ä 1691 ½g¦^À³
¦Ñ¥v¤j, ¤H¯uªº«Ü¦n, ½²¸³¨Æªø¼z²´

¯S©w¤Hªº½T¤£¬O¬Ý»ù®t

¦pªG¬O

«e´X¦¸¼W¸êªº»ù®t¤]³£¤£¤j

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/6/7 ¤U¤È 04:36:16²Ä 1690 ½g¦^À³
¥Í¥­²Ä¤@¦¸¥´¹q¸Üµ¹§ë¸êªº¤½¥q

µo¨¥¤H......¦¿´ò¤¤ªº¦Ñ¥v¤j¤j¤j?

²á¤F´X¤ÀÄÁ«D±`¿Ë¤Ánice«Ü¹³¦ÑªB¤Í¦b¸ò§A²á¤Ñ

§Ú¤@ª½«Ü¼~¼{²{ª÷¼W¸ê,ÁöµM¦³­Ó¨ÓÀY«Ü¤jªº°]°Èªø,¦ý¨S¦³»ù®t·|¦³¤H·Q»{?Â_ª¤«ç»ò¿ì

µo¨¥¤H»¡¥L¤£¯à»¡¦³Ãö²{ª÷¼W¸êªº¶i«×,but,»ù®t¨Ã¤£¬O¯S©w¤Hú¤£Ãº¿ú(ÁÙ¬O°Ñ¤£°Ñ¥[?§Ú¸£¤l¤£ÆF¥ú)ªº°ß¤@±ø¥ó

#$^^*(@)**¦nÃø²z¸Ñ³á ¦ý§Ú«Ü¶}¤ß¤½¥q¦³³o»òniceªºµo¨¥¤H,¦^µª¤F¦n´X­Óªº°ÝÃD

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/4 ¤U¤È 07:39:31²Ä 1689 ½g¦^À³

Pentarlandir™ Ultrapure and Potent Tannic Acid (UPPTA)

Pentarlandir™ ¶W¯Â±j®Ä³æ¹ç»Ä (UPPTA)

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤¸´¼9110137200  µoªí®É¶¡:2021/6/4 ¤W¤È 11:40:01²Ä 1688 ½g¦^À³
½Ð°Ý¤@¤U¦³Ãº´Úªº¡A´N¦³»{¨ì¶Ü
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gº©¹CªÌ10144096  µoªí®É¶¡:2021/6/4 ¤W¤È 10:10:22²Ä 1687 ½g¦^À³
¼ç¤ô¤w¤[¡A«Üªø¤@¬q®É¶¡¨Sµo¨¥¡A¥D­n¬O¹ï©ó¤½¥q«e´X¦~¶i«×ªº©ì©µ·P¨ìµL©`

¤£¹L¤µ¦~¥H¨Ó·P¨ü¨ì«Ü¤£¤@¼Ëªºª^³ò

±q¦~ªì°]°Èªø´N¥ô¡APrevail Partners ·¸»ù¤JªÑ

¨ìªñ´Á¦~³ø¡A·s»D½Z¿n·¥ªº©ÜÅS»¡©ú¤½¥qªºÁ{§É¥Ó½Ð¦¬®×¶i«×

¨­¬°ªÑªF­nªº´N¬O°È¹êªº¶i«×¡A´Á«Ý¤½¥q±µ¤U¨Ó¥i¥Hºû«ù³o¼Ë·s®ð¶H¡A§OÅýªø´Á¤ä«ùªºªÑªF¥¢±æ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/4 ¤W¤È 07:55:48²Ä 1686 ½g¦^À³
ÁÂÁ¤۷Q¤p³½¤jªº²Ä¤@¤â¸ê°T

¸ÕÅç¤å¥ó´£¨ìÃĪ«ªº¦WºÙ¬O Pentarlandir™ UPPTA

½Ð°Ý¦³¤j¤jª¾¹D UPPTA ¬O¬Æ»ò·N«ä¶Ü?

¬O upper TA ªº·N«ä¶Ü? ¦]¬°¤ß®®ªºTA¬O¯S§O´I¶°ªº , ¨ã¦³±M§Qªº

¥t¥~ClinicalTrials.gov Identifier: NCT04911777 ¤]«Ü¤£¿ù§r!

§Æ±æPentarlandir™ UPPTA¦³«Ü¦nÀø®Ä !

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²V¥P10151740  µoªí®É¶¡:2021/6/4 ¤W¤È 07:28:31²Ä 1685 ½g¦^À³
¨S¥hú´Ú¡A¦]¬°ºÉ¶q¤£¥Xªù¡A¦AªÌ¨S¤°»ò»ù®t¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤Û·Q¤p³½10151823  µoªí®É¶¡:2021/6/4 ¤W¤È 07:20:00²Ä 1684 ½g¦^À³
¬ü°êNIHÁ{§É¸ÕÅç#¬ü°ê°ê°È°|Á{§É¸ÕÅçºô¤w¸gµn¿ýµù¥U

www.clinicaltrials.gov/ct2/show/NCT04911777?cond=Pentarlandir&draw=2&rank=1

¦b²Ä¤@¶¥¬q¡A45 ¦W¨ü¸ÕªÌ±N«ö 2:1 ªº¤ñ¨ÒÀH¾÷¤À°t¦Ü Pentarlandir™ UPPTA §C¾¯¶q²Õ©Î¦w¼¢¾¯²Õ¡C¦b¤¤´Á¤ÀªR©M DSMB µû¦ô«á¡A45 ¦W¨ü¸ÕªÌ±N¦b²Ä¤G¶¥¬qÀH¾÷¤À°t¦Ü Pentarlandir™ UPPTA °ª¾¯¶q²Õ©Î¦w¼¢¾¯²Õ¡A¤ñ¨Ò¬° 2:1¡C³Ì²×¼Ë¥»±N«ö 1:1:1 ªº¤ñ¨Ò¤À¬°°ª¾¯¶q²Õ¡B§C¾¯¶q²Õ©M¦w¼¢¾¯²Õ¡C

§Æ±æ¯à¥[³tÁ{§É¡AÀ°§U¥@¬É¡AÀ°§U¥xÆW.

¤ß®®¥[ªo¡I¥xÆW¥[ªo¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/6/4 ¤W¤È 07:19:08²Ä 1683 ½g¦^À³
·Q½Ð±Ðª©¤W½Ñ¦ì¤j¤j

¤ß悦¼W¸ê¤w©ó¬Q¤ÑºI¤î

±z­Ìú´Ú¤F¶Ü¡H

¤½¥q·s»Dªí¥Ü

­ì¸³¨Æ¥þ³¡©ñ±ó»{ÁÊ

¤½¥q³w¬¢¯S©w¤H

¦ó®É¯àª¾¹D­þ¨Ç¯S©w¤H参»P»{ªÑ©O¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/4 ¤W¤È 06:00:59²Ä 1682 ½g¦^À³
¦Ñ¥v¤j¤jªº·s»D½Z¼g±o¯u¦n¡A§âSNB001ªº¥\¯à¦h©Pª¾¤F¡A§Æ±æSNB001¤]¯à¦p¹w´Áµo´§Àø®Ä¡A¦h¤è¦ìªvÀø·s«a¯f¬r¹ï¤HÅé©Ò¤Þ°_ªº½Ñ¦h¯gª¬¡A¥]¬Aºë¯«¯«¸g¯gª¬¡C

¥t¥~¡A§Ú­Ì¨Ó¬Ý¤@«h¤£¬Û¤zªº³ø¾É¡A¦ý©M¤ß®®²£«~½u¤¤¤]¥i¯à¨ã¦³ªº§@¥Î

µo²{ºë¯«¬ìÃĪ«¥i¹w¨¾¸zÀù«á±Ò°ÊÁ{§É¸ÕÅç

medicalxpress.com/news/2021-06-clinical-trial-discovery-psychiatric-drug.amp

¤wÃÒ©ú¨ã¦³ APC °ò¦]¬ðÅܪº¸z¹D·F²Ó­M¤ñ°·±dªº·F²Ó­M¨ã¦³Ävª§Àu¶Õ¡A¨Ã¥B¸g±`¶W¹L¥¦­Ì¡A¾É­P¤£¨ü­­¨îªº¥Íªø©MÀù¯g¡C

¨ì¥Ø«e¬°¤î¡A©|¤£²M·¡¬ðÅÜ·F²Ó­M¦p¦ó¥e¤W­·¡A¦ýµoªí¦b¡m¦ÛµM¡nÂø»x¤Wªº·s¬ã¨s²{¦bªí©ú¡A¬ðÅÜ·F²Ó­M·|¥D°Êµo¥X¯}Ãa¸z¹D°·±d·F²Ó­M¥\¯àªº«H¸¹¡C

¦ÜÃö­«­nªº¬O¡A¬ã¨s¤H­ûÁÙµo²{¤F¤@ºØ¨¾¤î¬ðÅÜ·F²Ó­M¤zÂZ°·±d·F²Ó­Mªº¤èªk¡C¾Y¬O¤@ºØªvÀø¦hºØºë¯«¯e¯fªº±`¥ÎÃĪ«¡A³q¹L¨Ï°·±d·F²Ó­M¹ï¯}Ãa©Ê«H¸¹¤£±Ó·P¡A±q¦Ó¨¾¤î¬ðÅÜ·F²Ó­M±µºÞ¨Ã¦b¤p¹«Å餺§Î¦¨¸~½F¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/6/3 ¤U¤È 08:18:04²Ä 1681 ½g¦^À³
¤ß®®¤µ¤Ñªº·s»D½Z, ½Ð°Ñ¦Ò

www.syneurx.com/2021/06/03/0603/?fbclid=IwAR3RdODzr1xyu3DrPXTLeA7khrd1LWyX06JFF8SCFhHtFuHRRwUpnyyGYjY

¤ß±o: §Y«K¬O¨C¦~¿ï¨ú¯f¬r®èªº¬y·P¬Ì­], ¬y·P½T¶E®É³B¤èªº§J¬y·P¤]¦P¼Ë¤£¥i©Î¯Ê

¦Ò¶q¬Ì­]±µºØ·NÄ@¤ÎÂл\²v, ½÷·ç»P¤ß®®ªº¬ãµo¦pªG¦¨¥\, ¹ï¤HÃþ³o¦¸ªº§Ü¬Ì¤j¾Ô, ¤]¬O¥\¤£¥i¨S

¬ì¾Çªº¶i¨BÅý§Ú­Ì¤@¨B¨B¨«¦V¥ú©ú....

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤Û·Q¤p³½10151823  µoªí®É¶¡:2021/6/3 ¤U¤È 07:22:37²Ä 1680 ½g¦^À³
¤ß®®¥ÍÂå«Å¥¬ ¥Ó½Ð¥xÆW§Ü·s«aªÍª¢·sÃÄÁ{§É¸ÕÅç

www.google.com/amp/s/money.udn.com/money/amp/story/5612/5507089

Pentarlandir¦P®É¥ç¬O·¥¨Îªº¥k±ÛÓi°ò»Ä®ñ¤Æ酶§í¨î¾¯¡A¥i¥H¬¡¤Æ¤j¸£NMDA¨üÅé¥\¯à¡A«OÅ@¤j¸£¯«¸g¡A¹ï©ó·s«aªÍª¢±wªÌ¬V¬Ì«á·¥¬°±`¨£ªº¼~Æ{µJ¼{¯gª¬¡B°O¾Ð¤O´î°hµ¥¤¤¼Ï¯«¸g¨t²Î°ÝÃD¡A¥ç¥i¯à¨ã¦³¤@¥Û¦h³¾ªº¥\®Ä¡C

¤ß®®¥[ªo¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GÀ³µL©Ò¦í10144738  µoªí®É¶¡:2021/6/3 ¤U¤È 06:32:00²Ä 1679 ½g¦^À³
¥»¸ê®Æ¥Ñ¡@ (¿³Âd¤½¥q) 6575 ¤ß®®¡@¤½¥q´£¨Ñ

§Ç¸¹ 2 µo¨¥¤é´Á 110/06/03 µo¨¥®É¶¡ 18:19:33

µo¨¥¤H «¸§Ó¿« µo¨¥¤H¾ºÙ °ÆÁ`¸g²z µo¨¥¤H¹q¸Ü 02-77422699

¥D¦® ¥»¤½¥q¬ãµo¤¤¤§ªvÀø«aª¬¯f¬r¯e¯f(COVID-19)·sÃÄ Pentarlandir¦V¥xÆW½ÃºÖ³¡¥Ó½Ð°õ¦æ¾÷¨îÅçÃÒ¸ÕÅç (SNB011 proof of principle trial)

²Å¦X±ø´Ú ²Ä 44 ´Ú ¨Æ¹êµo¥Í¤é 110/06/03

»¡©ú

1.¨Æ¹êµo¥Í¤é:110/06/03

2.¤½¥q¦WºÙ:¤ß®®¥ÍÂåªÑ¥÷¦³­­¤½¥q

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q

4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î

5.µo¥Í½t¥Ñ:

¤½§i¥»¤½¥q¬ãµo¤¤¤§ªvÀø«aª¬¯f¬r¯e¯f(COVID-19)·sÃÄPentarlandir¦V¥xÆW½ÃºÖ³¡¥Ó½Ð°õ¦æ¾÷¨îÅçÃÒ¸ÕÅç(SNB011 proof of principle trial)¡C

(1)¬ãµo¤¤·sÃĦWºÙ©Î¥N¸¹¡G Pentarlandir

(2)¥Î³~¡GªvÀø¦­´Á»´¯g«aª¬¯f¬r¯e¯f(mild and early COVID-19)¨Ã¨¾¤îÁ{§É¯f¯g´c¤Æ¡C

(3)¹w­p¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q¡G¤HÅé¾÷¨îÅçÃÒ¸ÕÅç¡C

(4)¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q¡G

A.´£¥X¥Ó½Ð/³q¹L®Ö­ã/¤£³q¹L®Ö­ã¡G¦V¥xÆW½ÃºÖ³¡´£¥X¥Ó½Ð/110¦~2¤ë4¤é¤wÀò¬ü°êFDA®Ö­ã°õ¦æ¾÷¨îÅçÃÒ¸ÕÅç¡C

B.¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¤½¥q©Ò­±Á{¤§­·ÀI¤Î¦]À³±¹¬I¡G¤£¾A¥Î¡C

C.¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G¬ü°êÁ{§É¸ÕÅç¤w©ó110¦~4¤ë27¤é±Ò°Ê¡A¥xÆWÁ{§É¸ÕÅç«h«Ý½ÃºÖ³¡®Ö­ã«á¡A¨Ì¸ÕÅç­pµe¼u©Ê¦¬®×¡B°õ¦æ¤HÅéÁ{§É¸ÕÅç¡A¨Ã±N¯Ç¤JSNB011¤§¥þ²y©ÊÁ{§É¸ÕÅç¡A¥D­nÁ{§É«ü¼Ð¬°¨ü¸ÕªÌªº¯f¬r­°§C¶q¡C

D.¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G¬°«O»Ù¤½¥q¤Î§ë¸ê¤HÅv¯q¡AÁקK¼vÅT°ê»Ú±ÂÅv½Í§P¡A¤£¤©¤½¶}´¦ÅS¡C

(5)±N¦A¶i¦æ¤§¤U¤@¬ãµo¶¥¬q¡G±N¨Ì¾Ú¥»Á{§É90¦ì¨ü¸ÕªÌ¤§¤HÅé¸ÕÅç¡A¿ï¾Ü³Ì¨Î¾¯¶q¡A¦A¶i¤J¤T´ÁÁ{§É¸ÕÅç¡C

A.¹w­p§¹¦¨®É¶¡¡G¹w­p¦¬®×45¤H«á¶i¦æ´Á¤¤¤ÀªR¡A110¦~©³-111¦~ªì§¹¦¨90¤H¦¬®×¶i¦æ¸Ñª¼¡A±©¹ê»Ú®Éµ{±N¨Ì¦¬®×¤H¼Æ¤Î°õ¦æ¶i«×¨M©w¬O§_½Õ¾ã¡C

B.¹w­pÀ³­t¾á¤§¸q°È¡GµL¡C

(6)¥«³õ²{ªp¡G¬Ì­]¤£©ö§¹¥þÂл\«OÅ@¡A¶·»PÃĪ«¦@¦P¨¾ªv¡A¤~§ó¦³§U©ó±±¨î¥þ²y¬Ì±¡¡C¥Ø«e¶È·ç¼w¦è­³(Remdersivir)Àò±o¬ü°êFDA¥¿¦¡®Ö­ã¥Î©ó¦í°|¯f±w¡A110¦~²Ä¤@©u¾P°â15»õ¬üª÷¡A¦ý¥@¬É½Ã¥Í²Õ´¨Ã¤£«Øij¨Ï¥Î¡C¦Ü©ó»´¤¤¯g«D¦í°|¯f±w¡A¶È¦³¨â´Ú³æ®è§ÜÅéÃĪ«Àò±oºò«æ¨Ï¥Î±ÂÅv¡A²Ä¤@©u¤À§O¾P°â8.1»õ¬üª÷(Eli Lilly)¡B2.6»õ¬üª÷(Regeneron)¡AµM¶·¦bÂå°|¶i¦æÀR¯ßª`®g¡AªvÀø©ù¶Q¤£«K¡C¥Ø«e¥þ²y°w¹ïM-Protease¾÷Â઺¤fªAÃĪ«¡A¶È¥»¤½¥qPentarlandir¥H¤Î½÷·çPF-07321332¦b°õ¦æ¤HÅéÁ{§É¸ÕÅç¡A«áªÌ¶i«×¬O¦bÁ{§É¤@´Á¡C¦bªvÀø¾÷¨î¤è­±Pentarlandir§ó³Ó¤@Äw¡A¥]¬AM-Protease¡BTMPRSS-2¤Îanti-inflammatory¤T¤j¾÷Âà¡C

6.¦]À³±¹¬I:µL

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê­±Á{­·ÀI¡A¥»¤½¥q¤£¹ªÀyµu´Á§ë¸ê¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/2 ¤W¤È 10:36:11²Ä 1678 ½g¦^À³
¯u±o³o»ò¨S¦³¤H½t¶Ü?

Alkermes ªº ALKS 3831 ¥u°w¹ï¶ø´á¥­¡]olanzapine¡^Åé­«¼W¥[ªº°Æ§@¥Î§ïµ½ , ¬Q¤ÑÀòFDA§å­ã

¬ü°êFDA§å­ã³Ð·s¤fªA½Æ¤èÃĪvÀøºë¯«¤Àµõ¯g©MÂù¬ÛI«¬»Ùê

¨Ó·½¡GÃÄ©ú±d¼w¡@2021-06-02

med.sina.com/article_detail_100_2_100381.html

2021¦~6¤ë1¤é¡AAlkermes«Å¥¬¡A¬ü°êFDA¤w§å­ã¨ä·sÃÄLybalvi¡]´¿¦W¬°ALKS 3831¡^¤W¥«¡A¥Î©óªvÀø¦¨¤Hºë¯«¤Àµõ¯g©MÂù¬ÛI«¬»Ùê¡]bipolar I disorder¡^¡CLybalvi¬O¤@ºØ¨C¤é¤fªA¤@¦¸ªº«D¨å«¬§Üºë¯«¯fÃÄ¡A¬O¥Ñ¶ø´á¥­¡]olanzapine¡^©Msamidorphan²Õ¦¨ªº½Æ¤è¤ù¾¯¡A¥¦¯à¦bºû«ù¶ø´á¥­Àø®Äªº¦P®É´î»´¥¦¼W¥[±wªÌÅé­«ªº¥NÁ²§±`°Æ§@¥Î¡C

¶ø´á¥­¬O¤@ºØ¤w¤W¥«ªººë¯«¯fÃĪ«¡AµM¦Ó¥¦ªº¤@­Ó¥D­n°Æ§@¥Î¬O·|ÅãµÛ¼W¥[±wªÌªºÅé­«¡A±q¦Ó´£°ª¥L­Ì±w¤W¨ä¥¦¥NÁÂÃþ¯e¯fªº­·ÀI¡CSamidorphan¬O¤@ºØªü¤ù¨üÅé«ú§Ü¾¯¡A³q¹L¼vÅT¤j¸£ªº¼úÀy¨t²Î¡A­°§C¶ø´á¥­±a¨ÓªºÅé­«¼W¥[¡C

¦b¸ÓÃÄENLIGHTENÁ{§É¶}µo¶µ¥Ø¤¤¡ALybalviÃÒ©ú¤F¨ä§@¬°§Üºë¯«¯fÃĪº¨}¦n¦³®Ä©Ê¡B¦w¥þ©Ê©M­@¨ü©Ê¡C¦b¦h¤¤¤ß¡BÀH¾÷Âùª¼¡B¦w¼¢¾¯¹ï·Óªº3´ÁÁ{§É¸ÕÅçENLIGHTEN-2¤¤¡A¦@¤J²Õ561¨Òí©w«¬ºë¯«¤Àµõ¯g±wªÌ¡C6­Ó¤ëªvÀøµ²ªGÅã¥Ü¡A¬Û¤ñ¹ï·Ó²Õ¡A¸ÕÅç²Õ±wªÌÅé­«¼W¥[ªº¥­§¡¦Ê¤À¤ñªí²{¥X²Î­p¾Ç·N¸qªºÅãµÛ­°§C¡]p=0.003¡^¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/2 ¤W¤È 06:25:04²Ä 1677 ½g¦^À³
À¹¤f¸n§O°µ³o¨Ç¹B°Ê¡IÂåÃn¥[­«­t¾á ¤ô®ð§óÅý¯f¬r¤J«I

06:13¡C2021/06/02 ¤¤®É·s»Dºô ¤µ°·±d

www.chinatimes.com/realtimenews/20210602000018-260418?ctrack=pc_main_rtime_p01&chdtv

À¹¤f¸n¹B°Ê©ö¥[­«­t¾á¡@¤£½×¦³®ñ©ÎÀRºA³£¤£©y¡I

¯ÝµÄ¤º¬ì/­«¯gÂå¾Ç¶À°aÂå®vªí¥Ü¡A¤£½×¬O§Ö¶]¡BºC¶]¡BÃM¨®¹B°Ê¡Bª¦¤s¡A©Î¬O·ìÏÉ¡Bµ¬°©¨­®iµ¥ÀRºA¬¡°Ê©Î¬O¦³®ñ¹B°Ê¡A³£¤£À³À¹¤f¸n°õ¦æ¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/1 ¤U¤È 09:08:29²Ä 1676 ½g¦^À³
¦³¬Ì­]ÁÙ¤£°÷¡I¦U°ê¥ø·~Äv¬Û¶}µo·s«aªÍª¢Àøªk

2021-06-01 20:56 ¸gÀÙ¤é³ø / ½sĶªL©_½å¡þºî¦X¥~¹q

udn.com/news/story/121707/5501684

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/1 ¤U¤È 12:11:05²Ä 1675 ½g¦^À³
¦U¤j¬Ì­]¹ïÅܺدf¬r¨ì©³¨ã¦³¦h¤Ö«OÅ@¤O ?

www.genetinfo.com/international-news/item/49121.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/6/1 ¤W¤È 06:47:04²Ä 1674 ½g¦^À³
Biogenªü¯÷®üÀq¯g·sÃÄ©R¹B FDA 6¤ë7¤é«Å§P

ÃC¹Å«n¡þºî¦X¥~¹q³ø¾É2021.05.31

ctee.com.tw/livenews/gj/ctee/A98602002021053122203347

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/5/31 ¤W¤È 11:06:18²Ä 1673 ½g¦^À³
¹ù¥S»¡

½²±Ð±Â¤µ¤é¦b¤u°Ó®É³ø[¦W®aµû½×]±MÄæµoªí¤å³¹ --- µûªR¾Ô¬Ì

¶ÂÀs¤ý³ò«°

view.ctee.com.tw/social/29682.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/5/30 ¤U¤È 09:52:23²Ä 1672 ½g¦^À³
¨¦ºq½Ķ½÷·ç¤fªAÃĪº·s»D3¤ë23¸¹

½÷·ç±Ò°Ê°w¹ï SARS-CoV-2 ªº·s«¬¤fªA§Ü¯f¬rªvÀøÃĪ«ªº 1 ´Á¬ã¨s

¬ü°êªF³¡®É¶¡ 2021 ¦~ 3 ¤ë 23 ¤é¤W¤È 11:00 ¬ü°ê°Ó·~¸ê°TPfizer Inc. (PFE)

¨´¤µ¬°¤î¶i¦æªºÅé¥~¬ã¨sªí©ú¡AÁ{§É­Ô¿ïª« PF-07321332 ¬O¤@ºØ±j®Ä³J¥Õ酶§í»s¾¯¡A¹ï SARS-CoV-2 ¨ã¦³±j®Ä§Ü¯f¬r¬¡©Ê

³o¬O²Ä¤@­Ó¦bÁ{§É¬ã¨s¤¤¶i¦æµû¦ôªº¤fªA«aª¬¯f¬r¯S²§©Ê¬ã¨s³J¥Õ酶§í»s¾¯¡AºòÀH½÷·çÀR¯ßª`®g¬ã¨s³J¥Õ酶§í»s¾¯¤§«á¡A¥Ø«e¥¿¦b±µ¨ü COVID-19 ¦í°|Á{§É¸ÕÅç°Ñ»PªÌªº 1b ´Á¦h¾¯¶q¬ã¨sµû¦ô

¯Ã¬ù--(BUSINESS WIRE)--½÷·ç¤½¥q( PFE ) ¤µ¤Ñ«Å¥¬¡A¦b°·±d¦¨¤Hªº1 ´Á¬ã¨s¤¤§¹¦¨³æ¦¸»¼¼W¾¯¶qµ¹ÃÄ«á¡A¥¦¥¿¦b¦V¦h­Ó»¼¼W¾¯¶q¶i¦æµ¹ÃÄ¡A¥Hµû¦ô¤@ºØÃĪ«ªº¦w¥þ©Ê©M­@¨ü©Ê¡C SARS-CoV-2¡]¾É­P COVID-19 ªº¯f¬r¡^ªº¬ã¨s©Ê·s«¬¤fªA§Ü¯f¬rÀøªk¡C¸Ó²Ä¤@¶¥¬q¸ÕÅ祿¦b¬ü°ê¶i¦æ¡C¤fªA§Ü¯f¬rÁ{§É­Ô¿ïÃĪ« PF-07321332 ¬O¤@ºØSARS-CoV2-3CL ³J¥Õ酶§í»s¾¯¡A¤wÅã¥Ü¥X¹ï SARS-CoV-2 ¥H¤Î¨ä¥L«aª¬¯f¬rªº¦³®ÄÅé¥~§Ü¯f¬r¬¡©Ê¡Aªí©ú¨ä¦³¥i¯à¥Î©óªvÀøCOVID-19 ¥H¤ÎÀ³¹ï¥¼¨Ó«aª¬¯f¬r«Â¯Ùªº¼ç¦b¥Î³~¡C

¡§À³¹ï COVID-19 ¤j¬y¦æ¬J»Ý­n³q¹L¬Ì­]¶i¦æ¹w¨¾¡A¤]»Ý­n¹ï·P¬V¸Ó¯f¬rªº¤H¶i¦æ°w¹ï©ÊªvÀø¡CŲ©ó SARS-CoV-2 ªºÅܲ§¤è¦¡¥H¤Î COVID-19 ªº«ùÄò¥þ²y¼vÅT¡A²{¦b©M¤j¬y¦æ¤§«áÀò±oªvÀø¿ï¾Ü¦ü¥G¦ÜÃö­«­n¡A¡¨ Mikael Dolsten»¡, MD, PhD., ­º®u¬ì¾Ç©x­Ý½÷·ç¥þ²y¬ã¨s¡B¶}µo©MÂåÀøÁ`µô¡C¡§§Ú­Ì±N PF-07321332 ³]­p¬°¤@ºØ¼ç¦bªº¤fªAÀøªk¡A¥i¥H¦b·P¬Vªº²Ä¤@­Ó¸ñ¶H®É¶}³B¤è¡A¦ÓµL»Ý±wªÌ¦í°|©Î±µ¨ü­«¯gºÊÅ@¡C¦P®É¡A½÷·çªºÀR¯ß¤º§Ü¯f¬r­Ô¿ïÃĪ«¬O¦í°|±wªÌªº¼ç¦b·s«¬ªvÀø¿ï¾Ü¡C¨âªÌ¤@°_¦³¥i¯à³Ð³y¤@ºØºÝ¨ìºÝªºªvÀø½d¦¡¡A¦b¯e¯f¤´µMµo¥Íªº±¡ªp¤U¸É¥R¬Ì­]±µºØ¡C¡¨

³J¥Õ酶§í»s¾¯»P¯f¬r酶¡]ºÙ¬°³J¥Õ酶¡^µ²¦X¡A¨¾¤î¯f¬r¦b²Ó­M¤¤´_¨î¡C³J¥Õ酶§í»s¾¯¥i¦³®ÄªvÀø¨ä¥L¯f¬r¯f­ìÅé¡A¦p HIV ©M¤þ«¬¨xª¢¯f¬r¡AµL½×¬O³æ¿W¨Ï¥ÎÁÙ¬O»P¨ä¥L§Ü¯f¬rÃĪ«Áp¦X¨Ï¥Î¡C¥Ø«e¤W¥«ªº°w¹ï¯f¬r³J¥Õ酶ªºÀøªk³q±`»P¬r©ÊµLÃö¡A¦]¦¹¡A³oÃþ¤À¤l¥i¯à·|´£¨Ñ­@¨ü©Ê¨}¦nªº COVID-19 ªvÀø¤èªk¡C

1 ´Á¸ÕÅç¬O¤@¶µÀH¾÷¡BÂùª¼¡BÃÙ§U°Ó¶}©ñ¡B¦w¼¢¾¯¹ï·Ó¡B³æ¾¯¶q©M¦h¾¯¶q»¼¼W¬ã¨s¡A¦b°·±d¦¨¤H¤¤µû¦ô PF-07321332 ªº¦w¥þ©Ê¡B­@¨ü©Ê©MÃÄ¥N°Ê¤O¾Ç¡C

³o¶µ¬ã¨sªº±Ò°Ê±o¨ì¤FÁ{§É«e¬ã¨sªº¤ä«ù¡A³o¨Ç¬ã¨sÃÒ©ú¤F³oºØ¼ç¦bªº¤@¬y SARS-CoV-2 ªvÀø¾¯ªº§Ü¯f¬r¬¡©Ê¡A¸ÓªvÀø¾¯±Mªù³]­p¥Î©ó§í¨î SARS-CoV2 ¯f¬rªº½Æ¨î¡CPF-07321332 ªºµ²ºc¥H¤ÎÁ{§É«e¼Æ¾Ú±N¦b 4 ¤ë 6 ¤é¬K©u¬ü°ê¤Æ¾Ç¾Ç·|·|ijªº COVID-19 ·|ij¤W¤À¨É¡C

½÷·çÁÙ¦b¬ã¨s¤@ºØÀR¯ß¤ºµ¹ÃĪº¬ã¨s³J¥Õ酶§í»s¾¯ PF-07304814¡A¸Ó§í»s¾¯¥Ø«e¥¿³B©ó COVID-19¦í°|Á{§É¸ÕÅç°Ñ»PªÌªº 1b ´Á¦h¾¯¶q¸ÕÅ礤¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GKingko10149198  µoªí®É¶¡:2021/5/29 ¤U¤È 01:28:05²Ä 1671 ½g¦^À³
±d°·Âø»x www.commonhealth.com.tw/article/84109

§â¤U­±ªº½÷·ç§ï¦¨¤ß®®,³Õº¸©Ô§ï¦¨½²ªG¯þ,§Ú«ç»ò¬Ý¤£¨ì¦³¥ô¦ó¤£§´°Ú

½÷·ç¡]Pfizer¡^°õ¦æªø³Õº¸©Ô¡]Albert Bourla¡^¤é«e«Å¥¬¡AºX¤U¬ãµo¥X·s«a¤fªAÃÄ¡A¯à¥Î©óªvÀø¬V¬Ìªì´Áªº¯gª¬¡C±wªÌ¥u­n¤fªA¡A¦b®a´N¯àÀò±oÂåªv¡A¤£¥²¦í¶iÂå°|¡u¶°¤¤ºÞ²z¡v¡B¼W²K·P¬V­·ÀI¡C

­È±oª`·Nªº¬O¡A³Õº¸©Ô»¡¡A¥L­Ì¹w´Á¡A³o´Ú¤fªAÃÄÁٯ঳®Ä¹ï§ÜÅܲ§¯f¬r¡C¦pªG¶¶§Q³q¹L¬ü°ê­¹«~ÃĪ«ºÞ²z§½¡]FDA¡^§å­ã¡A¤µ¦~¦~©³¡A¸Ó·sÃĦ³±æ¦b¬ü¤W¥«¡C

³Õº¸©Ô«ü¥X¡A³o´Ú·s«a¤fªAÃÄ¥i¯à§ïÅܬ̱¡¥ÍºA¡C¦]¬°¥Á²³§Y¨Ï¬V¬Ì¡A¤]¤£¥²¤J°|ªvÀø¡A¥i¥H¬Ù¤U¤jµ§ÂåÀø¸ê·½¡F¦p¦¹¤@¨Ó¡A¤]¯à¤j´T­°§C»P¤@½u¤H­û±µÄ²ªº¥²­n©Ê¡A¨¾°ô¬Ì±¡¶i¤@¨BÂX´²¡C

³o´Ú¤fªAÃÄÄÝ©ó¡u³J¥Õ酶§í¨î¾¯¡v¡A³J¥Õ酶¬O¯f¬r¯à¦bÅ餺½Æ»sªºÃöÁä­n¯À¡A¸Ó§í¨î¾¯Âǥѧí¨î³J¥Õ酶¡A¨Óªý¼¸¯f¬r¼W¥Í¡B¨¾¤î¯f±¡´c¤Æ¡AHIV¡BC«¬¨xª¢ÃĪ«¤]³£¬O¨Ï¥Î³J¥Õ酶§í¨î¾¯¡C

*************************************************

¾Ô°«¤O¦Ê¤À¦Ê,§åµûÁ`¬O¤@°w¨£¦åªº«i¤j±z¦n,§Ú¤]»{¬°¬F©²À³¸Ó¤ä«ù¥xÆW¦Û²£ªºCOVID-19ª©§J¬y·P

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/5/28 ¤U¤È 11:55:13²Ä 1670 ½g¦^À³
Kinmen3015¤j±z¦n, ÁÂÁ±zªº¦^¤å

¤ñ¸ûºë½T¤@ÂIªº»¡ªk¬O:

SNB-01ªº¥D­n¦¨¤À³æ¹ç»Ä¥»¨­¦b°ê¥~¤w¸g¦³³\¦hÃĪ«§t¦³³o­Ó¦¨¤À, ³o¬O¬°¤°»òSNB-01¥i¥Hª½±µ¶i¤J¤G´ÁÁ{§Éªº­ì¦]

ÃĵØÃĪºÃĪ«¦³¹L¬õ¦å²y¼W¥Í¯g¤T´ÁÁ{§Éªº¼Æ¾Ú

°ê¹©ªºÃĪ«¬O¤w¸gÁ{§É¦b¯ØŦÀùªÍÀùªº

¥ÍµØ¬ìªºÃĪ«¬O¤w¸gÁ{§É¦bÁxºÞÀù

¥H¤W¤T¶¡¤½¥qªºsolution ³£¬O¤w¸g¥HÃĪ«ªº«ººA°µ¹L¤HÅéÁ{§É

¦ÓSNB-01³o­ÓÃĪ«¥»¨­¬OÁÙ¨S¦³¥ô¦ó¤HÅéÁ{§É¹êÅç, ©Ò¥H¼f¬d¬yµ{¤WÁÙ¬O¦³¨Ç³\®t²§

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/5/28 ¤U¤È 11:35:48²Ä 1669 ½g¦^À³
­è­è¬Ý¨ì50¥x¬ðµoµX·Qªº¸`¥Ø, ¦³´£¨ì½÷·ç¤fªAÃĹ³§J¬y·P¤@¼Ë.....

¤£ª¾¹Dª©¤W¾K¤ß¤ß®®ªºªB¤Í¦³¨S¦³©M§Ú¤@¼Ë¸£¤¤ÆF¥ú¤@²{?

www.syneurx.com/2021/04/27/0427/?fbclid=IwAR3omSviejX1O93lHQnVeryR2rMnwr5AxCUS4TrT6ysXUPDgZJJgSJGXNdM

¤£ª¾¹D¦³¨S¦³¤èªkÅý¤ß®®SNB-01¼s¬°¤Hª¾? ³yºÖ§ó¦h¤H? ©Î³\³o¤S¬O¥t¤@®yÅ@°ê¯«¤s, ¥xÆW¤§¥ú......

¦b¦¹®É¬F©²¤j¤O¤ä«ù°ê²£¬Ì­], ¤£ª¾¬O§_¤]Ä@·N¦P¼Ë¤ä«ù¥xÆW¦Û²£ªºCOVID-19ª©§J¬y·P

ª©¤W®®¤Í¦pªG¦³§ó¦nªº¤è¦¡¨Ó¼W¥[¯à¨£«×, ¤]¤£§«¤@°_§V¤O, Åý¥xÆW¥Í§Þ¥´¶i¥@¬É¬×!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gkinmen301510141987  µoªí®É¶¡:2021/5/28 ¤U¤È 08:31:43²Ä 1668 ½g¦^À³
«i©¹ª½«e¤j±z¦n

Ãö©ó±z²Ä¤@ÂIªº説ªk¡A¥i¯à­n­×¥¿

SNB011¬Oª½±µ°µ¤G´Á¡A¤]´N¬O説¦³¤HÅé¸ÕÅç¹L

¨ä¹êSNB011¬O¦]¬°°w¹ïªº¬O»´¯g±wªÌ¡A©Ò¥H¤£²Å®¦·OÀøªk³W©w¡C

¥u¯à«ö¨B¨Ó¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/5/28 ¤U¤È 06:45:48²Ä 1667 ½g¦^À³
§Ú¬Û«H¤j®a³£«Ü«æ¤Á¤]«Ü´Á«Ý¤ß®®¦¹¨è¯à¦³©Ò§@¬°, ¦ý¬O§Ú­Ì¤]¥²¶·²z¸Ñ¤½¥q¥²¶·¦³©Ò¬°¦³©Ò¤£¬°

1. ¥H¤Û·Q¤p³½¤j´£¤Îªº´X®a·sÃĤ½¥q, ¦p¥ÍµØ¬ì, ¶h¹F, °ê¹©»PÃĵØÃÄ, ³o¨Ç¤½¥q´£¥Xªº solution ³£¤w¸g¦³¨ä¥L¤HÅé¾AÀ³¯gªº¸gÅç, ¦Ó¤ß®®ªºSNB-01©|¥¼¦³¤HÅé¾AÀ³¯gªº¹êÅç, ·Q·íµM¦Õ¤ß®®µLªk°Ñ»PCOVID-19ªº®¦·OÀøªk, §K¶OÃØÃĪº¸qÁ|

2. ¦¹¥~, ´N¦b¤U¹L¥hªºª÷¿Ä§ë¸ê¸gÅç, ¤@®a¤½¥q¦b²{ª÷¼W¸ê´Á¶¡¦³½pÀq´Áªº³W©w, »¡¥Õ¤F´N¬O¤£¯à¦³¹L«×ÅýªÑªF²£¥Í¹w´Á¤ß²zªº¨¥½×©Î·s»D, ¥H§K¼vÅTªÑ»ùªi°Ê

¥H¤W¬O­Ó¤H·Qªkªº¤p¤p¤À¨É, ÁöµM§Ú¤@ª½ªÃ«ùµÛºÊ·þ¤½¥qÀç¹Bªº¤ßºA, ¯¥ÅF°_¨Ó¤]µ·²@¤£«È®ð, ¦ý¬O¦b¤U¤]¬O²`²`´Á«Ý¤½¥q¦b¤£»·ªº¥¼¨Ó¯à¦³¤@µf§@¬°!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2021/5/28 ¤W¤È 11:00:05²Ä 1666 ½g¦^À³
¤½¥q³o¥b¦~¨Ó½T¹ê¦b¸ê°Tªº³z©ú¤W§ïµ½³\¦h¡A­È±o¹Å³\¡A

´Á³\¤½¥q¦bÁ{§É¶i«×¤WÄ~Äò¥[ªo¡A

ÁöµM³\¦h¤H¥H²{¦bªºªÑ»ù°ª§C½×­^¶¯¡A

¦ý­Y«D²{¦b³\¦h¤H¤£¬Ý¦n¤½¥q¡A

«ç¯à¦³¦p¦¹«K©yªºªÑ»ùÅý¬Ý¦n¤½¥qªº§ë¸ê¤H«ùÄò³{§C¶R¤J¡A

§ë¸ê¤ß®®¹ï§Ú¦Ó¨¥¡A¤£¶È¦b©ó´Á«Ý¥¼¨ÓªºÀò§Q¡A

¤]¬O¥H¹ê»Ú¸êª÷¤ä«ù·sÃIJ£·~µo®i¡A

§ó­«­nªº¬O¤ß®®ÃĪ«¦­¤é°Ý¥@¡A³yºÖ¤HÃþ!!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/5/28 ¤W¤È 07:52:43²Ä 1665 ½g¦^À³
·s«aªÍª¢¹Ü©R3¤j¯S¼x 3­«ÂIÁקK¬V¬ÌÅÜ­«¯g

04:232021/05/28 ¤¤®É·s»Dºô ±d°·Âø»x

www.chinatimes.com/realtimenews/20210528000013-260418?ctrack=pc_main_recmd_p09&chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/5/28 ¤W¤È 07:41:16²Ä 1664 ½g¦^À³
COVID-19¬Ì­] ­±¹ï·sªºÅܺدf¬r ¥i¹w¨¾­«¯g ¦ý¥¼¥²¯à°÷ÁקK¨ü·P¬V

www.genetinfo.com/international-news/item/48739.html

½×¤å :

What level of neutralising antibody protects from COVID-19?

www.medrxiv.org/content/10.1101/2021.03.09.21252641v1.full-text

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GSmi10150402  µoªí®É¶¡:2021/5/26 ¤U¤È 02:55:21²Ä 1663 ½g¦^À³
°ê¥~CRO¡B70¦h¨p¶Ò»{ªÑ¡AªÑ»ù¤]¨S¦³¥ô¦ó°_¦â

§Ú·Q¤j®a´N¤£­n¬°Ãø¥L¤F

·í¤j®a³£¸õ¥X¨Ó¡A¨S¯à¤Oªº·íµMÄ~ÄòÀtÁY°Õ

§O¦A¬°Ãø¤ß®®¤F¡A³s¨p¶Ò77.33³£¨ì¤£¤F¡A³o¤½¥q¯à¦³¤°»ò°µ¬°

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤Û·Q¤p³½10151823  µoªí®É¶¡:2021/5/26 ¤U¤È 12:40:12²Ä 1662 ½g¦^À³
¥ÍµØ¬ì´£¨Ñ¥xÆW·s«a·sÃĦ@¦P§Ü¬Ì

ªv·s«aªÍª¢ °ê¹©´£¨Ñ2,000¤H¥÷Á{§É·sÃÄ

¶h¹F¥Í§Þ±N´£¨Ñ·sÃÄ ¨ó§UªvÀø¥xÆW·s«aªÍª¢­«¯g±wªÌ

ÃĵØÃÄCan Help¡I¤w¨çCDC¥Ó½Ð¯Ç¤J·s«aªvÀø«ü¤Þ

¤j®a³£¸õ¥X¨Ó¡A¤ß®®³o®É­ÔÁÙ¤£¸õ¥X¨Ó¶Ü¡H¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2021/5/25 ¤U¤È 06:42:12²Ä 1661 ½g¦^À³
¤j®a¦n, ¨j²¤Åª§¹¤µ¦~ªº¦~³ø, ¬Ý¨ìª©¤W°Q½×¬O§_¸Ó²{¼W, ¦b¤U¤À¨É¤@¨Ç¦Û¤vªº·Qªkµ¹¦U¦ì°Ñ¦Ò

109ªº¦~³ø©Z¥Õ»¡Åý¤H²´·ú¤@«G! ¤£¦A¬O©¹¦~°ª¤j¤WÁ¿±o¤fªj¾î­¸, °µªº½w¦p¤û¨Bªº½Æ»s¶K¤W, ­Ë¬O²³æ©úÁAªº³ø§i¤u§@¶i«×, ·Pı¬Û·í°È¹ê! ¥ú¬O³o¤@ÂI, ¦b¤U´N¬Û·íªÖ©w!

³z©ú¤½¶}ªº¸ê°T¬O¤@¶¡¤½¥q³Ì¬Ã¶Qªº¸ê²£, »P¨ä¶}µØÄRªºªÑªF·|, ²bÁ¿¤@¨Ç¬ì¬ã¤Ñ®Ñ, ¤Þµo¥«³õ¹L¦hªºÁr´ú, ¶}¤jªù¨«¤j¸ô±µ¦a®ð°µ¹ê¨Æ¤Ï¦Ó¯à°÷űoªÑªF«H¥ô!

¦A¨Ó´N¤u§@¶i«×¤W, ¥H¤U¦³´XÂIµ¹¦U¦ì°Ñ¦Ò

1. SND-13: ³o¬Û·í¥O¤H·N¥~, ©~µM¨ãÅ餽¥¬¥Ø«e¦¬®×¶i«×! ¥H«e®Ú¥»´N¬O­Ó´c©Ê´`Àô : ¤½¥q¤T½p¨ä¤f, ±µµÛª©¤W®®¤Í¤£Â_¸£¸É, ªÑªF·|½²¸³²{¨­µM«á®®¤Í¥¢±æ, ¦A¸£¸É...... ²{¦bª½±µ¤½¥¬¶i«×, ¥H¥Ø«e¬Ý¨Ó¦¬®×216¤H, ´Á¤¤¤ÀªR¥Ø¼Ð¤j·§232¤H, ¬Ý¨Ó¬Ì±¡ÁöµM´î½w¦¬®×,¦ý¬O¨Ã¨S¦³§¹¥þ°±º¢, ¥[¤W¥xÆW¥[¶}¦¬®×¤¤¤ß, ¬Ý¨Ó¦~©³«eÀ³¸Ó¥i¥H¦³©Ò´Á«Ý

2. SNB-01: §¹¥þ»{¦Pª©¤W¬Y¤j´£ªº«ç»ò¥i¥H³o»ò©ì, ¦b¤U¤]·P¦P¨­¨ü

¦ý¬O«ÈÆ[µû¦ô, SNB-01¦¬®×¤H¼Æ90, ¦Ó45¤H§Y¥i°µ´Á¤¤¤ÀªR, ¦b¬Ì±¡¸v­hªº¦¹¨è, ³o¸Ì«GÂIÀWÀW! §Ú²q´Á¤¤¤ÀªR¥i±æ¦b9¤ë, µM«á¦~©³¸Ñª¼¡AÀ³¸Ó·|¦³¤H·Q¶R±i±m¨é¶}¤T¦¸¼ú? ¹ïªÑ»ù©Î³\¦³¥¿­±®ÄªG!

ºî¤W©Ò­z, ÁöµM¦]¬°¥xªÑ¦]¯À³y¦¨ªÑ»ù²{¦b§C°g, ¦ý¬O¦b¤U¬Ý¨Ó, ¤µ¦~¥i»¡¬O¤ß®®¤¸¦~, ±q°]°Èªøªº¥[¤J¨ìªÑªF·|¦~³ø´¦ÅS, ¤u§@¶i«×°È¹ê³ø§i, ¬O¤£¬O­È±o¦U¦ìªÑªF¦A¤ä«ù, ¤j®a©Î³\¥i¥H¦h¤è«ä¦Ò

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/5/18 ¤U¤È 04:30:23²Ä 1660 ½g¦^À³
¥ÍµØ¬ì¥D°Ê´£¨Ñ¥xÆW·s«a·sÃÄ¡A¬ß­«²{¤­¤Ñ±d´_¥X°|µ²ªG

§@ªÌ «À ´f¯ø | µo¥¬¤é´Á 2021 ¦~ 05 ¤ë 18 ¤é 14:44

finance.technews.tw/2021/05/18/shenghua-branch/

¥ÍµØ¬ì¤µ¤é«Å¥¬¡A¬°¤F¹ï¥xÆW¬Ì±¡ºÉ³Ì¤j¤ß¤O¡AÄ@·NµLÀv´£¨Ñ¥Ø«e¥¿¦b¬ü°ê¶i¦æ¨â¶µ·s«a¤HÅéÁ{§Éªº·sÃÄ Silmitasertib¡]CX-4945¡^µ¹¥xÆW¦U¤jÂå°|¥Ó½Ð¥Î¨ÓªvÀø­«¯g¯f±wªº®¦·OÀøªk.

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/5/13 ¤W¤È 06:04:44²Ä 1659 ½g¦^À³
¥x¼t·m·f·s«a¸ÑÃÄ°Ó¾÷ °ªºÝ¡B¤ß®®¡B¥x·LÅé¡B¬R«p°Ê°_¨Ó

www.chinatimes.com/newspapers/20210513000135-260210?chdtv

04:102021/05/13 ¤u°Ó®É³ø §ù¿·»T

¤ß®®¥ÍÂå«h»P¬ü°êCRO¦X§@¹Ù¦ñPrevail InfoWorks¶}µo¥i§í¨îÂù¹vÂIªº¤fªAÃĪ«Pentarlandir¡A¹w­p6¤ë¤U¦¯¶i¤JÁ{§É

­ì¥»Âê©w¶}µoºë¯«¥ÎÃĪº¤ß®®¥ÍÂå¡A«h¬O»PPrevail InfoWorks¦X§@¶}µoªv·s«aªº¤fªAÃĪ«Pentarlandir¡A¥Ø«e¤wÀò¬ü°êFDA®Ö­ã°õ¦æ·s«a¯e¯f(COVID-19)¦­´Á»´¯g¯f±wªº¤HÅéÁ{§É¸ÕÅç¡A¨ÃÀòFDA«Øij¼W¥[°ª¾¯¶q²Õ¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYendis10145808  µoªí®É¶¡:2021/5/12 ¤W¤È 10:35:16²Ä 1658 ½g¦^À³
¦³¥h²{¼Wú´Úªº³£½ß¿ú¤F§a¡H¤½¥q³o¼Ë¾Þ§@¯uªº«ÜÁV¿|
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²V¥P10151740  µoªí®É¶¡:2021/5/7 ¤W¤È 10:31:10²Ä 1657 ½g¦^À³
²{¦b¬O¬y¦æ¥ý¶^¦^²{¼W»ù¶Ü¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªü¤Ñ10149120  µoªí®É¶¡:2021/4/20 ¤W¤È 10:10:45²Ä 1656 ½g¦^À³
²q·Q¤j ·PÁ¦^ÂÐ

ªÑ»ù¤@ª½¤U¥h ¼W¸ê©È¤£¶¶§Q⋯⋯¯¬ºÖ¤½¥q¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/4/20 ¤W¤È 09:41:24²Ä 1655 ½g¦^À³
ªü¤Ñ¤j

700P¬O¥üOO¨Êªº¥N¸¹ , ¬O¤ß®®ªñ´ÁªÑ»ù±²°_¤d°ï³· ( ­É¨ä[§N]·N )ªº¥D¦]

[ ¶È³Ñ ¤­¤é¨Ê¥ü ªº¾l«Â ? ] ¬O¦b²q´ú³o¦ì¤j­ô¤j©j§Y±N½æ§¹¤F¶Ü ?

²¦³º¥L ( ¦o )¤w¥X²æ¶W¹L 2,300 ±i¤F

µM¤]½Ð³o¦ì¤j­ô¤j©j¦b³o¤ß®®²{¼W´Á¶¡°ª©ï¶Q¤â , Åý¤ß®®¼W¸ê¶¶§Q

µü¤£¹F·N¤§³B , ·q½Ð®ü²[

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªü¤Ñ10149120  µoªí®É¶¡:2021/4/20 ¤W¤È 09:06:01²Ä 1654 ½g¦^À³
²q·Q¤j ±z¬O«ü¤°»ò©O¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/4/20 ¤W¤È 07:48:33²Ä 1653 ½g¦^À³
700Pªº«Â¤O´N¨¬¥H±²°_¨Ê¥ü­·¶³ ?

ÁÙ¬O¶È³Ñ ¤­¤é¨Ê¥ü ªº¾l«Â ?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/4/17 ¤W¤È 10:43:29²Ä 1652 ½g¦^À³
³oºØ¤W¥«¥Ó½Ð , ¤ß®®¦³¿³½ì¶Ü ?

¡mÃÒ¥æ©Ò¡n¥xÆW³Ð·sªO §Y°_¨ü²z¤W¥«¥Ó½Ð

www.chinatimes.com/realtimenews/20210401001142-260410?chdtv

***

ÃÒ¥æ©Ò³Ð·sªO¥Í·N¤Wªù¡A¤¯·sÂåÃÄ·m¤UÀY­»¡I¹w­p²Ä¤T©u¥¿¦¡¶}ªO

www.bnext.com.tw/article/62279/taiwan-innovation-board-first

¤¯·sÂåÃÄÄÝ·sÃĬãµo¤½¥q¡A«Y¥H²Ä¤GÃþ¼Ð·Ç-¥«­È¤£§C©ó30»õ¤¸¡A»ÝÃÒ©ú¦³¨¬¨Ñ¤W¥«±¾µP«á12­Ó¤ëÀç¹B¸êª÷¹F125%¤Î®Ö¤ß²£«~»Ý³q¹L²Ä¤@¶¥¬qÁ{§É¸ÕÅçµ¥³W¼Ò´£¥X¥Ó½Ð¡C

²Ä2Ãþ­­¥Í§Þ·~¡A¥«­È»Ý°ª©ó30»õ¤¸¡A¥B¦³¨¬¨Ñ±¾µP«á1¦~¤ºÀç¹B¸êª÷125%ªº°]¤O¡A·sÃĤ½¥q²£«~¥u»Ý³q¹L°ê¤º¥~²Ä¤@¶¥¬qÁ{§É¸ÕÅç¡A·mÀY­»ªº¤¯·sÂåÃħYÄݦ¹Ãþ¡F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/4/7 ¤U¤È 05:46:02²Ä 1651 ½g¦^À³
°k¤£¥X·s«aÅ]´x ¬ã¨sÃn1¡þ3±wªÌ¦AÃz¤j¸£¡Bºë¯«¯e¯f

16:092021/04/07 ¤¤®É·s»Dºô §d¬Mêd

www.chinatimes.com/realtimenews/20210407005104-260408?ctrack=pc_main_recmd_p12&chdtv

¥ý«e¤w¸g¦³¬ã¨s¤Î®×¨Ò«ü¥X¡A·s«a±wªÌ·|¸g¾ú«Üªø¤@¬q®É¶¡ªºÀY¸£´ý¨P¡Bª`·N¤O´î°hµ¥«á¿ò¯g¡A³Ì·s¬ã¨sÅã¥Ü¡A¬V¬Ì«á6­Ó¤ë¤º¾ú¸g³oÃþºë¯«¡B¤j¸£¯e¯fªº±wªÌ¦h¹F1/3¡A¨ä¤¤³Ì±`¥X²{ªº¯gª¬¬°µJ¼{¤Î±¡ºü»Ùê¡C

ºî¦X¸ô³zªÀ¡B¬ü°ê¦³½u¹qµø·s»Dºô¡]CNN¡^³ø¾É¡A­^°ê¡B¬ü°ê¬ã¨s¤H­û¬Q¡]6¡^¤é¦b­^°êÂå¾Ç´Á¥Z¡m¨ë¯Þ°wºë¯«Âå¾Ç¡n¡]Lancet Psychiatry¡^¥Zµn³Ì·s¬ã¨s¡A°lÂܬù23.6¸U¦W¥D­n¥H¬ü°ê¤H¬°¥Dªº·s«a±wªÌ¼Æ¾Ú«á¡Aµo²{°ª¹F34%ªº±wªÌ¦b½T¶E·s«aªÍª¢«áªº6­Ó¤ë¤º¡A¤]¶EÂ_¥X¤F¯«¸g¨t²Î©Îºë¯«¤è­±ªº¤j¸£¯e¯f¡C

¬ã¨s¤H­û¤@¦@°lÂܤF14ºØ¯gª¬¡A¨ä¤¤³Ì±`¶EÂ_¥Xªº¯gª¬¬°µJ¼{¡A¤ñ²v¬°17%¡A¨ä¦¸¬°ºë¯«»Ùê¡A¤ñ²v¹F14%¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/31 ¤W¤È 07:40:39²Ä 1650 ½g¦^À³
Âå¾Ç¬É¼~ ¥i¯à¤@¦~¤º²Ä¤@¥N·s«a¬Ì­]´N·|¥¢®Ä

2021¦~3¤ë30¤é ¶g¤G ¤U¤È8:17

tw.news.yahoo.com/%E9%86%AB%E5%AD%B8%E7%95%8C%E6%86%82-%E5%8F%AF%E8%83%BD%E4%B8%80%E5%B9%B4%E5%85%A7%E7%AC%AC%E4%B8%80%E4%BB%A3%E7%96%AB%E8%8B%97%E5%B0%B1%E6%9C%83%E5%A4%B1%E6%95%88-121721167.html

¬I¥´¬Ì­]¬O¹K¤î·s«aªÍª¢¬Ì±¡ªºÃöÁä¡A­^°ê¡u½Ã³ø¡v³ø¾É¡AÂå¾Ç¬É¾á¼~¡A¥þ²y¥i¯à¥u³Ñ¤@¦~©Î§óµu®É¶¡¡A²Ä¤@¥N¬Ì­]´N·|¥¢®Ä¨Ã«æ»Ý§ï¶i¬Ì­]°t¤è¡C

¤H¥Á¬Ì­]Áp·ù¡]People¡¦s Vaccine Alliance¡^°õ¦æ¤@¶µ²[»\¨Ó¦Û28°ê¦@77¦ì¬ì¾Ç®aªº½Õ¬dÅã¥Ü¡A2/3ªº¨ü³XªÌ«D±`¾á¼~¡A®É¶¡¥i¯à³Ñ¤@¦~©Î§óµu¡A±Nªñ1/3»{¬°¡A¥i¯à¥u³Ñ9­Ó¤ë©Î§óµu¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/30 ¤W¤È 09:59:28²Ä 1649 ½g¦^À³
¤£¤Ó§®°Ú!

¬ü¬Ì±¡¦A´c¤Æ¡ICDC¥D¥ô¼~¡u¥@¬É¥½¤é¡v®£±N¨ì¨Ó

2021-03-30 09:34 Áp¦X³ø / ½sĶ®}·®²[¡þ§Y®É³ø¾É

udn.com/news/story/120944/5353026?from=udn_ch2_menu_v2_main_index

¬ü°êÁ`²Î«ôµn¤é«eªí¥Ü¡A¥þ¬ü¤w±µºØ¹O1»õ¾¯·s«a¬Ì­]¡AÁnºÙ¬Ì­]±µºØ¤j¦¨¥\¡A¦ý¬ü±M®a¥Üĵ¡Aªñ¨Ó¬ü°ê½T¶E®×¨Ò¦A«×«ùÄò¼W¥[¡AÅý¦o¾á¤ß¡u¥@¬É¥½¤é¡v®£±N¨ÓÁ{¡C

¬ü°ê¯e¯fºÞ¨îº[¹w¨¾¤¤¤ß¡]CDC¡^¥D¥ô¥Ë­Û´µ°ò¡]Rochelle Walensky¡^¦b¥Õ®c°OªÌ·|¤¤ªí¥Ü¡A¡u§Ú·Qªí¹F³oªÑ¦b§Ú¤ß¤¤¤£Â_´é²{ªº¥½¤é·P¡A§Ú­Ì¦³«D±`¦hªº²z¥Ñ©ê«ù§Æ±æ¡A¦ý²{¦b§Ú«Ü®`©È¡v¡C

¾ÚCDC²Î­p¡A¤W©P¬ü°ê7¤Ñ¥­§¡ªº¨C¤é½T¶E¼Æ¬ù6¸U¥ó¡A¤ñ«e¤@©P¼W¥[10%¡C¦P¤@®É´Á¡A¨C¤é¦í°|¤H¼Æ¤]±q4600¤H¼W¥[¨ì4800¤H¡C

«ôµn¬F©²29¤é©Ó¿Õ¡A±NÂX¤j±À°Ê¥þ¬ü¬Ì­]±µºØ¡A¨Ãªí¥Ü±q4¤ë19¤é¶}©l¡A90%¦¨¦~¤H±N¯à¶}©l±µºØ¬Ì­]¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/29 ¤W¤È 08:19:40²Ä 1648 ½g¦^À³
°²©w¯u¦p³oºØ¦ô­p , ¤£³×¬°§Ü¯f¬rÃĪ«±a¨Ó¾÷·| , ¦ý¤]¬°¥@¬É«ì´_¥¿±`¥Í¬¡ªº´Á«Ý±a¨ÓÁô¼~

¤£¹L , ­Y¦³ÃĪ«¥i¥H±N»´¯g±wªÌªv¡ , ¤£¦A´c¤Æ¦¨­«¯g , ©Î³\´N¥i§ïÆ[

SNB11 ¥[ªo !

[ ·s«a¬Ì­]«OÅ@¤O¦ô­p±q±µºØ«á¥|¡ã¤»¤ë©úÅã¤U·Æ¡A¥¼¨Ó¨C¥b¦~¡ã¤@¦~´N¥²¶·±µºØ¤@¦¸·s«a¬Ì­]¡F¦ý¥Ø«eªº·s«a¬Ì­]°Æ§@¥Î»P¤£¨}¤ÏÀ³¡B¨Ï¥Î¤£«K§Q¡A²×¨s·|²£¥Í¡u±µºØ¯h¥F¡v®ÄÀ³¡C ]

¸`¿ý¦Û : ¤u°Ó®É³ø 04:10 2021/03/29 §ù¿·»T°OªÌªº³ø¾É

±µºØ¯h¥F®ÄÀ³ °ê²£¬Ì­]¦³±æ¥´¥@¬É¬×

www.chinatimes.com/newspapers/20210329000080-260202?chdtv

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/28 ¤U¤È 06:23:36²Ä 1647 ½g¦^À³
mRNAµo©ú¤H Katalin Karikó ªº¬ãµoÁ}¨¯¾úµ{

¡§mRNA¬Ì­]¤§¥À¡¨¡X¡X±O¤Ò¤§¤k30·³³Qª£¾{³½ 40¦~«á¶ê¹Ú

¨Ó·½¡G EÃĸg²z¤H¡@§@ªÌ¡G Crystal¡@2021-03-28

med.sina.com/article_detail_103_1_98033.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/28 ¤U¤È 12:34:14²Ä 1646 ½g¦^À³
¤ß®®¥ÍÂå¼~Æ{¯g¤Î¦Û±þ¯gª¬·sÃÄ ÀòFDA®Ö­ã¶i¦æ¤G´ÁÁ{§É

2021-03-27 18:27¸gÀÙ¤é³ø °OªÌÁ¬f§»¡þ§Y®É³ø¾É

money.udn.com/money/story/5612/5348298?from=edn_catenewest_story

¤ß®®·sÃĤG´Á¤HÅéÁ{§É¸ÕÅç Àò¬üFDA®Ö­ã

19:542021/03/27 ¤u°Ó §ù¿·»T

www.chinatimes.com/realtimenews/20210327003416-260410?chdtv

ÁÂÁ¨â¤j°]¸g´CÅ骺¤ä«ù

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GÀ³µL©Ò¦í10144738  µoªí®É¶¡:2021/3/26 ¤W¤È 11:31:52²Ä 1645 ½g¦^À³

1.¨Æ¹êµo¥Í¤é:110/03/26

2.¤½¥q¦WºÙ:¤ß®®¥ÍÂåªÑ¥÷¦³­­¤½¥q

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q

4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î

5.µo¥Í½t¥Ñ:

¤½§i¥»¤½¥q¬ãµo¤¤¡BÃøªv«¬¼~Æ{¯g(treatment-resistant depression, TRD)¤Î¨ä¦Û±þ

¯gª¬¤§·sÃÄSNA11¡BÀò¬ü°êFDA®Ö­ã°õ¦æ¤HÅéÁ{§É²Ä¤G´Á¸ÕÅç¡C

(1)¬ãµo¤¤·sÃĦWºÙ©Î¥N¸¹¡GSNA11(Synxyrin)

(2)¥Î³~¡G¥Î©óÃøªv«¬¼~Æ{¯g¤Î¨ä¦Û±þ¯gª¬¤§ªvÀø¡C

(3)¹w­p¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q¡G®Ö­ã°õ¦æ¤G´Á¸ÕÅç¡C

(4)¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q¡G

A.´£¥X¥Ó½Ð/³q¹L®Ö­ã/¤£³q¹L®Ö­ã¡GÃøªv«¬¼~Æ{¯g¤Î¨ä¦Û±þ¯gª¬¤§ªvÀø(SNA11)¡B

Àò­ã°õ¦æ¤HÅéÁ{§É¸ÕÅç¡C

B.¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¤½¥q©Ò­±Á{¤§­·ÀI¤Î¦]À³±¹¬I¡G¤£¾A¥Î¡C

C.¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G±N¨Ì¸ÕÅç­pµe¶i¦æ¤HÅé¸ÕÅç¡C

D.¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G¬°«O»Ù¤½¥q¤Î§ë¸ê¤HÅv¯q¡AÁקK¼vÅT°ê»Ú±ÂÅv½Í§P¡A¤£¤©

¤½¶}´¦ÅS¡C

(5)±N¦A¶i¦æ¤§¤U¤@¬ãµo¶¥¬q¡G±N®Ú¾Ú144¤H¦¸(¤À¬°°ª¾¯¶q²Õ¡B§C¾¯¶q²Õ¡B¦w¼¢¾¯²Õ)

Á{§É¸ÕÅçµ²ªG¡A¿ï¾Ü¸û¨Î¾¯¶q¶i¤J¤T´ÁÁ{§É¸ÕÅç¡C

A.¹w­p§¹¦¨®É¶¡¡GSNA11±N»PSNG12¤T´ÁÁ{§É¸ÕÅç¦@¦P°õ¦æ¡A¹w­p113¦~¥i§¹¦¨Á{§É¸Õ

Åç¡A±©¹ê»Ú®Éµ{±N¨Ì¦¬®×¤H¼Æ¤Î°õ¦æ¶i«×¨M©w¬O§_½Õ¾ã¡C

B.¹w­pÀ³­t¾á¤§¸q°È¡GµL¡C

(6)¥«³õ²{ªp¡G­««×¼~Æ{¯g¬O³Ì¼sªxµo¥Íªººë¯«¯e¯f¡A­««×¼~Æ{¯g¤@¥Íªºµo¥Í²v¬O20.1%

¡A¤]´N¬O¤­¤H¤¤¦³¤@¤H¤@¥Í¤¤·|µo¥Í¦³»Ý­nªvÀøªº­««×¼~Æ{¯g¡C¦ý¬O¥Ñ©ó²{¦³ÃĪ«ªº

¾÷ÂàÃþ¦ü¡A¨ä¤¤30%¥H¤WÄÝ©óÃøªv«¬¼~Æ{¯g(TRD)¡A(TRD«Y«ü¯f¤HªA¥Î¦Ü¤Ö¨âºØ¥H¤W¡B

¨¬°÷¶q¥H¤Î¨¬°÷®É¶¡ªº§ÜÆ{¾¯¦ÓµL¨¬°÷¤ÏÀ³ªº¯f¤H)¡C2019¦~3¤ë¬ü°êFDA®Ö­ã¥v¤W²Ä¡@

¤@­ÓTRDÃĪ«Spravato (Esketamine)¡A¦¨¤À¬°K¥L©R¡A°£¤F¨Ï¥Î©ó³Â¾K¡A¤]ÂkÃþ©ó¦¨

Å}©Êªº¬r«~¡A¦]¤£¨}¤ÏÀ³¤§¬G¡AFDA­n¨D¹ê¬IÃÄ«~­·ÀIµû¦ôº[ºÞ±±­pµe(Risk

Evaluation and Mitigation Strategies, REMS)¡A¯f±w¥u¯à¦b³q¹L»{ÃÒªºÂå°|±µ¨ü

ªvÀø¡AÄY­«¼vÅT¯f¤H¨Ï¥Î·NÄ@¡A¥çÄY­«­­¨î¨ä¾P°â¡CSpravatoÄÝ·s¾÷Âà·sÃÄ¡A¨C¤ëÃÄ

¶O2700¬üª÷¥H¤W¡A»·°ª©ó¦å²M¯À¾÷ÂàÃĪ«ªº400¬üª÷¡A¥i¨£TRDªvÀø¿ï¶µªº¤í¯Ê¡ATRD

¥«³õ¤´ÄÝÄY­«¥¼Àòº¡¨¬¤§ÂåÀø»â°ì¡CSNA11¬ONMDA¨üÅ骺¤¤©Ê«ú§Ü¾¯¡A°£¤FÃøªv«¬¼~

Æ{¯g¡ASNA11ÁÙ°w¹ï¦Û±þ¯gª¬¡A¦Ó¦bTRDªº¦Û±þ¯gª¬¤è­±¥Ø«e¨Ã¨S¦³³Q®Ö­ãªºÃĪ«¡C

6.¦]À³±¹¬I:µL

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï

§ë¸ê­±Á{­·ÀI¡A¥»¤½¥q¤£¹ªÀyµu´Á§ë¸ê¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/23 ¤U¤È 06:47:16²Ä 1644 ½g¦^À³
²{¼W®×©ú¤é½T©w¥Í®Ä

www.sfb.gov.tw/ch/home.jsp?id=95&parentpath=0,2&mcustomize=news_view.jsp&dataserno=202103230001&dtable=News

°ò¥»¤W

¥~¸ê³z¹L¤j¼¯¨é°Ó¦b¥«³õ¶R¶i¤ß®®ªÑ²¼ , §Ú­Ì«D±`«D±`¸Û¼°¦aÅwªï

¤pªº»{¬°¦³¤@­ÓÆ[¹îÂI

¦b²{¼W¹L«á , ­Y¥~¸êÁÙ¬O«ùÄò¶R¶i , ¥i¯à´N§ó¦³À¸¤F !?

¤j®a»{¬°¦p¦ó©O ?

°w¹ï³oÂI , ¹ù¥S¤]´£¥X¬Ýªk

liawbf.pixnet.net/blog/post/49615926

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GSmi10150402  µoªí®É¶¡:2021/3/22 ¤U¤È 09:06:07²Ä 1643 ½g¦^À³
¿³Âd²Ä¤@¤Ñ¶R¶i257¨ì²{¦b¡A´X¥G¨S¦³¬Ý¹L¥~¸ê¶R¶i¡A³Ìªñ´X¤ÑÁÙ³sÄò¶R¡A¬O«ç»ò¤F¶Ü¡H
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/22 ¤W¤È 11:58:59²Ä 1642 ½g¦^À³
¡iAZ¶}¥´¡j10±µºØ¸T§Ò¤@¦¸¬Ý 2ºØ¤H¬O¦å®ê¦MÀI¦]¤l

11:262021/03/22 ¤¤®É·s»Dºô ²ø·¡¶²

www.chinatimes.com/realtimenews/20210322001892-260405?ctrack=pc_main_headl_p01&chdtv

AZ¬Ì­]¤£¬O¤H¤H³£¥i¥H¥´¡A«ü´§¤¤¤ß¤½¥¬ªºAZ¬Ì­]¬I¥´«Øij«ü¥X¡A¦³3ºØ¤H¤£¥i¬I¥´¡A¤À§O¬°18·³¥H¤U«C¤Ö¦~¡B¹ï¬Ì­]©Ò§t¦¨¥÷¡u½á§Î¾¯¡v·|¹L±Óªº¤H¡B¬I¥´²Ä¤@¾¯AZ¬Ì­]«á¥X²{«æ©ÊÄY­«¹L±Ó¤ÏÀ³ªº¤H¡C

«ü´§¤¤¤ß¤]¦C¥X¡A¼È½w¬I¥´AZ¬Ì­]ªÌ¡A¥]¬A«æ©ÊÄY­«¯e¯f¥B¦ñÀHµo¿N©Î«æ©Ê·P¬V¡A²¬Â¡«á¤~¥i±µºØ¡C

«ü´§¤¤¤ß«ü¥X¡A4ºØ¥²¶·¡u¼f·Vµû¦ô¡v¬I¥´ªº¡A«h¬°¦å¤pªO´î¤Ö©Î¥ô¦ó¾®¦å²§±`¡A¦p¦å¤Í¯f¡B§K¬Ì¥\¯à¤£¥þªÌ¡A¥]¬A±µ¨ü§K¬Ì§í¨î¾¯ªvÀø¡BÃh¥¥©Î¬O¥i¯àÃh¥¥¤§¤k©Ê¡B¥¿¦b­÷¨Åªº¤k©Ê¡A¥²¶·¥ÑÂå®vÂÔ·Vµû¦ô¬I¥´®Ä¯q¤Î­·ÀI¡C

¦Ó¼Ú¬w±µºØAZ¬Ì­]«áÀW¶Ç¦å®ê¨Æ¥ó¡A¬Ì±¡«ü´§¤¤¤ß±M®a¤]¯S§O´£¿ô¡AªA¥ÎÁ×¥¥ÃĤΰµ²üº¸»XªvÀøªÌ¥ý¼È½w±µºØ¡C¦]¬°ªA¥ÎÁ×¥¥ÃÄ»P±µ¨ü²üº¸»XªvÀø¬°¤Þ°_¦å®êªº¦MÀI¦]¤l¡C¥t¥~¡A±µºØ¬Ì­]«á­Y14¤Ñ¤º¥X²{©I§l§xÃø¡B¯Ýµh©Î¸¡µh¡B¥|ªÏ¸~µÈ©Î¦B§N¡BÄY­«ÀYµh©Î¯kµh¥[¼@¡Bµø¤O¼Ò½k¡B«ùÄò¥X¦å¡B¥Ö½§¥X²{¦Ûµo©Ê·ï«C¡Bµµ´³µ¥¯gª¬¡AÀ³¥ß§Y´NÂå¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gtnfsh91083510145698  µoªí®É¶¡:2021/3/19 ¤U¤È 07:04:13²Ä 1641 ½g¦^À³
½Ð°Ý¤@¤U¡A¤°»ò®É­Ô¤~·|¦¬¨ì­ì©lªÑªF¼W¸êªÑ¥ÓÁʪºÃº´Ú³æ?ÁÂÁÂ
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/19 ¤W¤È 07:40:40²Ä 1640 ½g¦^À³

§Ú­Ìµo²{ , ³Ìªñ´X¤ÑÄw½X¤Wªº¤p¤pÅÜ¤Æ , §Y¥~¸ê«ùªÑªº¤p´T¼W¥[

³o¬O , ¤ß®®²{¼WªºÃö«Y , ÁÙ¬O¥t¦³¥L·N

´NÅý§Ú­ÌÄ~Äò°lÂÜ

www.tpex.org.tw/web/emergingstock/historical/daily/EMdss005.php?l=zh-tw&f=EMdss005.20210312-C.csv

www.tpex.org.tw/web/emergingstock/historical/daily/EMdss005.php?l=zh-tw&f=EMdss005.20210318-C.csv

6575¤ß®® 19,320,926 ( ªÑ )

6575¤ß®® 19,413,926 ( ªÑ )

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/13 ¤U¤È 05:48:06²Ä 1639 ½g¦^À³
¦³ªÑªF±¼¥X 400 ±i«ùªÑ¤§ªL

norway.twsthr.info/StockHolders.aspx?stock=6575

§Æ±æ¬O¥L ?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/12 ¤W¤È 08:08:48²Ä 1638 ½g¦^À³
¥´AZ¬Ì­]«áÄY­«¦å®ê ¥_¼Ú3°ê¼È°±±µºØ

07:392021/03/12 ¤¤¥¡ªÀ

www.chinatimes.com/realtimenews/20210311006354-260405?ctrack=pc_main_headl_p03&chdtv

¤¦³Á¡B®¿«Â¤Î¦B®q¤µ¤Ñ«Å¥¬¼È®É°±¥Îªü´µ¯S±¶§Q±d¡]AstraZeneca¡^¬Ì­]¡A¦]¬°³¡¤À2019«aª¬¯f¬r¯e¯f¡]COVID-19¡^±wªÌ±µºØ³o¤ä¬Ì­]«á¥X²{¦å®ê¡A¤Þµo¦U¬É¾á¼~¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/10 ¤U¤È 08:04:18²Ä 1637 ½g¦^À³
¤£¥u¤¤®É·s»Dºô¥Zµn

Áp¦X·s»Dºô¤]¦³³ø¾É³á¡I

¤ß®®¥ÍÂå¨âºë¯«¤Àµõ·sÃÄ ÀòTFDA®Ö­ã¶i¦æ¤G¡þ¤T´ÁÁ{§É

2021-03-10 13:59¸gÀÙ¤é³ø °OªÌÁ¬f§»¡þ§Y®É³ø¾É

money.udn.com/money/story/5612/5307862?from=edn_catenewest_story

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GE6410149118  µoªí®É¶¡:2021/3/10 ¤U¤È 02:46:56²Ä 1636 ½g¦^À³
¤ß®®ªvºë¯«¤Àµõ¯g·sÃÄ Àò¥xÆW½ÃºÖ³¡®Ö­ã°õ¦æ²Ä¤G(b)¡þ¤T´ÁÁ{§É¸ÕÅç

www.chinatimes.com/realtimenews/20210310002644-260410?chdtv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/8 ¤W¤È 08:10:01²Ä 1635 ½g¦^À³
³o­Ó¼Æ¦r¦³ÂI¥i©È

ªñ¥|¤À¤§¤@°ê¤¤¥Í©M¤­¤À¤§¤@±j°ª¤¤¥Í»{¯u¦Ò¼{¹L¦Û±þ

¸ê®Æ¨Ó·½ : ½ÃºÖ³¡°ê°·¸p°·±d¦æ¬°½Õ¬d³ø§i

newmedia.udn.com.tw/2021/teenage_depression/?utm_source=udn&utm_medium=banner&utm_campaign=udn_website

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/8 ¤W¤È 06:58:07²Ä 1634 ½g¦^À³
«C¤Ö¦~¬°¦ó¨«¤Wµ´¸ô ºë¯«°·±d¦¨¬°¥D¦]

2021-03-08 02:16 Áp¦X³ø / °OªÌ¬xªY·O¡B´å©þ¯Ð¡B±i瀞¤å¡þ¥x¥_³ø¾É

udn.com/news/story/122028/5301670?from=udn_ch2_menu_v2_main_index

¾Ú½ÃºÖ³¡²Î­p¡A¤Q¤­¨ì¤Ü¥|·³¦]¦Û±þ¦º¤`ªº¤H¼Æ¤w³s¤T¦~¼W¥[¡C¤G¡³¤@¤E¦~²Î­p¡A»W·N¦Û§Ú¶Ë®`¡]¦Û±þ¡^¬O¤Q¤­¨ì¤Ü¥|·³±Ú¸s²Ä¤G¤j¦º¦]¡A¤Ê·³¥H¤UªA¥Î§Ü¼~Æ{ÃĪ«ªº¤H¼Æ³v¦~¼W¥[¡A±q¤G¡³¡³¤E¦~ªº¤QÂI¤»¸U¤H¼W¥[¨ì¤G¡³¤@¤E¦~ªº¤Q¤»ÂI¤G¸U¡A¼~Æ{¯gµ¥ºë¯«°·±d°ÝÃDªñ¦~¦¨¬°«C¤Ö¦~¨«¤Wµ´¸ô¥D¦]¤§¤@¡C

°ª«×ªº§lµÒ¨Ì¿à©Ê©M§íÆ{¯gªºµo¥Í¦³Ãö

www.genetinfo.com/international-news/item/46122.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2021/3/2 ¤W¤È 07:23:54²Ä 1633 ½g¦^À³
·sÃĪѥXÀY¤Ñ 2021¥þ­±¦¬³Î

04:10 2021/03/02 ¤u°Ó®É³ø §ù¿·»T

www.chinatimes.com/newspapers/20210302000184-260204?chdtv

¬Q©]¥Ñ¨È·à±d ( ASLN )ªíºt , ªÑ»ù½L¤¤¤Wº¦¶W¹L 50 % , ¨ì¬ü°ê±¾µP¤w¥Ñ 1 ¶ô¦h¬ü¤¸ , ¤Wº¦¨ì¤µ¤é¦¬½Lªº 5.25 ¬ü¤¸

¤µ¤é¥i¯à½ü¥Ñ¥_·¥¬PÃÄ·~ªíºt

¤ß®®¤]¤£®t§r ! ¦ó®É½ü¥Ñ§Ú­Ìªí²{ ?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
¤W¤@­¶12345678910¤U¤@­¶³Ì«á¤@­¶

         

¡@

§Ú¡@¡@­n¡@¡@¦^¡@¡@À³¡@¡@¥»¡@¡@¸Ü¡@¡@ÃD

·| ¡@­û¡G

  

§@ ªÌ ¡G

 

¬ÛÃöªÑ²¼¤½¥q¦WºÙ ¡G

¤ß®®¥ÍÂå

¤º¡@ ®e¡G

¡@
½Ð¥ýµn¤J ­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹ ¡@
¡@

°Q½×°Ï¬ÛÃö³W©w¡G
    1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
    2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C


¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178   ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѠ ¬ÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ  ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß  ¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!